{
  "mode": "prepared_offline",
  "modelCalls": 0,
  "samples": [
    {
      "task": "R42581103",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 3
        },
        {
          "id": "H2",
          "hypothesisIndex": 2
        },
        {
          "id": "H3",
          "hypothesisIndex": 4
        },
        {
          "id": "H4",
          "hypothesisIndex": 0
        },
        {
          "id": "H5",
          "hypothesisIndex": 1
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nIntestinal stem-cell function and regenerative capacity decline with age, compromising maintenance and repair of the intestinal epithelium. Both cell-intrinsic changes and signals from the aged systemic environment may contribute to this decline. Chronic inflammation and altered cellular metabolism are common features of ageing, but how circulating conditions are translated into functional defects in intestinal regeneration was unresolved. It was also unclear whether manipulating systemic or metabolic processes could preserve or restore aged stem-cell activity.\n\nRESEARCH QUESTION\nHow does the aged systemic environment causally impair intestinal stem-cell metabolism and regenerative function?\n\nHYPOTHESES\n[H1] Elevated circulating kynurenine in aged animals persistently activates aryl hydrocarbon receptor signaling in intestinal stem cells, reducing their capacity to use fatty acids for regeneration. Mechanism: Sustained kynurenine–aryl hydrocarbon receptor signaling represses the PPAR-regulated fatty-acid oxidation program, limiting mitochondrial substrate flexibility during regenerative proliferation. Prediction: Kynurenine at concentrations measured in aged plasma reproduces reduced fatty-acid oxidation and regenerative output; stem-cell aryl hydrocarbon receptor deletion prevents both effects despite equivalent kynurenine exposure.\n\n[H2] An age-associated increase in circulating saturated fatty acids impairs intestinal stem cells through ceramide accumulation rather than through inflammatory cytokines alone. Mechanism: Excess saturated fatty acids drive de novo ceramide synthesis in stem cells, disrupting mitochondrial membrane function and increasing reactive oxygen species sufficiently to impair self-renewal. Prediction: The lipid fraction of aged serum reproduces the metabolic and regenerative defects, whereas lipid depletion removes them; inhibiting stem-cell ceramide synthesis rescues function even when aged-serum cytokines remain present.\n\n[H3] The aged systemic environment impairs intestinal stem-cell metabolism primarily by disrupting metabolic support from Paneth cells. Stem-cell defects therefore arise secondarily from an altered local niche. Mechanism: Circulating inflammatory factors suppress Paneth-cell glycolysis and lactate export, reducing the supply of lactate available for oxidation by neighboring intestinal stem cells. Prediction: Paneth cells exposed to aged serum impair otherwise untreated young stem cells after serum washout, with reduced transfer of isotope-labeled lactate into stem-cell mitochondrial metabolites; restoring Paneth-cell lactate export rescues regeneration.\n\n[H4] Elevated circulating TNF in aged animals impairs intestinal regeneration by suppressing mitochondrial pyruvate oxidation in intestinal stem cells. This metabolic restriction directly limits their expansion after injury. Mechanism: TNF activates stem-cell TNFR1–NF-κB signaling, increasing pyruvate dehydrogenase kinase activity and inhibitory phosphorylation of pyruvate dehydrogenase, thereby reducing glucose-derived carbon entry into the tricarboxylic acid cycle. Prediction: Aged serum reduces glucose-derived mitochondrial carbon flux and organoid formation; stem-cell-specific TNFR1 deletion or blockade of pyruvate dehydrogenase inhibition restores both despite continued exposure to aged serum.\n\n[H5] Chronic exposure to circulating interferons in old age depletes intestinal stem-cell NAD+ and thereby compromises mitochondrial function and regeneration. Mechanism: Sustained interferon signaling induces oxidative DNA damage and PARP-dependent NAD+ consumption, reducing NAD+-dependent mitochondrial enzyme activity and respiratory capacity. Prediction: Aged serum increases stem-cell PARylation before NAD+ and respiration decline; interferon-receptor deletion or selective suppression of PARP activity prevents these changes and restores regeneration without correcting circulating lipid or nutrient levels.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4604,
          "promptSha256": "97531535af651dcf20a8ce342340ed554be0e5904aa56b1767e93990676052cb"
        }
      ]
    },
    {
      "task": "R42601407",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 1
        },
        {
          "id": "H2",
          "hypothesisIndex": 3
        },
        {
          "id": "H3",
          "hypothesisIndex": 4
        },
        {
          "id": "H4",
          "hypothesisIndex": 2
        },
        {
          "id": "H5",
          "hypothesisIndex": 0
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nOvarian ageing progressively reduces fertility, disrupts endocrine function and contributes to later-life disease risk. This decline involves losses in follicle quantity and quality as well as deterioration of the ovarian tissue environment. Although lifestyle and systemic metabolic factors have been associated with reproductive ageing, the causal mechanisms connecting them to ovarian function remain poorly understood. No approved treatment currently delays ovarian ageing or reliably extends reproductive lifespan.\n\nRESEARCH QUESTION\nThrough what molecular mechanism does physical activity delay ovarian ageing and extend reproductive lifespan?\n\nHYPOTHESES\n[H1] Physical activity delays ovarian ageing through muscle-derived irisin, which suppresses profibrotic activation of ovarian stromal fibroblasts. Preserving a compliant extracellular matrix supports follicle survival and sustained reproductive function. Mechanism: Exercise-induced irisin engages αV-containing integrins on ovarian fibroblasts and attenuates TGF-β–SMAD2/3 signalling. Reduced myofibroblast differentiation and collagen deposition limit tissue stiffening and secondary follicular injury. Prediction: Adult muscle-specific Fndc5 deletion should eliminate exercise-associated reductions in ovarian fibrosis and reproductive decline despite comparable training adaptations. Physiological irisin replacement should restore these effects, while fibroblast-restricted disruption of the relevant integrin should prevent rescue.\n\n[H2] Physical activity delays ovarian ageing by repeatedly stimulating endothelial KLF2–eNOS signalling, preserving ovarian microvascular function. Improved perfusion reduces hypoxic injury to growing follicles and maintains steroidogenic capacity. Mechanism: Exercise-associated changes in ovarian vascular shear activate endothelial KLF2 and NOS3, increasing nitric-oxide availability and stabilizing capillary function. Sustained oxygen delivery limits hypoxia-associated oxidative damage and follicular atresia. Prediction: Exercise should improve ovarian perfusion before measurable preservation of follicle survival. Ovarian endothelial Klf2 or Nos3 disruption should prevent these benefits despite intact muscle-derived signals, whereas local restoration of endothelial nitric-oxide signalling should reproduce them in sedentary animals.\n\n[H3] Physical activity delays loss of oocyte quality through circulating apelin acting on granulosa-cell APLNR to enhance mitochondrial quality control. Better granulosa-cell metabolism sustains oocyte developmental competence at older reproductive ages. Mechanism: Exercise-associated apelin activates granulosa-cell AMPK and PINK1–Parkin-dependent mitophagy, removing damaged mitochondria and reducing mitochondrial reactive oxygen species. Improved metabolic support protects the enclosed oocyte from cumulative oxidative injury. Prediction: Adult granulosa-cell Aplnr deletion should abolish exercise-associated increases in mitophagic flux and late-age embryo competence despite preserved vascular and insulin responses. Apelin should reproduce the benefit in sedentary animals, with rescue blocked by granulosa-cell Pink1 deletion.\n\n[H4] Repeated exercise-associated lactate pulses delay ovarian ageing by activating HCAR1 in ovarian macrophages and reducing inflammasome-mediated follicular damage. The benefit depends on transient lactate signalling rather than chronically elevated lactate. Mechanism: Lactate–HCAR1 signalling reduces macrophage NF-κB priming and NLRP3 inflammasome activation, lowering local IL-1β production. Reduced inflammatory signalling limits granulosa-cell injury and follicular atresia. Prediction: Inducible macrophage Hcar1 deletion should abolish exercise-induced reductions in ovarian caspase-1 activation, IL-1β and atresia while preserving systemic metabolic improvements. Lactate pulses matched to exercise exposure should reproduce the ovarian benefit in sedentary controls but fail in the deletion group.\n\n[H5] Moderate physical activity delays ovarian ageing by lowering chronic insulin exposure and preventing excessive primordial-follicle activation. This preserves the follicle reserve through reduced oocyte PI3K–AKT signalling and sustained nuclear FOXO3. Mechanism: Improved skeletal-muscle insulin sensitivity reduces compensatory hyperinsulinaemia, decreasing insulin-receptor signalling in primordial oocytes. Reduced AKT-mediated FOXO3 phosphorylation maintains follicle dormancy and slows reserve depletion. Prediction: In initially hyperinsulinaemic mice, exercise should reduce primordial-oocyte AKT phosphorylation, retain nuclear FOXO3 and extend the age of last successful reproduction. Maintaining sedentary-range insulin exposure during training under matched glycaemia should abolish these benefits, whereas lowering insulin in sedentary animals should reproduce them.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5515,
          "promptSha256": "6ddc5f12c9a2a45fe06cf21013315897c0944515c9200a7d19fa4f57c81e9291"
        }
      ]
    },
    {
      "task": "R42605193",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 4
        },
        {
          "id": "H2",
          "hypothesisIndex": 1
        },
        {
          "id": "H3",
          "hypothesisIndex": 2
        },
        {
          "id": "H4",
          "hypothesisIndex": 3
        },
        {
          "id": "H5",
          "hypothesisIndex": 0
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nCellular senescence increases with age and can disrupt tissue function through persistent changes in cell state and signaling. Metabolic dysfunction and chronic inflammation are closely associated with this process and with broader age-related deterioration. Circulating factors can coordinate physiological changes across organs, but it remains unclear which factors actively cause senescence rather than merely correlate with ageing. Identifying the responsible signals and their intracellular mechanisms could reveal targets for extending healthspan.\n\nRESEARCH QUESTION\nWhich circulating regulator causally promotes cellular senescence and organismal ageing, and through what intracellular signaling mechanism does it act?\n\nHYPOTHESES\n[H1] Elevated lipoprotein-associated C16:0 ceramide acts as a circulating driver of cellular senescence and accelerates organismal functional decline. Mechanism: Delivery of C16:0 ceramide to recipient cells increases mitochondrial ceramide, impairs respiratory function and raises mitochondrial reactive oxygen species. Subsequent DNA damage activates p53–p21 and persistent senescence. Prediction: Lipoproteins enriched with C16:0 ceramide at age-relevant concentrations induce persistent senescence more strongly than otherwise matched particles containing very-long-chain ceramides; recipient-cell mitochondrial ceramide clearance prevents this effect and protects tissue function during chronic exposure.\n\n[H2] Circulating ANGPTL2 drives endothelial senescence and thereby accelerates vascular and systemic ageing. Its effects require sustained inflammatory signaling within endothelial cells. Mechanism: ANGPTL2 engages integrin α5β1 and activates Rac1-dependent oxidative stress and NF-κB signaling. The resulting persistent DNA-damage response activates p53–p21 and reinforces inflammatory secretion. Prediction: Selective depletion of ANGPTL2 from aged plasma reduces its senescence-inducing activity in endothelial cultures, and physiological add-back restores it; endothelial disruption of integrin α5β1 signaling blocks the response.\n\n[H3] Elevated circulating CCL11 directly induces senescence in susceptible neural progenitor cells, contributing to age-associated loss of neurogenesis and cognitive function. Mechanism: CCL11 activates progenitor-cell CCR3, increasing intracellular calcium and NADPH-oxidase-dependent reactive oxygen species. Persistent oxidative DNA damage engages ATM–p53–p21 signaling and stabilizes senescence. Prediction: Exposure to age-relevant CCL11 concentrations produces persistent arrest and multiple senescence features in purified neural progenitors; progenitor-specific CCR3 deletion preserves neurogenesis and cognition during chronic exposure without reducing systemic CCL11.\n\n[H4] Chronically elevated circulating resistin promotes senescence in human vascular and adipose stromal cells, linking metabolic inflammation to tissue ageing. Mechanism: Resistin activates a TLR4-dependent signaling pathway involving MyD88, NF-κB and mitochondrial oxidative stress. Sustained signaling establishes p38–p16–RB-mediated arrest and an inflammatory secretory feedback loop. Prediction: Resistin depletion from aged human plasma reduces persistent senescence in human vascular and adipose tissue models, while physiological add-back restores it; TLR4 deletion prevents the response. Neutralization also improves tissue function in a model expressing human resistin.\n\n[H5] Age-associated elevation of circulating activin A causally promotes senescence in tissue stromal cells and accelerates functional decline. Sustained exposure converts a reversible stress response into stable cell-cycle arrest. Mechanism: Activin A activates ACVR2A/ACVR2B–ACVR1B receptor complexes and SMAD2/3 signaling, inducing p15 and p21. Prolonged signaling establishes persistent arrest and a senescence-associated secretory phenotype. Prediction: Maintaining circulating activin A at concentrations measured in old animals induces persistent senescence and functional impairment in young animals; stromal-cell-specific ACVR1B deletion prevents these effects despite equivalent circulating exposure.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4790,
          "promptSha256": "97a634f7d226287f3c7dc6c1b25456f50ff39e9ad9da5385ae9d76aef4c89139"
        }
      ]
    },
    {
      "task": "R42608398",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 3
        },
        {
          "id": "H2",
          "hypothesisIndex": 2
        },
        {
          "id": "H3",
          "hypothesisIndex": 1
        },
        {
          "id": "H4",
          "hypothesisIndex": 0
        },
        {
          "id": "H5",
          "hypothesisIndex": 4
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nIdiopathic pulmonary fibrosis is a progressive, age-associated disorder characterized by recurring tissue injury and excessive fibrotic remodeling. Abnormal cell-fate programs, including apoptosis, senescence, and phenotypic transitions, are thought to contribute to disease progression. Changes in the lung microbiota have also been associated with disease severity, but association alone has not established a direct pathogenic mechanism. It remained unclear whether a microbiota-derived product could independently initiate the cellular dysfunction and progressive fibrosis observed in this disease.\n\nRESEARCH QUESTION\nCan a microbiota-derived factor directly cause the cellular dysfunction and progressive tissue remodeling characteristic of idiopathic pulmonary fibrosis, and if so, through what mechanism?\n\nHYPOTHESES\n[H1] Extracellular bacterial DNA directly sustains profibrotic alveolar macrophage activity through TLR9 signaling, initiating remodeling without requiring primary epithelial toxicity. Mechanism: Internalized bacterial CpG-rich DNA activates macrophage TLR9–MyD88 signaling, increasing production of TGF-β and other fibroblast-activating mediators. Repeated exposure maintains myofibroblast differentiation and matrix accumulation. Prediction: Endotoxin-free bacterial DNA activates fibroblasts in macrophage-containing cultures but has little effect on epithelial-only cultures. Macrophage-specific TLR9 deletion prevents fibrosis after repeated pulmonary DNA exposure, whereas epithelial apoptosis blockade provides limited protection.\n\n[H2] A lung microbiota-derived pore-forming toxin, such as pneumolysin, drives fibrosis through sublethal disruption of alveolar epithelial differentiation. Mechanism: Repeated membrane injury and calcium influx activate epithelial TGF-β signaling, trapping alveolar type II cells in a persistent transitional state instead of allowing maturation into functional alveolar type I cells. These arrested cells sustain fibroblast activation through paracrine signaling. Prediction: Sublethal purified toxin produces persistent transitional epithelial cells and fibrosis with limited apoptosis. A pore-deficient toxin fails to do so, while epithelial TGF-β receptor inhibition restores differentiation and reduces fibrosis despite equivalent initial membrane injury.\n\n[H3] Bacterial outer-membrane vesicles directly induce persistent senescence in alveolar epithelial progenitors, producing fibrosis through their senescence-associated secretory phenotype. Mechanism: Vesicle uptake delivers bacterial cargo that causes mitochondrial oxidative stress and persistent DNA damage, activating p53–p21 and p16–RB growth arrest. Senescent epithelial cells release mediators that impair regeneration and activate neighboring fibroblasts. Prediction: Purified vesicles induce durable epithelial growth arrest after exposure ends, and conditioned medium from these cells activates fibroblasts. Selective clearance of senescent epithelial cells after vesicle exposure suppresses subsequent fibrosis without changing the initial vesicle burden.\n\n[H4] A microbiota-derived proapoptotic peptide, such as corisin, initiates pulmonary fibrosis by repeatedly killing alveolar type II epithelial cells. Sustained peptide exposure causes epithelial loss faster than regenerative replacement. Mechanism: The peptide activates mitochondrial apoptosis in alveolar type II cells, compromising alveolar repair and promoting profibrotic signaling that activates fibroblasts and increases extracellular matrix deposition. Prediction: Purified peptide at concentrations measured in diseased lungs induces epithelial apoptosis before progressive collagen accumulation in microbiota-free experimental models. Peptide neutralization or epithelial-specific inhibition of mitochondrial apoptosis prevents both effects despite equivalent exposure.\n\n[H5] A secreted microbial protease initiates progressive fibrosis by releasing active TGF-β from latent extracellular stores in the alveolar matrix. Mechanism: Proteolytic cleavage of the latent TGF-β complex activates fibroblast SMAD2/3 signaling and myofibroblast differentiation. Subsequent matrix stiffening supports continued host-mediated TGF-β activation after microbial protease exposure ends. Prediction: Purified protease activates TGF-β in an acellular lung-matrix preparation and induces contraction and collagen production when fibroblasts are subsequently added. Catalytically inactive protease fails, and TGF-β neutralization blocks the response even in the absence of epithelial or immune cells.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5221,
          "promptSha256": "8d8efa2842b0d838f31c8d0117be1365b5e3f43ee7fd69163e4ee07cbc769dcb"
        }
      ]
    },
    {
      "task": "R42627902",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 1
        },
        {
          "id": "H2",
          "hypothesisIndex": 2
        },
        {
          "id": "H3",
          "hypothesisIndex": 3
        },
        {
          "id": "H4",
          "hypothesisIndex": 0
        },
        {
          "id": "H5",
          "hypothesisIndex": 4
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing alters blood-cell production, commonly shifting lineage output and reducing regenerative balance. These changes can contribute to anemia, impaired immunity, and abnormal clotting in older organisms. Age-related transcriptional and epigenetic remodeling has been implicated, but the regulators that causally connect altered gene programs to lineage imbalance remain incompletely understood. Identifying such regulators could reveal ways to restore healthier blood production during ageing.\n\nRESEARCH QUESTION\nWhich regulatory mechanism drives the age-associated shift away from erythroid differentiation and toward platelet-producing lineage programs?\n\nHYPOTHESES\n[H1] Chronic IL-1 signaling instructs aged hematopoietic stem cells to enter a megakaryocyte-primed state, reducing their contribution to erythropoiesis. Mechanism: Persistent IL-1R–MYD88–NF-κB signaling increases accessibility and activity of megakaryocytic regulatory elements before lineage commitment, favoring subsequent platelet-producing differentiation. Prediction: Inducible hematopoietic Il1r1 deletion in aged animals shifts the output of individual multipotent clones toward erythroid cells despite an unchanged aged niche. Sustained downstream NF-κB activation prevents this rescue.\n\n[H2] Age-dependent failure of TET2-mediated DNA demethylation selectively silences erythroid commitment enhancers, allowing megakaryocytic programs to dominate. Mechanism: Reduced TET2 recruitment or catalytic activity causes methylation to accumulate at KLF1 and other erythroid regulatory elements, limiting erythroid transcription while preserving competing megakaryocytic programs. Prediction: Targeted demethylation of the affected erythroid enhancers restores erythroid differentiation in aged progenitors without lowering inflammatory signaling. Catalytically inactive targeting constructs fail, and targeted remethylation recreates the bias in young cells.\n\n[H3] Reduced heme availability in aged progenitors stabilizes BACH1 and creates an erythroid-specific transcriptional barrier that redirects bipotent cells toward megakaryocytes. Mechanism: Insufficient heme-dependent BACH1 inactivation sustains repression of erythroid maturation genes, weakening erythroid commitment relative to an available megakaryocytic program. Prediction: BACH1 deletion restores erythroid fate allocation under low-heme conditions, whereas a heme-insensitive BACH1 variant blocks rescue by heme supplementation. Single-cell lineage tracing demonstrates fate redirection rather than merely improved survival of existing erythroblasts.\n\n[H4] Ageing increases FLI1 activity relative to KLF1 in progenitors retaining both erythroid and megakaryocytic potential, redirecting their differentiation toward platelet-producing megakaryocytes. Mechanism: Increased FLI1 occupancy favors megakaryocytic regulatory elements and antagonizes the KLF1-dependent erythroid program, changing how shared factors such as GATA1 activate lineage-specific genes. Prediction: Partial FLI1 suppression in aged, clonally tracked bipotent progenitors restores erythroid output at the expense of megakaryocytic output without selectively killing megakaryocytic cells. KLF1 suppression abolishes this rescue.\n\n[H5] Ageing increases MPL receptor signaling sensitivity in megakaryocyte-primed stem cells, selectively expanding their contribution to blood production and thereby reducing the relative erythroid contribution. Mechanism: Reduced expression of the signaling inhibitor LNK, encoded by SH2B3, amplifies thrombopoietin–MPL–JAK2–STAT5 signaling and preferentially maintains or expands platelet-biased clones. Prediction: Restoring physiological LNK expression in aged stem cells normalizes thrombopoietin responses and reduces the abundance of platelet-biased clones. Clonal tracking shows altered clone contributions with little change in each clone's intrinsic lineage preference, distinguishing selection from fate reprogramming.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4604,
          "promptSha256": "145c4ddff48d7512e894740dc767d2df04a10153c97edf7bfed9d5f43096b48f"
        }
      ]
    },
    {
      "task": "R42630044",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 4
        },
        {
          "id": "H2",
          "hypothesisIndex": 2
        },
        {
          "id": "H3",
          "hypothesisIndex": 1
        },
        {
          "id": "H4",
          "hypothesisIndex": 3
        },
        {
          "id": "H5",
          "hypothesisIndex": 0
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nMechanical loading normally stimulates bone formation and helps maintain skeletal strength. This anabolic response becomes weaker with age, contributing to cortical bone loss and osteoporosis risk. Bone cells detect physical forces and translate them into signals that regulate the balance between bone formation and resorption. The molecular defect responsible for diminished mechanosensitivity in aged bone, and whether it can be overcome, remained unclear.\n\nRESEARCH QUESTION\nWhat mechanism limits the anabolic response of aged bone to mechanical loading, and can targeted stimulation restore this response?\n\nHYPOTHESES\n[H1] Senescent cells in the aged bone microenvironment suppress the osteoblast progenitor response to mechanically stimulated osteocytes. Removing these cells restores loading-induced bone formation. Mechanism: Senescence-associated inflammatory factors inhibit progenitor proliferation and osteogenic differentiation downstream of otherwise adequate osteocyte mechanotransduction. Prediction: Conditioned medium from senescent bone cells suppresses osteogenesis driven by mechanically stimulated osteocytes. Selective senescent-cell clearance restores loading-induced progenitor expansion and cortical formation without materially changing early osteocyte calcium signals.\n\n[H2] Aged osteocytes detect loading but fail to release sufficient prostaglandin E2 because connexin-43 hemichannel opening is impaired. Selective stimulation of the downstream EP4 receptor restores the anabolic response. Mechanism: Defective connexin-43-dependent prostaglandin release interrupts paracrine signaling between mechanically stimulated osteocytes and bone-forming cells. Prediction: Aged bone retains early loading-induced calcium signals but exhibits reduced extracellular prostaglandin E2. Local EP4 agonism restores the incremental bone-formation response to loading, whereas increasing calcium entry alone does not.\n\n[H3] Ageing disrupts osteocyte pericellular matrix attachments, reducing force transmission from load-induced fluid flow to otherwise functional mechanosensors. Direct stimulation of downstream mechanosensors bypasses this physical coupling defect. Mechanism: Loss of pericellular tethering structures reduces membrane deformation and integrin engagement during loading without intrinsically impairing the downstream anabolic signaling machinery. Prediction: Aged osteocytes respond poorly to fluid flow but retain responses to direct membrane deformation or pharmacological channel activation. Restoring pericellular attachments rescues flow responses without increasing mechanosensor abundance.\n\n[H4] Persistent sclerostin expression in aged osteocytes prevents mechanical loading from activating sufficient Wnt signaling in osteoblast-lineage cells. Sclerostin neutralization restores responsiveness to loading. Mechanism: An age-associated failure to repress Sost maintains inhibition of LRP5/6-mediated Wnt signaling despite intact upstream mechanical sensing. Prediction: Aged bone shows normal early calcium and prostaglandin responses but fails to suppress Sost or activate osteoblastic Wnt targets. Sclerostin neutralization restores the additional formation attributable to loading, beyond its effect in unloaded bone.\n\n[H5] Age-related loss of functional PIEZO1 channels in osteocytes reduces mechanically evoked calcium signals and limits loading-induced bone formation. Pharmacological sensitization of residual PIEZO1 restores the anabolic response. Mechanism: Reduced PIEZO1 activity weakens calcium-dependent signaling that normally suppresses sclerostin and activates osteoblast-supporting Wnt signaling. Prediction: At matched tissue strain, aged bone shows reduced osteocyte calcium responses; a PIEZO1 agonist restores both these responses and loading-induced cortical bone formation, with rescue abolished by osteocyte-specific Piezo1 deletion.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4533,
          "promptSha256": "441f697161750535d17a6e2a08388878732dffe55ef054e26e9678da80ea1b09"
        }
      ]
    },
    {
      "task": "R42639736",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 0
        },
        {
          "id": "H2",
          "hypothesisIndex": 3
        },
        {
          "id": "H3",
          "hypothesisIndex": 2
        },
        {
          "id": "H4",
          "hypothesisIndex": 4
        },
        {
          "id": "H5",
          "hypothesisIndex": 1
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nPersistent DNA damage responses contribute to cellular senescence and age-related loss of tissue function. Disturbances in intracellular homeostasis can promote genomic stress through several mechanisms, including metabolic dysfunction and impaired cell-cycle control. Communication between organelles is increasingly recognized as an important regulator of stress responses during ageing. However, the causal mechanisms connecting disrupted cellular homeostasis to DNA damage in senescent cells remain incompletely understood.\n\nRESEARCH QUESTION\nWhat molecular mechanism links disrupted intracellular homeostasis to DNA damage and senescence?\n\nHYPOTHESES\n[H1] Loss of lysosomal acidity initiates senescence by redistributing redox-active iron from lysosomes to the nucleus. Nuclear iron converts basal hydrogen peroxide into locally damaging radicals, producing persistent DNA lesions. Mechanism: Impaired lysosomal acidification disrupts iron sequestration and promotes lysosomal membrane permeabilization. Released labile iron accumulates near chromatin, driving oxidative base damage and strand breaks that activate the ATM–p53–p21 pathway. Prediction: Lysosomal deacidification should precede increased nuclear labile iron and DNA damage. A nucleus-targeted iron chelator should suppress DNA lesions and durable cell-cycle arrest despite continued lysosomal dysfunction, whereas an equivalent mitochondria-targeted chelator should provide substantially less protection.\n\n[H2] Defective RNA-processing homeostasis induces senescence by allowing persistent RNA–DNA hybrids to accumulate at transcribed genes. These hybrids create transcription–replication conflicts that generate DNA breaks. Mechanism: Disrupted assembly or nuclear localization of RNA-processing factors impairs cotranscriptional RNA packaging. Persistent R-loops obstruct replication forks, generating ATR activation, fork collapse, and a sustained senescence-associated DNA damage response. Prediction: RNA-processing disruption should increase RNase H-sensitive hybrids before DNA breaks, with damage enriched at highly transcribed loci. Nuclear expression of catalytically active RNase H1, but not an inactive control, should reduce locus-associated damage and durable arrest without restoring the broader RNA-processing defect.\n\n[H3] Mitochondrial metabolic dysfunction causes senescence by limiting aspartate-dependent nucleotide synthesis rather than primarily by increasing oxidants. Resulting nucleotide insufficiency converts ordinary DNA replication into persistent genomic stress. Mechanism: Impaired mitochondrial electron transport restricts aspartate production and de novo nucleotide synthesis. Depleted or imbalanced deoxynucleotide pools slow replication forks, promote fork collapse, and engage ATR–CHK1 followed by sustained p53–p21 signaling. Prediction: In proliferating cells, nucleotide depletion should precede replication-fork slowing and DNA breaks. Balanced deoxynucleoside supplementation should restore fork progression and reduce subsequent senescence despite persistent mitochondrial dysfunction, whereas mitochondrial antioxidant treatment should fail if nucleotide pools remain depleted.\n\n[H4] Disrupted membrane-lipid homeostasis promotes senescence by making the nuclear envelope susceptible to repeated rupture. Rupture exposes chromatin to cytoplasmic nucleases and transiently depletes nuclear repair factors, allowing DNA damage to accumulate. Mechanism: Altered endoplasmic-reticulum phospholipid composition propagates to the continuous nuclear envelope and weakens its mechanical resilience. Under actomyosin tension, envelope rupture permits TREX1 access to chromatin and loss of repair-factor compartmentalization, producing persistent strand breaks. Prediction: Live-cell imaging should show nuclear-envelope rupture preceding DNA damage after lipid-homeostasis perturbation. TREX1 deletion should reduce rupture-associated breaks and senescence while leaving the lipid abnormality and rupture frequency largely unchanged; restoring envelope stability should prevent both rupture and damage.\n\n[H5] Excessive calcium transfer from the endoplasmic reticulum to mitochondria drives senescence through mitochondrial oxidant production. This mechanism links disturbed calcium homeostasis to persistent nuclear DNA damage. Mechanism: Sustained IP3 receptor–GRP75–VDAC coupling increases mitochondrial calcium uptake through MCU. Calcium overload disrupts electron transport, increasing hydrogen peroxide delivery to the nucleus and activating DNA damage checkpoints. Prediction: Following a defined calcium-homeostasis perturbation, partial MCU inhibition should prevent mitochondrial calcium overload, nuclear oxidative lesions, and senescence without correcting endoplasmic-reticulum stress. Restoring nuclear hydrogen peroxide experimentally should bypass this protection.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5521,
          "promptSha256": "927b8143cf728aa36d6e6d5a6338f1b4c2d5c4902eeb81516ea3260ee68bae2a"
        }
      ]
    },
    {
      "task": "R42642518",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 2
        },
        {
          "id": "H2",
          "hypothesisIndex": 1
        },
        {
          "id": "H3",
          "hypothesisIndex": 4
        },
        {
          "id": "H4",
          "hypothesisIndex": 3
        },
        {
          "id": "H5",
          "hypothesisIndex": 0
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nBiological ageing progresses at different rates among individuals and is associated with broad changes in physiology and chronic-disease risk. Women and men can follow different ageing trajectories, particularly during midlife, but the biological basis and functional significance of these differences remain incompletely understood. Large clinical datasets can identify circulating features that change with age, although association alone cannot establish whether such features actively promote ageing. Experimental validation is therefore needed to distinguish causal contributors from passive biomarkers.\n\nRESEARCH QUESTION\nWhich circulating factors that accumulate with age actively induce ageing-related cellular phenotypes, and is their resulting biological burden reversible?\n\nHYPOTHESES\n[H1] Age-associated accumulation of circulating advanced-glycation-modified albumin induces cellular senescence through RAGE signaling rather than merely reporting prior glucose exposure. Removing this circulating stimulus reverses inflammatory dysfunction, but established growth arrest is less reversible. Mechanism: Glycated albumin activates RAGE, sustaining NF-κB signaling and oxidative DNA damage that promote a senescence-associated secretory phenotype. Prediction: Replacing glycated albumin in older-donor plasma with an equal amount of unmodified albumin reduces inflammatory secretion and persistent arrest under matched glucose conditions. Physiological add-back restores the effects in receptor-intact cells but not RAGE-deficient cells; withdrawal reduces secretion more readily than it restores proliferation.\n\n[H2] Circulating oxidized LDL that increases with age actively drives vascular cellular ageing through LOX-1 signaling. Its removal reverses endothelial dysfunction before stable senescence develops. Mechanism: Oxidized LDL activates LOX-1-dependent oxidative stress, reduces nitric oxide availability, and triggers DNA damage and inflammatory signaling. Prediction: Selective oxidized-LDL depletion from older-donor plasma restores endothelial nitric oxide production and reduces persistent senescence after exposure; add-back at the original concentration reinstates both effects. Native LDL matched for particle number does not reproduce the phenotype, and LOX-1 disruption prevents it.\n\n[H3] Age-associated accumulation of uptake-accessible extracellular mitochondrial DNA actively propagates inflammatory cellular ageing. Removing the circulating DNA reverses innate immune activation and prevents secondary senescence, although it may not reverse senescence already established in recipient tissues. Mechanism: Internalized mitochondrial DNA activates endosomal TLR9 and, when delivered to the cytosol, cGAS–STING signaling, causing inflammatory secretion that induces senescence in neighboring cells. Prediction: Selective mitochondrial-DNA depletion from older-donor plasma reduces innate immune activation and the ability of exposed immune-cell conditioned medium to induce persistent fibroblast arrest. Add-back in the original carrier form restores these effects, with pathway-specific receptor disruption identifying the required DNA-sensing route.\n\n[H4] Elevated circulating activin A in older adults directly suppresses skeletal-muscle regenerative capacity and promotes a senescence-like state in muscle progenitors. This functional burden is substantially reversible by transient activin A neutralization. Mechanism: Excess activin A activates activin type II receptors and SMAD2/3 signaling, increasing cell-cycle inhibitors and suppressing myogenic differentiation. Prediction: Activin A neutralization in older-donor plasma restores progenitor expansion, differentiation, and subsequent tissue repair, while concentration-matched add-back abolishes rescue. Recovery after washout would distinguish reversible signaling-dependent suppression from irreversible progenitor depletion.\n\n[H5] Age-associated accumulation of circulating indoxyl sulfate directly induces endothelial senescence, independently of other consequences of declining kidney function. Removing indoxyl sulfate reverses early mitochondrial dysfunction, whereas established senescence requires clearance of affected cells. Mechanism: Indoxyl sulfate activates aryl hydrocarbon receptor signaling and mitochondrial oxidative stress, producing persistent DNA damage and stable cell-cycle arrest. Prediction: At concentrations and free fractions measured in older adults, indoxyl sulfate induces persistent arrest and impaired endothelial function. Selective depletion from older-donor plasma prevents these effects, physiological add-back restores them, and receptor disruption blocks them; withdrawal restores function more effectively after brief than prolonged exposure.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5414,
          "promptSha256": "34ca1652215e25161927d569ddf7f4f7a3a40963f5270a0ad5eefa47c3abd324"
        }
      ]
    },
    {
      "task": "R42642521",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 0
        },
        {
          "id": "H2",
          "hypothesisIndex": 3
        },
        {
          "id": "H3",
          "hypothesisIndex": 1
        },
        {
          "id": "H4",
          "hypothesisIndex": 4
        },
        {
          "id": "H5",
          "hypothesisIndex": 2
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nThe gut microbiome changes with age and is associated with immune dysregulation, chronic low-grade inflammation and functional decline. Microbiome composition also varies substantially among individuals and populations, making it difficult to distinguish consequential changes from incidental biomarkers of ageing. Animal studies suggest that manipulating gut microbial communities can influence age-related physiology, but the responsible organisms and molecular mediators have remained poorly defined. Establishing causality requires showing that a defined microbial intervention improves ageing phenotypes and identifying a functional mechanism that reproduces those effects.\n\nRESEARCH QUESTION\nCan a specific age-depleted gut microbe and one of its metabolites causally suppress inflammaging and improve healthspan in old animals?\n\nHYPOTHESES\n[H1] In old mice with age-depleted Faecalibacterium prausnitzii, restoring a defined butyrate-producing strain will suppress inflammaging and improve physical function. Butyrate supplementation will reproduce these benefits through HCAR2-dependent regulation of intestinal macrophages. Mechanism: Microbial butyrate activates macrophage HCAR2, reducing NF-κB signaling and inflammatory cytokine production and thereby limiting systemic inflammation. Prediction: The strain and colon-targeted butyrate will reduce circulating IL-6 and TNF and improve frailty scores and grip strength in aged controls, but these benefits will be substantially attenuated by macrophage-specific Hcar2 deletion despite comparable intestinal butyrate exposure.\n\n[H2] Restoring an age-depleted Akkermansia muciniphila strain will reduce inflammaging and age-related metabolic dysfunction through its acetate production. Physiologically matched acetate delivery will reproduce the benefits through regulatory T-cell FFAR2 signaling. Mechanism: Microbially derived acetate activates FFAR2 on colonic regulatory T cells, increasing their abundance or suppressive activity and limiting inflammatory effector responses. Prediction: Bacterial treatment and acetate delivery will improve insulin sensitivity and frailty trajectories while increasing colonic regulatory T-cell activity. Regulatory T-cell-specific Ffar2 deletion will abolish these effects, and isotope tracing will establish that the administered strain contributes to the increased acetate pool.\n\n[H3] Restoring an age-depleted, indole-3-propionic-acid-producing Clostridium sporogenes strain will improve healthspan in old mice by repairing intestinal barrier function. Its metabolite indole-3-propionic acid will be sufficient to reproduce the effect. Mechanism: Indole-3-propionic acid activates epithelial pregnane X receptor, strengthening barrier function and reducing microbial-product translocation that drives systemic innate immune activation. Prediction: Wild-type bacteria will reduce intestinal permeability, circulating microbial products, inflammatory cytokines and frailty more effectively than a colonization-matched metabolite-deficient strain. Metabolite supplementation will rescue the deficient strain's effects, whereas epithelial Pxr deletion will block the rescue.\n\n[H4] Replenishing an age-depleted Roseburia intestinalis strain will suppress inflammaging and preserve muscle function through butyrate-dependent reprogramming of intestinal inflammatory monocytes. This benefit will depend on intracellular histone deacetylase inhibition. Mechanism: Locally available butyrate inhibits monocyte histone deacetylase activity, producing a sustained transcriptional state with reduced NLRP3 inflammasome responsiveness and IL-1β release. Prediction: The strain and colon-targeted butyrate will reduce monocyte inflammasome activity and improve muscle performance even when HCAR2 and FFAR2 signaling is absent. Benefits will coincide with monocyte histone acetylation, persist transiently after metabolite washout and be reproduced by monocyte-targeted histone deacetylase inhibition.\n\n[H5] Replenishing an age-depleted Bifidobacterium longum strain that produces indole-3-lactic acid will suppress inflammaging and preserve physical function in old mice. The benefit will require metabolite-dependent activation of an intestinal AhR–IL-22 repair pathway. Mechanism: Indole-3-lactic acid activates aryl hydrocarbon receptor in intestinal group 3 innate lymphoid cells, increasing IL-22-mediated epithelial repair and reducing chronic exposure to microbial inflammatory signals. Prediction: The producer strain and purified metabolite will improve barrier integrity and longitudinal frailty scores, whereas an otherwise matched production-deficient strain will not. Disrupting AhR in group 3 innate lymphoid cells or neutralizing IL-22 will eliminate these benefits despite maintained metabolite exposure.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5444,
          "promptSha256": "028d7f44726b4c952c86901c8f706a90af94fe04c5b23dd11ab9d8ad32bb6e6b"
        }
      ]
    },
    {
      "task": "R42647119",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 4
        },
        {
          "id": "H2",
          "hypothesisIndex": 2
        },
        {
          "id": "H3",
          "hypothesisIndex": 0
        },
        {
          "id": "H4",
          "hypothesisIndex": 3
        },
        {
          "id": "H5",
          "hypothesisIndex": 1
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nCellular reprogramming offers a potential way to replace neurons lost through injury or neurodegenerative disease. Most regenerative strategies have been developed and validated in young experimental animals, although advanced age is the principal risk factor for many neurological disorders. Aging can alter both the plasticity of resident cells and the tissue response to injury. It was therefore unclear whether neuronal reprogramming would remain effective in aged neural tissue and which age-associated processes might limit it.\n\nRESEARCH QUESTION\nHow does aging affect injury-induced neuronal reprogramming in the retina, and what mechanisms account for any age-related loss of regenerative capacity?\n\nHYPOTHESES\n[H1] Part of the age-related reduction in regenerated retinal neurons results from selective death of newly reprogrammed cells rather than reduced initiation of neuronal conversion. Mechanism: The aged retinal environment provides insufficient trophic and synaptic support, causing apoptosis during the maturation of newly generated neurons. Prediction: Permanent Müller glial lineage tracing would reveal similar early numbers of newly specified neurons in young and aged retinas, followed by greater apoptosis and attrition in aged retinas. Trophic support supplied only after fate conversion would restore long-term neuronal survival without increasing initial conversion.\n\n[H2] Aging reduces neuronal reprogramming by limiting the mitochondrial adaptation required for Müller glia to acquire a neuronal identity. Mechanism: Impaired mitochondrial quality control and reduced respiratory reserve prevent the metabolic transition needed to complete neuronal differentiation, even when the initial proneural program is activated. Prediction: Aged and young Müller glia would initiate comparable proneural transcription, but aged cells would stall before neuronal maturation and exhibit deficient respiratory reserve. Müller glia-specific restoration of mitochondrial quality control would rescue conversion without first correcting neuronal enhancer accessibility or inflammatory signaling.\n\n[H3] Aging reduces injury-induced neuronal reprogramming by making Müller glial chromatin less accessible to proneural transcription factors. This creates a cell-intrinsic barrier to neuronal fate conversion. Mechanism: Age-dependent stabilization of repressive chromatin at neuronal regulatory elements prevents reprogramming factors such as ASCL1 from activating a neurogenic program. Prediction: With injury severity and ASCL1 expression matched, aged Müller glia would show reduced accessibility and ASCL1 occupancy at neuronal enhancers. Targeted reopening of those enhancers would restore lineage-traced neuronal conversion despite an unchanged aged inflammatory environment.\n\n[H4] In reprogramming protocols that require a proliferative intermediate, aging reduces neuronal output by imposing a persistent DNA damage-dependent cell-cycle checkpoint in Müller glia. Mechanism: Accumulated DNA damage activates p53–p21 signaling, preventing injury-responsive Müller glia from entering or completing the divisions that generate neurogenic progenitors. Prediction: Aged Müller glia would show increased DNA damage and p21 expression, with loss of neuron production concentrated in division-dependent lineages. A direct-conversion protocol that bypasses proliferation would exhibit a smaller age penalty despite similar damage burdens.\n\n[H5] Aging suppresses retinal neuronal reprogramming because injury elicits a prolonged inflammatory response that maintains Müller glia in a reactive state. Mechanism: Persistent microglial cytokine production sustains NF-κB and STAT3 signaling in Müller glia, favoring reactive gliosis over neuronal differentiation. Prediction: Transient, post-injury inhibition of microglial cytokine production or Müller glial inflammatory signaling would preferentially restore conversion in aged retinas. Conversely, an aged microglial secretome would suppress conversion in young retinal preparations, with rescue following cytokine neutralization.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4725,
          "promptSha256": "eaeaf9ea3bb510408cbfbaaf0f5ef1e2d516d8ec8eaf12185ed5917fe3bb8bfb"
        }
      ]
    },
    {
      "task": "R42647635",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 2
        },
        {
          "id": "H2",
          "hypothesisIndex": 3
        },
        {
          "id": "H3",
          "hypothesisIndex": 0
        },
        {
          "id": "H4",
          "hypothesisIndex": 1
        },
        {
          "id": "H5",
          "hypothesisIndex": 4
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing is accompanied by progressive molecular damage, impaired tissue maintenance, and declining physiological function. Genetic studies in laboratory organisms have identified processes that can influence lifespan and cellular senescence. However, findings from small-animal models do not always translate directly to humans because of major differences in physiology, metabolism, and lifespan. A large-mammal model is therefore valuable for testing whether a proposed source of molecular damage can directly produce systemic ageing phenotypes.\n\nRESEARCH QUESTION\nDoes experimentally increasing somatic mitochondrial DNA mutation burden cause premature ageing and shortened lifespan in a large mammal?\n\nHYPOTHESES\n[H1] Increasing somatic mitochondrial DNA mutations in adult stem and progenitor cells causes premature ageing and shortened lifespan by exhausting tissue regenerative capacity. Mechanism: Mitochondrial dysfunction induces progenitor apoptosis or durable proliferative arrest, reducing replacement of damaged cells and progressively impairing tissue maintenance. Prediction: Mutation elevation restricted to stem and progenitor cells produces greater regenerative failure than elevation in matched differentiated-cell compartments. Preserving low-mutation progenitors delays tissue decline despite persistent mutations in differentiated cells.\n\n[H2] Elevated somatic mitochondrial DNA mutation burden causes premature systemic ageing and shortened lifespan through accumulation of senescent cells and their secreted signals. Mechanism: Mitochondrial metabolic and redox disturbances induce cellular senescence; senescence-associated secretions then propagate inflammation, fibrosis, and dysfunction into neighbouring tissues. Prediction: Senescent-cell accumulation precedes widespread organ dysfunction, and selective clearance of senescent cells delays decline and extends survival without materially reducing mitochondrial mutation burden in surviving nonsenescent cells.\n\n[H3] Experimentally increasing somatic mitochondrial DNA mutation burden after development causes premature multisystem ageing and shortens lifespan in a large mammal by impairing oxidative phosphorylation. Mechanism: Pathogenic mutations compromise respiratory-chain function, reducing ATP production and causing progressive failure in tissues with high energy demands. Prediction: Respiratory impairment precedes functional decline, and mutation burden predicts ageing phenotypes through its effect on respiratory capacity. An intervention that restores respiratory function without lowering mutation burden delays decline and improves survival.\n\n[H4] Elevated somatic mitochondrial DNA mutation burden causes premature ageing and shortened lifespan primarily through mitochondrial DNA–triggered innate immune activation. Mechanism: Mutation-associated mitochondrial dysfunction promotes mitochondrial DNA release into the cytosol, activating cGAS–STING signalling and persistent inflammation that damages multiple organs. Prediction: Blocking cGAS–STING signalling reduces inflammation, delays multisystem decline, and extends survival despite comparable mitochondrial mutation burdens and persistent respiratory impairment.\n\n[H5] Increasing somatic mitochondrial DNA mutation burden causes premature ageing and shortened lifespan only when pathogenic variants clonally expand beyond functional heteroplasmy thresholds in enough cells. Mechanism: Intracellular expansion of damaging variants produces a mosaic of respiratory-deficient cells; organ function deteriorates when the affected cellular fraction exceeds tissue-specific tolerances. Prediction: Among animals with similar bulk mutation burdens, decline and survival track the fraction of cells carrying high-heteroplasmy pathogenic variants. Animals with many dispersed low-heteroplasmy mutations remain comparatively healthy.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4515,
          "promptSha256": "8b4ee95e830d402681d6cb92a376402fc665b36c0fd70ea0006051d14e380576"
        }
      ]
    },
    {
      "task": "R42663085",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 0
        },
        {
          "id": "H2",
          "hypothesisIndex": 4
        },
        {
          "id": "H3",
          "hypothesisIndex": 3
        },
        {
          "id": "H4",
          "hypothesisIndex": 2
        },
        {
          "id": "H5",
          "hypothesisIndex": 1
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing commonly impairs the cyclical regeneration of hair follicles, contributing to progressive hair thinning and alopecia. Hair growth depends on the orderly transition of follicles from a resting phase into a proliferative growth phase. With age, this transition becomes less efficient as regenerative cells lose functional capacity. Whether this decline can be reversed by directly restoring an intrinsic molecular control of follicle regeneration remained unresolved.\n\nRESEARCH QUESTION\nCan an intrinsic molecular regulator be enhanced to reactivate quiescent hair follicles and restore hair regeneration, and through what mechanism?\n\nHYPOTHESES\n[H1] Enhancing lactate dehydrogenase A (LDHA) activity in aged hair follicle stem cells will promote exit from quiescence and restore entry into the growth phase. Mechanism: Increased conversion of pyruvate to lactate regenerates cytosolic NAD+, sustaining the glycolytic flux required for stem-cell activation and subsequent progenitor expansion. Prediction: Stem-cell-specific LDHA enhancement will increase glycolytic flux before proliferation and accelerate hair regrowth. A catalytically inactive LDHA control will fail, while an independent intervention that restores cytosolic NAD+ recycling will reproduce the effect.\n\n[H2] Transient enhancement of FOXM1 in aged hair follicle stem cells will restore productive cell-cycle progression and thereby improve hair regeneration. Mechanism: FOXM1 increases expression of DNA-replication, chromosome-segregation, and mitotic genes, enabling activated stem cells to generate sufficient progenitors for sustained follicular growth. Prediction: FOXM1 enhancement will increase completed stem-cell divisions and hair-shaft production without necessarily increasing early Wnt signaling. A DNA-binding-defective FOXM1 variant will fail, and lineage tracing will show expansion followed by appropriate differentiation rather than persistent undifferentiated proliferation.\n\n[H3] Enhancing SIRT1 activity in aged hair follicle stem cells will reverse a reversible stress-associated arrest and restore regenerative activation. Mechanism: SIRT1-mediated deacetylation of p53 reduces excessive p21 expression, allowing viable, quiescent stem cells to re-enter the cell cycle without requiring stem-cell replacement. Prediction: SIRT1 activation will lower acetylated p53 and p21 before follicular activation. Maintaining p21 expression independently of p53 will block regeneration, whereas selective p21 reduction will mimic the response.\n\n[H4] Transient enhancement of β-catenin transcriptional activity in aged follicular stem and hair-germ cells will overcome an intrinsic activation threshold and restore hair production. Mechanism: Nuclear β-catenin activates TCF/LEF-dependent transcription, initiating the progenitor proliferation and differentiation program needed for the resting-to-growth transition. Prediction: A brief, lineage-restricted β-catenin pulse will restore anagen and hair-shaft production even during extracellular Wnt inhibition. Disrupting β-catenin–TCF/LEF transcriptional coupling will eliminate this rescue.\n\n[H5] Enhancing ATG7-dependent autophagy in aged hair follicle stem cells will restore their capacity to activate and regenerate hair across successive cycles. Mechanism: Increased autophagic flux clears damaged proteins and organelles that accumulate during prolonged quiescence, restoring cellular fitness and responsiveness to growth signals. Prediction: Inducible ATG7 enhancement will improve autophagic flux and reduce cellular damage before anagen entry. Blocking lysosomal degradation will abolish the regenerative benefit despite maintained ATG7 expression.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4329,
          "promptSha256": "397fbd14acf875ef4826d8929c3d2fbe5e1238d09bdd343b1ad948496489dfcd"
        }
      ]
    },
    {
      "task": "R42664348",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 2
        },
        {
          "id": "H2",
          "hypothesisIndex": 4
        },
        {
          "id": "H3",
          "hypothesisIndex": 3
        },
        {
          "id": "H4",
          "hypothesisIndex": 0
        },
        {
          "id": "H5",
          "hypothesisIndex": 1
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nOsteoarthritis is a common age-related disorder characterized by progressive joint deterioration, inflammation, pain, and loss of mobility. Obesity substantially increases osteoarthritis risk, including in joints that do not bear additional body weight, suggesting that mechanical loading alone cannot explain the association. Adipose tissue can influence distant organs through circulating signals, but the molecular basis of its contribution to joint degeneration remained unclear. Identifying the responsible signals and downstream processes could reveal targets for preventing or treating obesity-associated osteoarthritis.\n\nRESEARCH QUESTION\nBy what causal molecular mechanism does excess adiposity promote osteoarthritis progression, and can disrupting that mechanism reduce joint pathology?\n\nHYPOTHESES\n[H1] Excess adiposity promotes osteoarthritis by increasing adipocyte-derived complement factor D, also called adipsin, which amplifies complement activation within damaged joints. Blocking this adipose-to-joint complement pathway will reduce cartilage degeneration. Mechanism: Circulating factor D supports alternative-pathway complement amplification on injured cartilage, increasing C5a-mediated inflammation and C5b-9 deposition on chondrocytes. Sublytic C5b-9 induces cartilage-degrading enzymes, while stronger activation causes cell death. Prediction: Adipocyte-specific factor D deletion will lower joint complement deposition and cartilage damage without reducing fat mass. Restoring circulating catalytically active factor D, but not an inactive variant, will reverse protection; chondrocyte resistance to membrane attack complex formation will attenuate the cartilage response despite persistent circulating factor D.\n\n[H2] IL-6 released by senescent adipose stromal cells promotes osteoarthritis through IL-6 trans-signaling in synovial fibroblasts. Selectively disrupting this pathway will reduce synovitis and cartilage destruction without requiring weight loss. Mechanism: Adipose-derived IL-6 complexes with soluble IL-6 receptor and activates gp130–STAT3 signaling in synovial fibroblasts, increasing CCL2 and matrix-degrading enzymes. Recruitment of inflammatory monocytes sustains a joint-local inflammatory feedback loop. Prediction: Adipose-stromal-cell-specific Il6 deletion or joint-local inhibition of IL-6 trans-signaling will reduce fibroblast STAT3 activation, monocyte recruitment, and cartilage loss at matched adiposity. Physiological IL-6–soluble-receptor replacement will reverse the effect of adipose Il6 deletion, but not protection from fibroblast-specific gp130 deletion.\n\n[H3] In obesity, excessive fatty-acid release from adipose tissue drives chondrocyte ferroptosis and thereby accelerates cartilage loss. Reducing adipose lipid delivery or blocking chondrocyte ferroptosis will limit osteoarthritis progression. Mechanism: Increased fatty-acid flux causes chondrocyte mitochondrial and endoplasmic-reticulum stress, weakening glutathione–GPX4 antioxidant defenses. Iron-dependent peroxidation of ACSL4-dependent polyunsaturated membrane phospholipids then triggers ferroptotic cell death. Prediction: Adipose lipid tracing will demonstrate increased lipid delivery to cartilage before ferroptotic injury. Inducible chondrocyte-specific Acsl4 deletion will preserve cartilage despite unchanged obesity and circulating inflammatory signals, and controlled restoration of fatty-acid flux after suppression of adipose lipolysis will restore damage only in ferroptosis-competent chondrocytes.\n\n[H4] Excess adiposity increases delivery of adipose-derived extracellular vesicles carrying miR-34a to articular chondrocytes, promoting senescence and cartilage degradation. Blocking this transfer or its intracellular target interaction will slow osteoarthritis progression. Mechanism: Vesicular miR-34a suppresses chondrocyte SIRT1, increasing p53 acetylation and a senescence-associated secretory phenotype that includes inflammatory cytokines and cartilage-degrading proteases. Prediction: Adipocyte-specific miR-34a deletion will reduce cartilage damage without changing adiposity or joint loading. Physiological replacement with miR-34a-containing adipocyte vesicles will restore pathology, whereas replacement with miR-34a-depleted vesicles will not; chondrocyte expression of miR-34a-resistant SIRT1 will prevent restoration.\n\n[H5] Elevated adipose-derived leptin accelerates osteoarthritis by activating inflammatory signaling in synovial macrophages. Interrupting macrophage leptin signaling will protect joints despite persistent obesity. Mechanism: Leptin receptor–JAK2–STAT3 signaling increases macrophage NLRP3 and pro-IL-1β expression, priming inflammasome activation by joint damage signals. Mature IL-1β then stimulates chondrocyte MMP13 and ADAMTS5 production. Prediction: Inducible macrophage-restricted leptin receptor deletion will reduce synovial IL-1β and cartilage loss at matched body weight and activity. Local mature IL-1β replacement will bypass this protection, whereas leptin replacement will not.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5702,
          "promptSha256": "cf91c06878d2d71eba382f341302ad306596a7277d33a7918934c01df45dfbb0"
        }
      ]
    },
    {
      "task": "R42665751",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 2
        },
        {
          "id": "H2",
          "hypothesisIndex": 0
        },
        {
          "id": "H3",
          "hypothesisIndex": 1
        },
        {
          "id": "H4",
          "hypothesisIndex": 4
        },
        {
          "id": "H5",
          "hypothesisIndex": 3
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nOvarian function declines earlier than the function of many other organs, reducing fertility and altering endocrine health. Age-related deterioration of cellular quality, tissue communication and inflammatory homeostasis has been implicated in this process. Mitochondrial dysfunction is common in ageing reproductive tissues, but whether it directly initiates ovarian decline rather than merely accompanying it has remained uncertain. The molecular signals linking mitochondrial stress to dysfunction across the ovarian follicle were unknown.\n\nRESEARCH QUESTION\nHow does age-associated mitochondrial dysfunction initiate and propagate inflammatory signaling that causes ovarian functional decline?\n\nHYPOTHESES\n[H1] Mitochondrial dysfunction in ageing follicular cells drives ATP release that activates the NLRP3 inflammasome in nearby ovarian macrophages. Macrophage-derived IL-1β then propagates follicular injury and suppresses ovarian endocrine function. Mechanism: Extracellular ATP activates macrophage P2X7 receptors, causing potassium efflux and NLRP3-dependent caspase-1 activation in inflammation-primed macrophages. Mature IL-1β induces inflammatory responses in granulosa and stromal cells, creating a tissue-level amplification loop. Prediction: Macrophage-specific NLRP3 deletion or extracellular ATP degradation suppresses mature IL-1β production and preserves follicular function despite persistent follicular mitochondrial defects. Local IL-1β replacement reverses this protection, supporting macrophage inflammasome signaling as the causal intermediary.\n\n[H2] Age-associated mitochondrial damage in granulosa cells initiates ovarian inflammation by releasing mitochondrial DNA into the cytosol. The resulting cGAS–STING activation propagates inflammatory signaling to neighboring follicular cells and promotes follicular atresia. Mechanism: Impaired mitochondrial quality control permits mitochondrial DNA leakage, activating cGAS–STING–TBK1/IRF3 and NF-κB. Secreted type I interferons and inflammatory cytokines impair granulosa-cell steroidogenesis and oocyte support. Prediction: Inducible granulosa-cell-specific deletion of cGAS or STING after follicle formation reduces inflammation and preserves follicle survival and steroidogenesis despite persistent mitochondrial respiratory defects. Cytosolic mitochondrial DNA accumulation precedes cytokine induction, distinguishing this mechanism from inflammation secondary to follicular death.\n\n[H3] Mitochondrially stressed oocytes initiate inflammation in surrounding cumulus cells by exporting mitochondrial DNA within extracellular vesicles. Endosomal TLR9 sensing converts an oocyte-localized defect into dysfunction across the follicle. Mechanism: Oocyte-derived vesicles deliver mitochondrial DNA into cumulus-cell endosomes, activating TLR9–MyD88–NF-κB signaling. The resulting cytokines disrupt cumulus metabolic support and gap-junction communication, amplifying oocyte dysfunction. Prediction: Purified vesicles from mitochondrially stressed oocytes induce inflammatory signaling in healthy cumulus cells, and this response disappears with recipient-cell TLR9 deletion but persists with recipient-cell cGAS deletion. Selectively blocking vesicle release from oocytes preserves cumulus function without correcting oocyte mitochondrial damage.\n\n[H4] Chronic mitochondrial oxidant production in ovarian stromal cells initiates a senescence-associated inflammatory secretory program that progressively damages otherwise functional follicles. The stromal response sustains ovarian decline after the initiating mitochondrial stress has subsided. Mechanism: Mitochondrial reactive oxygen species induce persistent nuclear DNA damage and senescence, activating p38 MAPK and NF-κB-dependent cytokine secretion. Stromal cytokines recruit inflammatory cells, promote fibrosis, and impair follicular growth and steroidogenesis. Prediction: Selective clearance of senescent stromal cells after mitochondrial stress has been withdrawn restores follicular growth and lowers inflammation even when follicular mitochondrial function remains unchanged. Previously stressed stromal cells continue to impair healthy follicles in coculture, whereas blocking their inflammatory secretory program prevents this effect.\n\n[H5] Age-related failure of mitochondrial RNA surveillance in granulosa cells initiates ovarian inflammation through cytosolic mitochondrial double-stranded RNA. MDA5–MAVS signaling generates an interferon response that spreads dysfunction between follicles. Mechanism: Reduced mitochondrial RNA degradation, involving factors such as PNPT1 or SUV3, permits complementary mitochondrial transcripts to accumulate and escape into the cytosol. MDA5–MAVS activation induces type I interferons, which impose inflammatory and metabolic stress on neighboring follicular cells. Prediction: Cytosolic mitochondrial double-stranded RNA increases before follicular dysfunction, and granulosa-cell-specific MDA5 deletion suppresses interferon production and preserves ovarian function despite continued mitochondrial RNA accumulation. Protection from MDA5 deletion, with little protection from cGAS deletion, distinguishes RNA sensing from mitochondrial DNA sensing.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5864,
          "promptSha256": "a1c7b73f1caa0c78d896e1057929399932a7db84c94008830d90a95c5e6c0465"
        }
      ]
    },
    {
      "task": "R42689491",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 1
        },
        {
          "id": "H2",
          "hypothesisIndex": 4
        },
        {
          "id": "H3",
          "hypothesisIndex": 0
        },
        {
          "id": "H4",
          "hypothesisIndex": 2
        },
        {
          "id": "H5",
          "hypothesisIndex": 3
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nHutchinson-Gilford progeria syndrome is a rare genetic disorder characterized by accelerated, multisystem features of ageing. Progressive skeletal abnormalities are a prominent component of the disease in both patients and experimental models. These abnormalities involve impaired bone formation, remodeling, and mechanical integrity. It remained unclear whether established skeletal pathology could be meaningfully reversed in vivo and how strongly therapeutic efficacy would depend on the age at treatment.\n\nRESEARCH QUESTION\nCan in vivo correction of the HGPS-causing mutation rescue molecular, cellular, and structural defects in bone, and how does treatment timing affect efficacy?\n\nHYPOTHESES\n[H1] Early mutation correction produces greater skeletal rescue because it preserves the osteogenic progenitor pool before progerin causes persistent senescence or progenitor depletion. Late correction restores function in surviving cells but cannot fully replenish lost bone-forming capacity. Mechanism: Cumulative progerin exposure reduces the abundance and clonogenic potential of skeletal progenitors, creating a cellular limitation that persists after mutation correction. Prediction: At matched correction efficiency and post-treatment follow-up, early-treated animals retain more clonogenic skeletal progenitors and achieve greater bone formation than late-treated animals. Supplementing corrected progenitors preferentially improves the late-treatment response.\n\n[H2] Skeletal rescue depends on the spatial distribution of corrected cells as well as their overall abundance. Early treatment achieves greater efficacy because corrected progenitors can expand and populate more bone-forming surfaces during growth. Mechanism: Clusters of corrected progenitors generate functional osteoblasts and osteocytes across local remodeling units, whereas scattered correction leaves many units dominated by progerin-expressing cells. Prediction: At the same bulk bone correction fraction, animals with greater coverage of bone-forming surfaces by corrected lineages show stronger structural and mechanical rescue. Spatial lineage mapping predicts treatment response better than bulk editing efficiency alone.\n\n[H3] In vivo correction of the HGPS-causing LMNA mutation in osteoblast-lineage cells rescues bone formation by reducing progerin-induced nuclear damage. This molecular and cellular rescue remains possible after skeletal abnormalities have developed. Mechanism: Corrected LMNA splicing lowers progerin abundance, restores nuclear organization, and reduces DNA-damage signaling, enabling osteoblast differentiation and matrix mineralization. Prediction: After treatment of established disease, corrected osteoblast-lineage cells show reduced progerin and DNA-damage markers followed by increased mineral apposition. Bone-targeted correction produces these benefits without requiring correction in other organs.\n\n[H4] Mutation correction in osteocytes rescues skeletal remodeling by normalizing signals that coordinate osteoblast and osteoclast activity. Restoring this coordination contributes to structural recovery beyond the direct rescue of osteoblasts. Mechanism: Reduced progerin restores osteocyte viability and mechanosensing, normalizing sclerostin and RANKL–OPG signaling and thereby improving the balance between bone formation and resorption. Prediction: Osteocyte-restricted correction improves load-responsive bone formation and remodeling balance despite persistent mutation in osteoblast progenitors. Experimentally maintaining abnormal osteocyte signaling attenuates this benefit.\n\n[H5] Late mutation correction can restore bone-cell function while leaving a substantial mechanical deficit because established skeletal geometry and accumulated matrix damage require prolonged remodeling to reverse. Early treatment is more effective structurally because it prevents these defects during skeletal growth. Mechanism: Cellular recovery occurs faster than replacement of damaged matrix or reconstruction of cortical and trabecular architecture, producing a delay between molecular rescue and mechanical recovery. Prediction: With comparable progerin reduction and normalized bone-formation indices, late-treated animals retain greater cortical porosity, architectural abnormalities, and reduced fracture resistance than early-treated animals. Extended follow-up improves matrix quality more readily than established bone shape.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5080,
          "promptSha256": "eb722ffbf153c96bdc5ce2269ea746647411452561e65cc47a0e2a353172fba1"
        }
      ]
    },
    {
      "task": "R42696595",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 0
        },
        {
          "id": "H2",
          "hypothesisIndex": 3
        },
        {
          "id": "H3",
          "hypothesisIndex": 2
        },
        {
          "id": "H4",
          "hypothesisIndex": 1
        },
        {
          "id": "H5",
          "hypothesisIndex": 4
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nSeeds progressively lose viability during storage, limiting crop propagation and the preservation of genetic resources. Longevity varies substantially among rice varieties and is influenced by both environmental conditions and inherited traits. Although several genomic regions associated with seed longevity had been identified, the causal genes and regulatory mechanisms underlying this variation remained poorly understood. It was also unclear whether naturally occurring longevity alleles could improve seed survival without compromising agronomic performance.\n\nRESEARCH QUESTION\nWhat genetic and molecular mechanism causes natural variation in seed longevity among rice varieties?\n\nHYPOTHESES\n[H1] Natural cis-regulatory variation at OsLOX3 causes differences in rice seed longevity by altering lipoxygenase abundance in mature seeds. Alleles that reduce seed-specific OsLOX3 expression extend survival during storage. Mechanism: Reduced lipoxygenase activity limits oxidation of polyunsaturated fatty acids, slowing membrane damage and the accumulation of reactive lipid-derived aldehydes. Prediction: Reciprocal replacement of the OsLOX3 promoter between short- and long-lived varieties reverses their longevity ranking in a shared genetic background, with lipid oxidation preceding viability loss. Seed-specific complementation restores the short-lived phenotype without changing dormancy.\n\n[H2] Natural regulatory alleles of a seed-expressed galactinol synthase cause longevity variation by changing raffinose-family oligosaccharide accumulation. Protective alleles improve the physical stability of the dry seed cytoplasm. Mechanism: Altered sugar composition promotes a stable intracellular glass and protects membranes and proteins, reducing molecular mobility and deterioration at low seed moisture. Prediction: Allele replacement changes seed sugar composition, cytoplasmic glass properties, and survival at matched moisture content. Its benefit varies predictably with storage temperature relative to the measured glass transition and is lost when raffinose synthesis is blocked.\n\n[H3] Natural variation in seed-specific regulation of OsABI3 causes longevity differences by altering the protective maturation program. Longevity-enhancing alleles increase maturation-stage protection while allowing normal release from dormancy. Mechanism: Stronger or better-timed ABA-dependent transcription increases late embryogenesis abundant proteins and other desiccation-protective factors before drying, stabilizing cellular structures during storage. Prediction: Replacing the candidate regulatory allele changes protective protein accumulation before harvest and subsequent storage survival. The survival advantage persists after dormancy is experimentally equalized and disappears when the relevant downstream protective program is disrupted.\n\n[H4] Natural coding or regulatory variants of OsPIMT1 determine seed longevity by changing the capacity to repair age-damaged proteins. Higher-activity alleles preserve proteins needed for successful germination. Mechanism: Protein L-isoaspartyl methyltransferase repairs abnormal isoaspartyl residues that accumulate during storage, maintaining enzyme function during hydrated storage intervals and early imbibition. Prediction: An allele swap increases post-storage germination and reduces protein isoaspartyl accumulation without reducing lipid oxidation. A catalytically inactive version fails to rescue longevity despite matching the protective allele's protein abundance.\n\n[H5] Natural coding or regulatory variation at OsALDH7 causes differences in rice seed longevity by altering detoxification of reactive aldehydes. Protective alleles reduce damage downstream of oxidative reactions rather than preventing their initiation. Mechanism: Greater aldehyde dehydrogenase capacity removes toxic carbonyl compounds during seed maturation and early rehydration, limiting covalent damage to proteins and other cellular components. Prediction: The protective allele improves storage survival and lowers aldehyde-derived protein adducts despite comparable initial lipid hydroperoxide levels. Catalytic inactivation abolishes protection, and controlled aldehyde exposure produces a stronger genotype difference than exposure to an oxidant that generates little aldehyde damage.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4963,
          "promptSha256": "9faac431b823b57939977c344dfd425e15a8628bada122f808b7580ed5d1d61e"
        }
      ]
    },
    {
      "task": "R42698274",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 0
        },
        {
          "id": "H2",
          "hypothesisIndex": 3
        },
        {
          "id": "H3",
          "hypothesisIndex": 4
        },
        {
          "id": "H4",
          "hypothesisIndex": 2
        },
        {
          "id": "H5",
          "hypothesisIndex": 1
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAndrogenetic alopecia is a common, progressive form of hair loss associated with genetic susceptibility and heightened follicular responses to dihydrotestosterone. Androgen exposure progressively impairs the cells that support follicle growth, contributing to follicular miniaturization and a shortened growth phase. Mitochondrial dysfunction, oxidative stress, inflammation and cellular senescence have been implicated in this deterioration. However, the molecular mechanism connecting androgen signaling to these pathogenic cellular changes remained incompletely understood.\n\nRESEARCH QUESTION\nWhat molecular mechanism exacerbates dihydrotestosterone-induced mitochondrial dysfunction, oxidative stress and senescence during androgenetic alopecia?\n\nHYPOTHESES\n[H1] Dihydrotestosterone exacerbates mitochondrial damage and senescence in susceptible scalp dermal papilla cells by promoting mitochondrial translocation of p66Shc. This creates a mitochondrial source of hydrogen peroxide that amplifies androgen-induced oxidative stress. Mechanism: Androgen receptor signaling activates a PKCβ-dependent pathway that phosphorylates p66Shc at Ser36, enabling its mitochondrial accumulation and oxidation of cytochrome c. The resulting hydrogen peroxide promotes membrane depolarization, DNA damage and p53–p21-mediated senescence. Prediction: Selective p66Shc depletion would reduce mitochondrial hydrogen peroxide, respiratory impairment and persistent senescence after dihydrotestosterone exposure. Re-expression of wild-type p66Shc, but not a Ser36 phosphorylation-deficient mutant, would restore these phenotypes despite comparable androgen receptor activation.\n\n[H2] Dihydrotestosterone increases endoplasmic-reticulum-to-mitochondrial calcium transfer in dermal papilla cells, producing mitochondrial calcium overload that amplifies oxidative stress and senescence. Mechanism: Androgen receptor signaling strengthens IP3R–GRP75–VDAC1 coupling at organelle contact sites, increasing calcium uptake through the mitochondrial calcium uniporter. Excess matrix calcium promotes permeability-transition events, membrane depolarization and reactive oxygen species production, triggering sustained DNA damage. Prediction: Increased mitochondrial calcium uptake would precede oxidative stress and respiratory decline. Partial inhibition of the mitochondrial calcium uniporter or selective disruption of IP3R–GRP75 coupling would prevent these changes and subsequent senescence while preserving proximal androgen receptor activation.\n\n[H3] Mitochondrial DNA released after initial dihydrotestosterone-induced injury activates a cGAS–STING inflammatory feedback loop that worsens mitochondrial dysfunction and stabilizes senescence. Mechanism: Cytosolic mitochondrial DNA activates cGAS–STING and downstream TBK1 and NF-κB signaling. The resulting inflammatory secretory program induces secondary mitochondrial oxidative stress in exposed cells and neighboring follicular support cells, sustaining senescence after the initial androgen insult. Prediction: Deleting cGAS or STING would preserve the early mitochondrial response to dihydrotestosterone but reduce delayed respiratory decline, inflammatory secretion and persistent senescence. Conditioned medium from exposed wild-type cells would induce more mitochondrial damage in untreated recipient cells than medium from exposed STING-deficient cells, after controlling for residual dihydrotestosterone.\n\n[H4] Dihydrotestosterone exacerbates follicular cell deterioration by impairing PINK1–Parkin-mediated clearance of damaged mitochondria. Defective mitochondrial turnover allows otherwise transient oxidative injury to become a self-sustaining senescence stimulus. Mechanism: Androgen receptor signaling compromises damage-induced PINK1 stabilization and Parkin recruitment, reducing selective mitophagy. Dysfunctional mitochondria accumulate, maintaining elevated reactive oxygen species and activating p53–p21 and p16–RB growth-arrest pathways. Prediction: Dihydrotestosterone would reduce mitophagic flux measured with a mitochondrial lysosomal-delivery reporter, even when mitochondrial damage is matched between conditions. Restoring PINK1–Parkin function would rescue respiration and persistent growth arrest, but that rescue would disappear when downstream autophagic delivery is blocked.\n\n[H5] Dihydrotestosterone suppresses SIRT3-dependent mitochondrial antioxidant protection in dermal papilla cells, making oxidative damage and senescence more severe. Loss of SIRT3 activity is a causal amplifier rather than merely a consequence of mitochondrial injury. Mechanism: Androgen receptor signaling lowers SIRT3 abundance or activity, increasing SOD2 acetylation and reducing superoxide detoxification. Accumulating mitochondrial superoxide damages respiratory machinery and activates a persistent DNA-damage response. Prediction: Reduced SIRT3 activity and increased SOD2 acetylation would precede respiratory failure. Catalytically active SIRT3, but not an inactive mutant, would rescue mitochondrial function and senescence; an acetylation-resistant SOD2 variant would reproduce a substantial part of that rescue without suppressing androgen receptor signaling.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5852,
          "promptSha256": "b43aa949cbf79bf6d1802be8b8d4ae026768cc19f673f542b175ca11c8ab5085"
        }
      ]
    },
    {
      "task": "R42717261",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 4
        },
        {
          "id": "H2",
          "hypothesisIndex": 2
        },
        {
          "id": "H3",
          "hypothesisIndex": 3
        },
        {
          "id": "H4",
          "hypothesisIndex": 1
        },
        {
          "id": "H5",
          "hypothesisIndex": 0
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nCellular senescence can develop in immune populations and alter tissue function through persistent inflammatory and dysfunctional states. Such immunosenescence has been associated with chronic inflammatory disorders, but whether senescent immune cells directly cause disease progression has remained uncertain. Metabolic disruption and mitochondrial damage are recognized triggers of senescence, including through the abnormal release of mitochondrial components into the cytosol. The causal sequence connecting these processes to intestinal inflammation and treatment resistance was unresolved.\n\nRESEARCH QUESTION\nWhat mechanism induces pathogenic immune-cell senescence in ulcerative colitis, and does this senescence causally exacerbate the disease?\n\nHYPOTHESES\n[H1] Mitochondrial DNA released by injured epithelial cells initiates senescence in intestinal monocyte-derived macrophages, establishing a self-sustaining inflammatory feedback loop. This macrophage state drives disease persistence after the original epithelial insult subsides. Mechanism: Internalized epithelial mitochondrial DNA escapes endolysosomal compartments and activates macrophage cGAS–STING signaling; senescent macrophages then release mediators that damage epithelium and provoke further mitochondrial DNA release. Prediction: Traceable epithelial mitochondrial DNA should accumulate in macrophage cytosol before senescence develops. Blocking macrophage DNA uptake or cGAS signaling should interrupt initiation, while selective removal of established senescent macrophages should reduce persistent colitis even after the initiating epithelial injury has ended.\n\n[H2] Excess mitochondrial reactive oxygen species drive senescence in proliferating intestinal T cells through persistent telomeric DNA damage. This senescence exacerbates ulcerative colitis independently of mitochondrial DNA sensing. Mechanism: Mitochondrial oxidants produce difficult-to-repair telomere-associated lesions, maintaining ATM–p53–p21 signaling and a tissue-damaging secretory program after the initial oxidative insult resolves. Prediction: T-cell-targeted mitochondrial catalase should reduce telomere-associated damage, durable proliferative arrest, and colitis severity, whereas cGAS or STING deletion should provide little protection. Transferring established senescent T cells should bypass the protective effect of mitochondrial antioxidant treatment.\n\n[H3] Repeated exposure to extracellular ATP from injured intestinal epithelium induces senescence in mucosal regulatory T cells. Loss of their suppressive function then causally amplifies ulcerative colitis. Mechanism: Chronic sublethal P2X7 signaling causes calcium overload, mitochondrial injury, and persistent stress signaling in regulatory T cells, producing durable arrest and impaired immune suppression. Prediction: Inducible P2X7 deletion specifically in mature regulatory T cells should preserve mitochondrial function and suppressive capacity and reduce colitis without directly protecting epithelial cells. Transfer of healthy regulatory T cells should rescue disease more effectively than equal numbers of viable ATP-induced senescent regulatory T cells.\n\n[H4] Inflammation-induced CD38 activity depletes NAD+ in intestinal T cells, producing mitochondrial dysfunction and stable senescence. These cells sustain ulcerative colitis through inflammatory pathways that persist despite TNF blockade. Mechanism: NAD+ depletion reduces sirtuin-dependent mitochondrial maintenance and DNA repair, activating p53–p21-mediated arrest alongside secretion of inflammatory mediators outside the TNF pathway. Prediction: T-cell-specific CD38 deletion or restoration of intracellular NAD+ should prevent mitochondrial dysfunction and senescence without requiring reduced antigen exposure. Selective removal of the resulting senescent cells should improve response to TNF blockade, whereas NAD+ restoration after senescence becomes established may be insufficient.\n\n[H5] Defective mitophagy in colonic CD4+ T cells induces pathogenic senescence in ulcerative colitis by allowing damaged mitochondria to release DNA into the cytosol. The resulting senescent cells causally worsen epithelial injury through persistent inflammatory secretion. Mechanism: Impaired PINK1–Parkin mitochondrial clearance causes cytosolic mitochondrial DNA accumulation, cGAS–STING activation, and sustained DNA-damage signaling that establishes a senescence-associated secretory phenotype. Prediction: Restoring mitophagy or deleting cGAS specifically in CD4+ T cells should prevent senescence and attenuate experimental colitis. Transfer of viable, established senescent T cells should restore disease severity despite correction of the initiating mitophagy defect.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5392,
          "promptSha256": "0626f7d7b388304ef00c8393df2583ff5420a23ab0c94d5807c32f5c0d78985e"
        }
      ]
    },
    {
      "task": "R42723546",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 1
        },
        {
          "id": "H2",
          "hypothesisIndex": 4
        },
        {
          "id": "H3",
          "hypothesisIndex": 3
        },
        {
          "id": "H4",
          "hypothesisIndex": 0
        },
        {
          "id": "H5",
          "hypothesisIndex": 2
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nChronic ultraviolet exposure causes skin photoaging characterized by impaired barrier function, collagen loss, cellular senescence, and persistent inflammation. Damaged cells can accumulate dysfunctional organelles and release intracellular danger signals that sustain sterile inflammatory responses. Regenerative cell-free therapies have shown potential for repairing aged or injured tissues, but their activity can involve many distinct biological processes. The causal mechanism by which such therapies might suppress photoaging-associated senescence and inflammation remained unresolved.\n\nRESEARCH QUESTION\nCan a cell-free regenerative treatment alleviate UV-induced skin photoaging, and which causal intracellular mechanism mediates its protective effects?\n\nHYPOTHESES\n[H1] MSC-EVs alleviate UV-induced skin photoaging by restoring lysosomal integrity and degradative capacity. This prevents cathepsin-dependent NLRP3 inflammasome activation and interrupts IL-1β-driven inflammation and secondary senescence. Mechanism: TFEB-dependent lysosomal renewal reduces lysosomal membrane permeabilization, cytosolic cathepsin activity, and NLRP3–caspase-1 signaling. Prediction: TFEB depletion abolishes EV-mediated reductions in lysosomal leakage, mature IL-1β, and senescence, while NLRP3 deletion restores downstream protection. Benefits persist after cGAS deletion and correlate with lysosomal repair rather than mitochondrial DNA clearance.\n\n[H2] MSC-EVs alleviate UV-induced skin photoaging by activating an NRF2-dependent antioxidant response in recipient skin cells. Increased glutathione synthesis and peroxide detoxification prevent oxidative damage from sustaining senescence, inflammation, and collagen breakdown. Mechanism: NRF2 activation induces GCLC, GCLM, and other antioxidant defenses, reducing lipid peroxidation and redox-sensitive stress signaling. Prediction: NFE2L2 deletion abolishes EV-induced antioxidant gene expression and tissue protection, while restoring glutathione availability partially rescues the phenotype. Protection remains detectable when PINK1-dependent mitophagy is disrupted and precedes any change in mitochondrial abundance.\n\n[H3] MSC-EVs alleviate UV-induced skin photoaging primarily by delivering functional miR-146a to recipient cells. Repression of IRAK1 and TRAF6 weakens NF-κB-dependent inflammatory feedback, reducing paracrine senescence and matrix-degrading enzyme production. Mechanism: EV-associated miR-146a enters recipient-cell silencing complexes and represses the IRAK1–TRAF6–NF-κB pathway. Prediction: EVs depleted of miR-146a lose protection at matched particle dose and uptake, and restoring miR-146a restores activity. Recipient cells expressing miR-146a-resistant IRAK1 and TRAF6 remain inflammatory despite treatment, whereas mitochondrial damage and UV photoproduct burden need not decrease.\n\n[H4] Mesenchymal stromal cell–derived extracellular vesicles (MSC-EVs) alleviate UV-induced skin photoaging by restoring PINK1–Parkin-dependent mitophagy in keratinocytes and dermal fibroblasts. Clearance of damaged mitochondria reduces cytosolic mitochondrial DNA, suppressing cGAS–STING signaling and the inflammatory reinforcement of cellular senescence. Mechanism: MSC-EVs increase mitochondrial delivery to lysosomes, reducing mitochondrial DNA leakage and downstream STING–TBK1–IRF3 signaling. Prediction: Protection is lost after PINK1 or PRKN disruption despite equivalent EV uptake; cGAS deletion rescues the inflammatory phenotype downstream of defective mitophagy. Increased mitophagic flux precedes reduced cytosolic mitochondrial DNA, senescence, and collagen degradation.\n\n[H5] MSC-EVs alleviate UV-induced skin photoaging by accelerating nucleotide excision repair of UV-induced nuclear DNA lesions before cells enter stable senescence. Reduced persistent DNA damage limits p53–p21 signaling and the subsequent senescence-associated secretory phenotype. Mechanism: Enhanced XPA-dependent nucleotide excision repair clears cyclobutane pyrimidine dimers and 6–4 photoproducts, reducing sustained DNA damage signaling. Prediction: EV treatment accelerates photoproduct clearance in nondividing cells, and XPA depletion eliminates both this effect and protection against senescence. Treatment is substantially less effective after stable senescence develops, even if inflammatory signaling remains suppressible.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5017,
          "promptSha256": "f5cca46f81b39297974c3f37cd4341deba49b4ce6f20673f3ef2591a408d0448"
        }
      ]
    },
    {
      "task": "R42725837",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 4
        },
        {
          "id": "H2",
          "hypothesisIndex": 1
        },
        {
          "id": "H3",
          "hypothesisIndex": 2
        },
        {
          "id": "H4",
          "hypothesisIndex": 0
        },
        {
          "id": "H5",
          "hypothesisIndex": 3
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nCellular senescence is a stable stress response that contributes to tissue dysfunction, chronic inflammation, and multiple age-related diseases. Senescent cells accumulate with age, and experimentally reducing their abundance or activity can improve health-related outcomes in animal models. Transmembrane proteins can regulate intracellular signaling networks involved in stress responses and cell-fate decisions, but many remain poorly characterized in ageing. Identifying upstream regulators that causally control senescence could reveal therapeutic targets for age-associated disorders.\n\nRESEARCH QUESTION\nDoes the transmembrane protein investigated in this study causally regulate cellular senescence and age-related tissue pathology, and through what signaling mechanism?\n\nHYPOTHESES\n[H1] The investigated transmembrane protein increases senescent-cell accumulation by protecting established senescent cells from apoptosis. Its inhibition reduces age-related pathology primarily through selective senescent-cell elimination. Mechanism: The protein sustains FAK–SRC-dependent survival signaling and BCL-XL activity, suppressing mitochondrial apoptosis in senescent cells. Prediction: Inhibition after senescence establishment selectively induces apoptosis without reversing arrest in surviving cells. BCL-XL restoration prevents both senescent-cell depletion and the associated tissue benefit, whereas the initial rate of senescence induction remains unchanged.\n\n[H2] The investigated transmembrane protein protects against cellular senescence by maintaining mitochondrial quality control. Age-dependent loss of its activity causes mitochondrial damage that drives senescence and tissue dysfunction. Mechanism: The protein supports AMPK–ULK1-dependent mitophagy, limiting mitochondrial reactive oxygen species and persistent DNA-damage signaling upstream of p53–p21. Prediction: Protein depletion impairs mitophagy before senescence develops, and restoring mitophagy prevents persistent arrest and tissue dysfunction despite continued protein depletion. Disabling ULK1 abolishes the protective effect of protein overexpression.\n\n[H3] The investigated transmembrane protein amplifies senescence-associated inflammation and its spread to neighboring cells, while being dispensable for the initial senescent arrest. Blocking it after senescence is established reduces age-related tissue pathology. Mechanism: The protein facilitates STING trafficking or activation, enhancing TBK1–IRF3 and NF-κB signaling in response to cytosolic DNA. Prediction: Post-arrest depletion reduces inflammatory secretion and conditioned-medium-induced senescence in recipient cells while preserving donor-cell arrest and viability. STING loss eliminates the protein-dependent inflammatory effect, and downstream activation restores it.\n\n[H4] The investigated transmembrane protein promotes cellular senescence by sustaining growth signaling after cellular damage. Its loss reduces senescence-associated inflammation and age-related tissue pathology. Mechanism: The protein activates PI3K–AKT–mTORC1 signaling, sustaining anabolic activity and the senescence-associated secretory phenotype (SASP) during damage-induced cell-cycle arrest. Prediction: Inducible loss of the protein reduces mTORC1 activity, persistent senescence markers, and SASP output under matched damage conditions; constitutively active Rheb restores these effects. Deletion in aged animals improves tissue function without increasing proliferation of damaged cells.\n\n[H5] The investigated transmembrane protein promotes stable senescence and age-related fibrosis by increasing cellular responsiveness to TGF-β. Its inhibition prevents a transient stress arrest from becoming self-maintaining. Mechanism: The protein stabilizes TGF-β receptors at the plasma membrane, prolonging SMAD2/3 signaling and inducing p15, p21, and profibrotic secretory factors. Prediction: Protein depletion accelerates TGF-β receptor internalization and reduces sustained SMAD2/3 activation; constitutively active TGF-β receptor signaling restores persistent arrest and profibrotic secretion. Tissue-specific deletion reduces fibrosis under matched injury exposure.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4829,
          "promptSha256": "961b50155ce032f16232867b6019f632a4898153a6a12fda5c694ae9c7eb912e"
        }
      ]
    },
    {
      "task": "R42736449",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 0
        },
        {
          "id": "H2",
          "hypothesisIndex": 3
        },
        {
          "id": "H3",
          "hypothesisIndex": 1
        },
        {
          "id": "H4",
          "hypothesisIndex": 2
        },
        {
          "id": "H5",
          "hypothesisIndex": 4
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAlzheimer's disease involves progressive neuronal dysfunction accompanied by broad molecular changes in the brain. Conventional genome annotation does not capture every translated product, leaving potentially functional proteins uncharacterized. Disease-associated changes in these overlooked products may occur independently of established proteins encoded at the same genomic loci. It remained unclear whether any such product contributes directly to cellular dysfunction in Alzheimer's disease.\n\nRESEARCH QUESTION\nCan an unannotated protein product that is altered in Alzheimer's disease causally regulate cellular function relevant to disease pathology?\n\nHYPOTHESES\n[H1] An unannotated microprotein elevated in Alzheimer's disease neurons directly impairs mitochondrial protein import, causing respiratory dysfunction independently of the annotated protein encoded at the same locus. Mechanism: The microprotein binds the TOM mitochondrial import complex and reduces import of nuclear-encoded respiratory-chain components, lowering ATP production and increasing oxidative stress. Prediction: Selective disruption of microprotein translation, while preserving host-transcript abundance and annotated-protein expression, restores mitochondrial import and respiration. Re-expression of the microprotein reverses this rescue, whereas a TOM-binding-deficient variant does not.\n\n[H2] An unannotated microprotein induced in Alzheimer's disease microglia promotes excessive synapse elimination by amplifying complement-receptor signaling. Mechanism: The microprotein inhibits internalization of complement receptor 3, increasing receptor availability and uptake of complement-tagged synapses. Prediction: Microprotein-specific disruption reduces surface complement receptor 3 and synapse engulfment in neuron–microglia cocultures while preserving microglial viability and annotated-protein expression. Complement receptor 3 blockade eliminates the difference between disrupted and control microglia.\n\n[H3] An unannotated microprotein depleted in Alzheimer's disease neurons normally supports lysosomal acidification, and its loss causes defective clearance of aggregation-prone tau. Mechanism: The microprotein stabilizes assembly of the lysosomal V-ATPase, maintaining the acidic environment required for proteolysis. Prediction: Selective microprotein depletion raises lysosomal pH before increasing insoluble tau, without changing the annotated protein at its locus. Restoring the microprotein rescues both phenotypes, and V-ATPase inhibition abolishes that rescue.\n\n[H4] An unannotated microprotein elevated in Alzheimer's disease neurons increases amyloidogenic processing of amyloid precursor protein by prolonging its residence in acidic endosomes. Mechanism: The microprotein interferes with retromer-dependent recycling of amyloid precursor protein, increasing its exposure to BACE1. Prediction: Selective suppression of the microprotein shortens endosomal residence of amyloid precursor protein and reduces β-cleavage products and secreted amyloid-β without changing precursor abundance. Retromer disruption eliminates this benefit.\n\n[H5] An unannotated microprotein depleted in Alzheimer's disease neurons restrains endoplasmic-reticulum calcium release, and its loss causes calcium-dependent synaptic dysfunction. Mechanism: The microprotein binds and limits opening of neuronal ryanodine receptors; depletion produces excessive calcium release, activates calpain, and destabilizes synaptic proteins. Prediction: Selective microprotein depletion increases ryanodine-receptor-dependent calcium release before synaptic impairment develops. Wild-type microprotein re-expression or ryanodine-receptor inhibition rescues calcium handling and synaptic function, whereas a receptor-binding-deficient microprotein does not.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4458,
          "promptSha256": "a156b6f35804cd92f5389d5e723fb90967d14edb59e15fa3d8e31e28cff7c484"
        }
      ]
    },
    {
      "task": "R42744804",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 2
        },
        {
          "id": "H2",
          "hypothesisIndex": 3
        },
        {
          "id": "H3",
          "hypothesisIndex": 4
        },
        {
          "id": "H4",
          "hypothesisIndex": 1
        },
        {
          "id": "H5",
          "hypothesisIndex": 0
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAmyotrophic lateral sclerosis is a progressive neurodegenerative disease characterized by motor-neuron loss, neuromuscular denervation and premature death. Inherited SOD1 mutations cause some forms of ALS and are widely used to model disease progression in mice. Degeneration in these models involves interactions between vulnerable neurons and surrounding cells, but it remained unclear which responses actively cause neuronal death rather than merely accompany it. Identifying causal mechanisms could reveal ways to preserve neuromuscular function and extend survival.\n\nRESEARCH QUESTION\nWhat disease-associated mechanism actively eliminates motor neurons and accelerates mortality in SOD1G93A mice?\n\nHYPOTHESES\n[H1] Cytotoxic CD8 T cells recognize disease-associated antigens on motor neurons and directly eliminate them in SOD1G93A mice. This adaptive immune attack accelerates functional decline and death. Mechanism: Motor-neuron MHC class I presentation recruits antigen-dependent CD8 T-cell contact, followed by perforin and granzyme-mediated killing. Prediction: Disrupting MHC class I presentation specifically in motor neurons reduces cytotoxic contacts, neuronal loss and mortality; disrupting perforin in CD8 T cells produces a similar, largely nonadditive benefit.\n\n[H2] Iron-dependent lipid peroxidation actively executes motor-neuron death in SOD1G93A mice and contributes to shortened survival. Mechanism: Mutant SOD1-associated oxidative stress overwhelms neuronal glutathione–GPX4 defenses, allowing iron-catalyzed oxidation of membrane phospholipids to trigger ferroptosis. Prediction: Inducible motor-neuron-specific ACSL4 deletion reduces oxidized phospholipids before neuronal loss, preserves innervation and extends survival despite continued inflammatory activation.\n\n[H3] Loss of astrocytic glutamate clearance actively kills motor neurons through excitotoxicity in SOD1G93A mice, accelerating respiratory motor-system failure and mortality. Mechanism: Reduced astrocytic EAAT2 activity elevates extracellular glutamate, driving excessive calcium entry through motor-neuron glutamate receptors and subsequent mitochondrial failure. Prediction: Restoring astrocytic EAAT2 after symptom onset normalizes extracellular glutamate and neuronal calcium transients, preserves respiratory motor units and extends survival without reducing mutant SOD1 abundance.\n\n[H4] Reactive astrocytes actively kill motor neurons in SOD1G93A mice by inducing necroptosis, thereby accelerating denervation and mortality. Mechanism: Astrocyte-derived TNF activates neuronal TNFR1 signaling under conditions favoring RIPK1–RIPK3–MLKL-dependent membrane rupture. Prediction: Motor-neuron-specific MLKL deletion preserves motor neurons and extends survival, while astrocyte-specific TNF deletion reduces neuronal MLKL activation and provides little additional protection when neuronal MLKL is already absent.\n\n[H5] Disease-activated microglia accelerate mortality in SOD1G93A mice by engulfing stressed but viable motor neurons. Complement tagging converts potentially reversible neuronal dysfunction into irreversible cell loss. Mechanism: C1q and C3 deposition on motor neurons promotes recognition by microglial complement receptor CR3, triggering phagocytosis before neuronal death. Prediction: Microglia-specific CR3 deletion after disease onset reduces engulfment of initially viable motor neurons, preserves neuromuscular innervation and extends survival despite persistent mutant SOD1 accumulation.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4140,
          "promptSha256": "cc673af8b513459835c20fa697fc026d89a963ee3ce1c1e29cfc2aee635f4d08"
        }
      ]
    },
    {
      "task": "R42749700",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 3
        },
        {
          "id": "H2",
          "hypothesisIndex": 0
        },
        {
          "id": "H3",
          "hypothesisIndex": 2
        },
        {
          "id": "H4",
          "hypothesisIndex": 4
        },
        {
          "id": "H5",
          "hypothesisIndex": 1
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nHutchinson–Gilford progeria syndrome is a rare genetic disorder characterized by accelerated ageing and markedly shortened lifespan. Cells affected by the disease develop nuclear abnormalities, loss of chromatin organization, and premature senescence. Senescent cells can reinforce tissue dysfunction by releasing pro-inflammatory factors collectively known as the senescence-associated secretory phenotype. The molecular mechanisms connecting altered nuclear architecture to this secretory state remained incompletely understood, limiting the development of mechanism-based treatments.\n\nRESEARCH QUESTION\nWhat molecular mechanism links disrupted chromatin regulation to cellular senescence in Hutchinson–Gilford progeria syndrome, and can targeting that mechanism ameliorate disease phenotypes and extend lifespan?\n\nHYPOTHESES\n[H1] Progerin-associated loss of Polycomb repression activates the CDKN2A locus, making p16–RB signaling a causal driver of premature senescence. Restoring repression specifically at this locus will preserve regenerative capacity and improve progeria phenotypes. Mechanism: Reduced PRC2 occupancy and H3K27me3 at CDKN2A permit p16 accumulation, RB activation, and stable cell-cycle arrest that subsequently supports tissue senescence. Prediction: Targeted restoration of H3K27me3 at the p16 regulatory region will delay durable arrest more effectively than STING inhibition despite persistent DNA-damage signaling. Tissue-restricted intervention in progeria mice will improve regeneration and survival only if restored proliferation does not increase genomic instability or tumors.\n\n[H2] Progerin-induced loss of lamina-associated heterochromatin promotes cytoplasmic chromatin accumulation, activating cGAS–STING signaling that reinforces senescence and its inflammatory secretory phenotype. Suppressing this pathway after disease onset will reduce tissue dysfunction and extend survival in a progeria mouse model. Mechanism: Defective chromatin anchoring and nuclear-envelope instability expose genomic DNA to cytoplasmic cGAS, driving STING–TBK1–IRF3 and NF-κB signaling. Prediction: Inducible cGAS deletion will reduce inflammatory secretion and improve vascular pathology and survival despite persistent progerin expression and nuclear deformation; restoring STING signaling downstream of cGAS will reverse the cellular benefit.\n\n[H3] Loss of heterochromatic repression in progeria derepresses LINE-1 retrotransposons, whose reverse-transcribed DNA activates innate immune signaling and accelerates senescence. Blocking LINE-1 reverse transcription will reduce inflammation and extend lifespan without requiring restoration of nuclear architecture. Mechanism: Reduced H3K9me3-dependent silencing permits LINE-1 expression and cytoplasmic accumulation of LINE-1-derived DNA, activating cGAS–STING and inflammatory signaling. Prediction: Genetic disruption of LINE-1 reverse-transcriptase activity will reduce cytoplasmic LINE-1 DNA, inflammatory secretion, and secondary senescence while leaving nuclear rupture frequency largely unchanged. Reverse-transcriptase-competent, but not catalytically inactive, LINE-1 will restore these phenotypes, distinguishing this mechanism from leakage of genomic chromatin.\n\n[H4] Disrupted telomeric chromatin in progeria causes replication-associated telomere damage that initiates persistent senescence and inflammatory secretion. Restoring telomere protection will ameliorate disease and extend survival even when global nuclear abnormalities persist. Mechanism: Altered lamina–chromatin interactions impair telomeric chromatin organization and shelterin function, producing persistent ATM–p53–p21 signaling and a downstream senescence-associated secretory phenotype. Prediction: Restoring the experimentally identified telomere-protection defect will reduce telomere-associated damage foci, durable arrest, and inflammatory secretion more strongly than matched correction of non-telomeric damage. Tissue-targeted rescue will improve vascular-cell retention and survival in progeria mice without substantially correcting overall nuclear shape.\n\n[H5] Disrupted chromatin organization in progeria redistributes BRD4 to newly activated inflammatory enhancers, establishing a transcriptional program that maintains the senescence-associated secretory phenotype. Selectively disrupting these enhancers will reduce paracrine senescence and ameliorate disease. Mechanism: Increased enhancer acetylation recruits BRD4 and transcriptional elongation machinery to inflammatory genes, sustaining secretion independently of the initiating nuclear damage. Prediction: BRD4 occupancy and H3K27 acetylation will increase at specific secretory-program enhancers before maximal cytokine secretion. CRISPR interference at these enhancers will suppress secretion and conditioned-medium-induced senescence without correcting nuclear morphology; appropriately targeted BRD4 inhibition will improve pathology and survival in progeria mice.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5622,
          "promptSha256": "3496fcf976dbf6244413f599acf516ed0c518cb8589f933d4d99cff59517a80b"
        }
      ]
    },
    {
      "task": "R42758848",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 2
        },
        {
          "id": "H2",
          "hypothesisIndex": 1
        },
        {
          "id": "H3",
          "hypothesisIndex": 0
        },
        {
          "id": "H4",
          "hypothesisIndex": 3
        },
        {
          "id": "H5",
          "hypothesisIndex": 4
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing is accompanied by a progressive weakening of adaptive immune responses, which reduces protection against infections and cancer. Effective immunity requires resting immune cells to preserve metabolic competence while remaining ready for rapid activation. Age-related changes in chromatin regulation and cellular metabolism have both been implicated in immune dysfunction. However, the mechanism that establishes this latent metabolic readiness and how ageing disrupts it remained unclear.\n\nRESEARCH QUESTION\nWhat developmentally established epigenetic mechanism preserves metabolic readiness for rapid immune activation, and how is it disrupted during ageing?\n\nHYPOTHESES\n[H1] During lymphocyte development, CTCF–cohesin architecture establishes persistent contacts between metabolic genes and activation-responsive enhancers. Ageing weakens these contacts, uncoupling antigen-induced transcription-factor binding from rapid metabolic gene expression. Mechanism: Preassembled enhancer–promoter contacts minimize the chromatin reorganization required for metabolic activation; age-related loss of architectural protein occupancy increases transcriptional latency. Prediction: Aged cells show reduced contacts at metabolic loci despite retained enhancer accessibility and histone priming, and experimentally restoring those contacts rescues early transcription and metabolic flux without correcting the histone marks.\n\n[H2] Immune-cell development establishes poised metabolic enhancers that retain H3K4me1 during quiescence and rapidly acquire H3K27ac after stimulation. Ageing disrupts maintenance of this enhancer state, preventing otherwise intact activation signals from inducing sufficient metabolic capacity. Mechanism: KMT2C/KMT2D-dependent enhancer priming lowers the threshold for stimulus-dependent p300 recruitment at genes controlling glucose uptake, amino-acid transport and mitochondrial expansion. Prediction: Aged resting cells lose enhancer H3K4me1 before losing promoter competence, and locus-specific enhancer re-priming restores stimulus-induced H3K27ac, nutrient uptake and proliferation even when promoter methylation is unchanged.\n\n[H3] During T-cell development, metabolic gene promoters acquire H3K4me2 marks that persist in resting naive T cells and enable rapid transcription after antigen recognition. Ageing erodes these marks, delaying metabolic activation despite preserved proximal receptor signalling. Mechanism: Developmentally deposited H3K4me2 maintains promoters of mitochondrial biogenesis and nutrient-utilization genes in a permissive state, accelerating recruitment of transcriptional machinery upon activation. Prediction: In phenotypically matched aged naive T cells, targeted restoration of H3K4me2 at affected promoters rescues early metabolic gene induction and subsequent proliferation without increasing baseline activation; targeted removal in young cells reproduces the defect.\n\n[H4] Developmental TET activity creates persistently hypomethylated regulatory elements at metabolic genes, preserving their responsiveness in resting lymphocytes. Age-related remethylation blocks activation-dependent transcription-factor binding and reduces metabolic readiness. Mechanism: Stable DNA hypomethylation permits inducible factors such as MYC to occupy metabolic regulatory elements rapidly after stimulation; declining TET-mediated maintenance permits inhibitory methylation to accumulate. Prediction: Targeted demethylation of affected elements in aged cells restores inducible factor binding and metabolic activation, whereas catalytically inactive TET recruitment does not; targeted remethylation produces the reciprocal defect in young cells.\n\n[H5] Lymphocyte development establishes a restricted Polycomb repression pattern that keeps metabolic response genes outside stably silenced chromatin while suppressing inappropriate lineage programs. During ageing, H3K27me3 spreads into these protected metabolic loci and prevents their rapid induction. Mechanism: Developmentally established boundaries constrain PRC2-mediated repression; deterioration of boundary maintenance allows metabolic promoters to enter a repressive chromatin state despite intact activation signalling. Prediction: Aged cells acquire H3K27me3 at previously protected metabolic loci before functional decline, and locus-specific removal of this mark restores activation-induced metabolic flux without requiring restoration of enhancer contacts or DNA demethylation.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5124,
          "promptSha256": "d5edd211ed169b4fad18660e34b9b678c62ec14279d0a0e1255ec36ebb8c01b1"
        }
      ]
    },
    {
      "task": "R42759510",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 3
        },
        {
          "id": "H2",
          "hypothesisIndex": 2
        },
        {
          "id": "H3",
          "hypothesisIndex": 0
        },
        {
          "id": "H4",
          "hypothesisIndex": 1
        },
        {
          "id": "H5",
          "hypothesisIndex": 4
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nWomen show a disproportionate increase in cognitive and systemic vulnerability during midlife despite their longer average lifespan. Ageing is accompanied by mitochondrial dysfunction, cellular senescence, and altered communication between peripheral tissues and the brain. Circulating regulatory signals can influence brain physiology, but the mechanisms responsible for the female-biased transition from resilience to vulnerability remain poorly understood. It was also unclear whether this transition is reversible or contributes causally to age-related neurodegenerative phenotypes.\n\nRESEARCH QUESTION\nWhat molecular mechanism drives peripheral-to-brain signaling that promotes senescence, mitochondrial dysfunction, and cognitive vulnerability during female midlife?\n\nHYPOTHESES\n[H1] Ovarian hormone decline promotes peripheral inflammation that redirects tryptophan metabolism toward circulating kynurenine, creating a toxic peripheral-to-brain metabolic signal. Female midlife vulnerability results when brain kynurenine metabolism favors quinolinic acid production over protective metabolites. Mechanism: Peripheral immune-cell IDO1 activity elevates blood kynurenine, which crosses the blood–brain barrier through LAT1. Microglial conversion to quinolinic acid increases NMDA-receptor-mediated calcium stress, mitochondrial injury, and secondary senescence-associated signaling in neighboring glia. Prediction: Peripheral-restricted IDO1 inhibition would reduce brain quinolinic acid and improve mitochondrial function and cognition; kynurenine replacement would reverse these benefits. Microglial KMO deletion would remain protective despite kynurenine replacement, locating the essential downstream step within the brain.\n\n[H2] Female midlife endocrine changes increase hepatic production of circulating C16:0 ceramide, which transmits peripheral metabolic stress to the brain. Excess ceramide drives mitochondrial dysfunction and establishes a self-sustaining glial senescence-associated state. Mechanism: Reduced hepatic estrogen signaling increases ceramide synthesis and lipoprotein-associated export. Uptake at the neurovascular unit increases mitochondrial membrane stress, impairs insulin–AKT signaling, and promotes oxidative damage and inflammatory glial responses. Prediction: Hepatocyte-specific CerS6 suppression would lower circulating C16:0 ceramide and rescue brain phenotypes without correcting ovarian hormone loss. Restoring circulating C16:0 ceramide in matched lipoprotein particles would abolish that rescue.\n\n[H3] During female midlife, declining ovarian estradiol increases adipose-derived extracellular vesicles carrying miR-34a, which impair mitochondrial maintenance in the brain. This circulating signal promotes glial senescence and cognitive vulnerability. Mechanism: Estradiol withdrawal increases adipocyte stress and vesicular miR-34a export. Brain uptake suppresses SIRT1–PGC-1α signaling, reducing mitochondrial biogenesis and increasing reactive oxygen species and senescence-associated inflammatory signaling. Prediction: Adipocyte-specific deletion of miR-34a would preserve brain mitochondrial function and cognition during ovarian ageing without restoring estradiol. Equal numbers of adipose vesicles from midlife females would transfer these defects to recipients, whereas miR-34a-depleted vesicles would not.\n\n[H4] Loss of ovarian endocrine support during female midlife induces mitochondrial DNA release from peripheral tissues, activating a senescence-promoting inflammatory relay at the blood–brain barrier. This vascular relay drives brain dysfunction without requiring circulating mitochondrial DNA to enter brain tissue. Mechanism: Circulating mitochondrial DNA enters brain endothelial endosomes and activates TLR9–NF-κB signaling. Endothelial senescence, impaired barrier function, and cytokine release subsequently induce glial mitochondrial stress and disrupt neuronal support. Prediction: Brain-endothelial-specific Tlr9 deletion would prevent vascular senescence, downstream glial dysfunction, and cognitive impairment despite persistently elevated circulating mitochondrial DNA. Selective removal of mitochondrial DNA from midlife plasma would reduce its endothelial toxicity.\n\n[H5] Female midlife ovarian decline expands senescent visceral-adipose stromal cells whose circulating IL-6 initiates a brain endothelial–glial inflammatory feedback loop. This loop maintains mitochondrial dysfunction and cognitive vulnerability after the initial peripheral trigger has subsided. Mechanism: Peripheral IL-6 combines with soluble IL-6 receptor to activate endothelial gp130–STAT3 trans-signaling. Endothelial inflammatory mediators induce astrocyte senescence and microglial activation, whose reciprocal signals sustain oxidative stress and impair neuronal energy support. Prediction: Inducible Il6 deletion in adipose stromal cells or selective blockade of IL-6 trans-signaling would prevent the transition despite continued estradiol decline. After dysfunction is established, combined peripheral blockade and interruption of astrocytic STAT3 signaling would outperform peripheral blockade alone, supporting a self-maintaining central loop.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5836,
          "promptSha256": "74d134034f19c1f8376f9118e237cd97b924ae94987f6743e7e71cec909c587b"
        }
      ]
    },
    {
      "task": "R42775695",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 2
        },
        {
          "id": "H2",
          "hypothesisIndex": 1
        },
        {
          "id": "H3",
          "hypothesisIndex": 0
        },
        {
          "id": "H4",
          "hypothesisIndex": 4
        },
        {
          "id": "H5",
          "hypothesisIndex": 3
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nCardiac function progressively deteriorates with age, increasing susceptibility to heart failure and other cardiovascular disorders. Defective mitochondrial quality control is considered an important contributor to this decline. Selective removal of damaged mitochondria must remain properly balanced, because disruption at multiple stages of the process can impair cellular homeostasis. The upstream causes of this age-associated defect and whether it can be therapeutically reversed were not well established.\n\nRESEARCH QUESTION\nWhat causes defective mitochondrial quality-control flux in the aging heart, and how can restoring mitochondrial homeostasis reverse cardiac aging?\n\nHYPOTHESES\n[H1] Age-associated loss of NAD+ impairs cardiac mitochondrial quality control through reduced SIRT1-dependent activation of the autophagy machinery. Restoring cardiomyocyte NAD+ will reverse established mitochondrial and contractile defects only when SIRT1-mediated autophagosome formation is preserved. Mechanism: Reduced SIRT1 activity increases inhibitory acetylation of autophagy proteins, limiting the formation of autophagosomes capable of capturing damaged mitochondria. Prediction: NAD+ restoration will reduce autophagy-protein acetylation and improve mitochondrial degradation and cardiac function in aged control mice, but not in cardiomyocyte-specific Sirt1-deficient mice, even if NAD+ concentrations rise similarly.\n\n[H2] Persistent mTORC1 activation in aged cardiomyocytes suppresses TFEB-dependent lysosomal renewal, making terminal degradation the principal bottleneck in mitochondrial quality-control flux. Restoring TFEB activity will clear accumulated mitochondrial cargo and reverse cardiac dysfunction more effectively than increasing mitophagy initiation alone. Mechanism: Reduced TFEB nuclear activity lowers lysosomal degradative capacity, allowing mitochondrial cargo to accumulate despite continued recognition and sequestration. Prediction: Inducible TFEB activation in aged cardiomyocytes will increase lysosomal proteolysis and mitochondrial cargo clearance and improve relaxation despite unchanged initial mitochondrial ubiquitination. Increasing Parkin alone will instead increase sequestered cargo without comparable functional recovery.\n\n[H3] Age-dependent elevation of mitochondrial USP30 activity causes defective cardiac mitophagy by removing ubiquitin signals required to recognize damaged mitochondria. Cardiomyocyte-specific USP30 inhibition will restore mitochondrial turnover and reverse established cardiac dysfunction when downstream lysosomal capacity remains intact. Mechanism: USP30 counteracts PINK1–Parkin-mediated mitochondrial ubiquitination, reducing recruitment of mitophagy receptors and sequestration of damaged mitochondria. Prediction: In aged hearts, USP30 inhibition will restore mitochondrial ubiquitination, lysosome-dependent mitochondrial degradation, and diastolic function without increasing lysosomal abundance. These benefits will disappear after cardiomyocyte-specific Parkin deletion.\n\n[H4] Age-related disruption of the cardiomyocyte microtubule transport system causes defective mitochondrial quality-control flux by preventing mitochondrial cargo-containing autophagosomes from reaching lysosomes. Restoring retrograde autophagosome transport will clear damaged mitochondria and reverse cardiac dysfunction despite unchanged mitophagy initiation. Mechanism: Reduced coupling of autophagosomes to dynein–dynactin limits their movement toward lysosomes, producing a delivery bottleneck in structurally crowded aged cardiomyocytes. Prediction: Aged cardiomyocytes will show reduced autophagosome motility and fewer autophagosome–lysosome encounters despite preserved lysosomal acidity and protease activity. Restoring motor recruitment will normalize mitochondrial cargo degradation and cardiac relaxation, whereas increasing lysosomal acidity alone will not.\n\n[H5] Loss of spatially restricted mitochondrial fission in aged cardiomyocytes prevents damaged mitochondrial regions from being separated for selective disposal. Restoring damage-coupled fission, without globally increasing fragmentation, will recover mitophagy flux and reverse cardiac functional decline. Mechanism: Defective recruitment of DRP1 to damaged mitochondrial regions prevents segregation of poorly functioning components into units that can be engulfed by autophagosomes. Prediction: Restoring damage-localized DRP1 recruitment will increase selective disposal of depolarized mitochondrial regions and improve cardiac function without changing lysosomal capacity. Equivalent untargeted DRP1 activation will cause fragmentation without comparable recovery.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5327,
          "promptSha256": "cb6e7b31b5ec518f67c6df7f133fe6b9c247f6d302ede0af6aa2918a5b60fca8"
        }
      ]
    },
    {
      "task": "R42775698",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 2
        },
        {
          "id": "H2",
          "hypothesisIndex": 1
        },
        {
          "id": "H3",
          "hypothesisIndex": 0
        },
        {
          "id": "H4",
          "hypothesisIndex": 4
        },
        {
          "id": "H5",
          "hypothesisIndex": 3
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nIntestinal structure and barrier integrity commonly deteriorate with age, contributing to altered nutrient handling, inflammation, and systemic metabolic dysfunction. Ageing is also accompanied by changes in circulating metabolites and intestinal gene expression. Observational studies have linked these features, but such associations cannot establish whether age-related changes in the intestinal ecosystem actively cause host dysfunction. The mechanisms connecting donor age-associated biological states to impaired intestinal physiology therefore remained unclear.\n\nRESEARCH QUESTION\nCan age-associated differences in the human gut microbial community causally reprogram intestinal barrier function, systemic metabolism, and mucosal gene expression, and what mediators contribute to these effects?\n\nHYPOTHESES\n[H1] Older-donor gut communities produce fewer tryptophan-derived aryl hydrocarbon receptor agonists, reducing mucosal repair and antimicrobial defense. This metabolite deficit causes barrier leakage and secondary systemic inflammation. Mechanism: Reduced microbial indole signaling lowers aryl hydrocarbon receptor activation in mucosal immune cells, diminishing IL-22-dependent epithelial repair and protective gene expression. Prediction: Recipients of older-donor communities show reduced indole metabolites, mucosal aryl hydrocarbon receptor activity, and IL-22 signaling. Supplementation with a defined microbial agonist restores barrier function and improves metabolic outcomes, but this rescue is lost after relevant immune-cell aryl hydrocarbon receptor deletion or IL-22 blockade.\n\n[H2] Age-associated differences in microbial bile acid transformation generate a bile acid pool that causally disrupts intestinal barrier regulation and systemic glucose metabolism. These effects arise from altered intestinal FXR and TGR5 signaling. Mechanism: Changes in microbial bile salt deconjugation and secondary bile acid synthesis alter epithelial transcription, enteroendocrine GLP-1 secretion, and intestinal–hepatic metabolic signaling. Prediction: Older-donor microbiota transfer produces a distinct bile acid profile alongside barrier and metabolic abnormalities. Reconstituting that bile acid profile reproduces the abnormalities in recipients of younger-donor microbiota, while targeted inhibition of the responsible microbial transformations prevents them; receptor-specific perturbations identify the required signaling pathway.\n\n[H3] Gut microbial communities from older human donors impair intestinal barrier function by producing less butyrate than communities from younger donors. Reduced epithelial butyrate availability causally alters mucosal gene expression and promotes systemic metabolic dysfunction. Mechanism: Loss of microbial butyrate production reduces colonocyte oxidative metabolism and protective hypoxia signaling, weakening junctional integrity and increasing translocation of inflammatory microbial products. Prediction: Under identical diets, germ-free mice colonized with older-donor communities exhibit lower colonic butyrate, increased permeability, and impaired glucose tolerance. Restoring microbial butyrate production rescues these outcomes, whereas matched communities carrying a disrupted butyrate-synthesis pathway do not.\n\n[H4] Age-associated enrichment of microbial mucin-degrading activity causally erodes the intestinal mucus barrier, particularly when dietary fermentable fiber is limited. Increased microbial contact with the epithelium then reprograms mucosal transcription and promotes systemic metabolic inflammation. Mechanism: Microbial glycosidases and sulfatases accelerate mucus consumption beyond host replenishment, increasing epithelial exposure to bacteria and activating inflammatory and tissue-repair programs. Prediction: Older-donor communities cause greater mucus thinning and epithelial bacterial proximity before permeability and metabolic abnormalities emerge. Disabling mucin-degradation pathways in implicated strains prevents these outcomes at comparable microbial loads, with a stronger protective effect under low-fiber conditions.\n\n[H5] Older-donor microbial communities contain a greater functional burden of strongly immunostimulatory lipopolysaccharide, which causally drives mucosal inflammation and systemic insulin resistance. The effect depends on endotoxin potency rather than simply Gram-negative bacterial abundance. Mechanism: Potent microbial lipid A structures activate TLR4–MyD88 signaling in intestinal myeloid cells, inducing cytokines that disrupt epithelial junctions and propagate inflammatory metabolic signaling. Prediction: At matched bacterial loads and lipopolysaccharide concentrations, older-donor communities produce stronger TLR4 activation and greater barrier and metabolic impairment. Myeloid TLR4 deletion or replacement of implicated strains with lipid A modification mutants attenuates these effects despite similar colonization.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5585,
          "promptSha256": "ef1292566c302dafcc17e1ebb70bf72e7df89becf9e762bf3da09d9a8d46e5b4"
        }
      ]
    },
    {
      "task": "R42786310",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 3
        },
        {
          "id": "H2",
          "hypothesisIndex": 2
        },
        {
          "id": "H3",
          "hypothesisIndex": 0
        },
        {
          "id": "H4",
          "hypothesisIndex": 1
        },
        {
          "id": "H5",
          "hypothesisIndex": 4
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing involves coordinated deterioration across metabolic, immune and organ systems, accompanied by changes in host-associated microbial communities. Microbiome composition correlates with biological age and age-related physiological states, but such associations do not establish whether individual microorganisms can modify the ageing process. Some microbial interventions alter host metabolism and longevity in experimental models, although causal effects often depend on organism viability, microbial products and host context. It therefore remained unclear whether systematic integration of diverse human biological measurements could identify a microorganism with experimentally reproducible geroprotective activity.\n\nRESEARCH QUESTION\nCan a commensal microorganism predicted from integrated human ageing profiles causally extend lifespan and healthspan and shift age-associated molecular and microbial states toward younger configurations?\n\nHYPOTHESES\n[H1] The nominated commensal extends lifespan and healthspan by restructuring the resident microbial community into a functionally younger state. Its direct interaction with the host is insufficient without cooperating community members. Mechanism: Microbial cross-feeding suppresses inflammation-promoting organisms and restores community metabolic functions depleted with age. Prediction: Protection occurs in a defined community containing the required partners but disappears when those partners are omitted. A transferred, restructured community retains protection after verified removal of the nominated organism, supporting a community-mediated effect.\n\n[H2] The nominated commensal prolongs lifespan and preserves healthspan primarily by preventing age-related intestinal permeability and the resulting chronic innate immune activation. Barrier restoration precedes improvements in systemic molecular ageing signatures. Mechanism: Enhanced epithelial junction maintenance and mucus integrity reduce microbial-product translocation and sustained inflammatory signaling in distant tissues. Prediction: Barrier improvements precede reduced circulating microbial products, inflammation and frailty. An inducible epithelial-specific disruption of the implicated barrier pathway eliminates the intervention's benefits despite preserved commensal abundance and metabolite exposure.\n\n[H3] A commensal nominated by integrated human ageing profiles extends remaining lifespan and preserves physical function when administered alive to aged mice. Its benefit requires ongoing microbial metabolism rather than exposure to inert microbial components. Mechanism: Viable organisms produce metabolites that improve intestinal barrier integrity, reduce systemic inflammation and slow functional decline. Prediction: Live organisms reproducibly improve survival, frailty and muscle performance relative to vehicle and heat-killed organisms under matched food intake. A metabolically impaired strain loses efficacy despite comparable intestinal abundance.\n\n[H4] The nominated commensal extends lifespan and healthspan through a specific secreted metabolite whose production declines in ageing-associated microbial communities. Restoring that metabolite is sufficient to reproduce the organism's protective effects. Mechanism: A microbial metabolite activates a defined host receptor and downstream stress-resistance pathways, shifting tissue transcription and metabolism toward independently established younger reference states. Prediction: Deleting the microbial metabolite-synthesis pathway abolishes protection, purified metabolite supplementation restores it, and disrupting its host receptor blocks both microbial and metabolite-mediated benefits.\n\n[H5] The nominated commensal extends lifespan and healthspan by activating host autophagy, thereby reducing age-related accumulation of damaged cellular material. Younger molecular profiles reflect improved tissue maintenance rather than merely altered immune-cell composition. Mechanism: Microbial signals activate an AMPK–autophagy program in intestinal and metabolic tissues, improving mitochondrial quality control and limiting cellular senescence. Prediction: Treatment increases measured autophagic flux before functional improvement and shifts ageing signatures within matched cell types. Adult-onset, tissue-specific disruption of essential autophagy machinery abolishes survival and functional benefits despite preserved microbial exposure.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5088,
          "promptSha256": "4479887858cfc3452598de73c194daeb140418df137e6835178efb604c9ac2e6"
        }
      ]
    },
    {
      "task": "R42805954",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 0
        },
        {
          "id": "H2",
          "hypothesisIndex": 2
        },
        {
          "id": "H3",
          "hypothesisIndex": 1
        },
        {
          "id": "H4",
          "hypothesisIndex": 4
        },
        {
          "id": "H5",
          "hypothesisIndex": 3
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing is associated with declining thermogenic capacity in adipose tissue, impaired energy expenditure, and increased susceptibility to metabolic dysfunction. Subcutaneous white adipose tissue can acquire heat-producing adipocytes in response to environmental stimuli, but this capacity diminishes with age. Communication between the nervous system and adipose tissue helps regulate this adaptive response. The mechanisms responsible for its age-related deterioration remained incompletely understood.\n\nRESEARCH QUESTION\nWhat causal mechanism contributes to the age-related decline of thermogenic adipocytes in subcutaneous white adipose tissue?\n\nHYPOTHESES\n[H1] Ageing reduces neurotrophic support from adipose stromal cells, causing sympathetic axon loss and insufficient norepinephrine delivery to subcutaneous white adipose tissue. This loss of local innervation limits the recruitment and maintenance of thermogenic beige adipocytes. Mechanism: Reduced stromal nerve growth factor production impairs sympathetic terminal maintenance, lowering cold-induced adrenergic stimulation of adjacent adipocytes. Prediction: Restoring stromal nerve growth factor in aged mice restores sympathetic axon density, local norepinephrine release, and cold-induced beige adipocytes; sympathetic denervation abolishes this rescue. Preserved responses to direct beta-adrenergic stimulation would distinguish this mechanism from adipocyte-intrinsic resistance.\n\n[H2] Ageing increases catecholamine resistance within subcutaneous adipocytes through elevated phosphodiesterase activity. Consequently, adequate sympathetic stimulation fails to sustain the intracellular signal needed for beige adipocyte recruitment and maintenance. Mechanism: Elevated adipocyte PDE3B activity accelerates cAMP degradation, weakening PKA–p38–PGC-1α signaling and UCP1 induction downstream of beta-adrenergic receptors. Prediction: Aged adipocytes exhibit reduced cAMP persistence and thermogenic induction under matched norepinephrine exposure. Adipocyte-specific Pde3b suppression restores these responses and tissue thermogenesis without altering innervation or extracellular norepinephrine availability.\n\n[H3] Ageing increases norepinephrine clearance by sympathetic nerve-associated macrophages, reducing the adrenergic signal available to subcutaneous adipocytes despite preserved neuronal release. Mechanism: Increased macrophage SLC6A2-mediated norepinephrine uptake and MAOA-mediated degradation shorten extracellular norepinephrine availability and suppress thermogenic gene induction. Prediction: Macrophage-restricted disruption of Slc6a2 in aged mice prolongs extracellular norepinephrine availability and restores cold-induced thermogenesis without increasing sympathetic axon density or neuronal firing.\n\n[H4] Ageing drives thermogenic adipocyte progenitors into a senescent state, limiting the supply of new beige adipocytes even when sympathetic stimulation remains adequate. Mechanism: Persistent p16INK4a-associated cell-cycle arrest reduces progenitor expansion, while progenitor-derived TGF-β promotes a fibrotic environment that inhibits thermogenic differentiation. Prediction: Lineage tracing reveals reduced progenitor-derived beige adipocyte formation in aged tissue under matched adrenergic stimulation. Selective removal of senescent progenitors followed by replacement with competent progenitors restores recruitment without changing sympathetic activity or mature-adipocyte adrenergic signaling.\n\n[H5] Ageing strengthens an inhibitory sensory feedback circuit from subcutaneous white adipose tissue to the central nervous system, suppressing cold-evoked sympathetic output to that depot. Mechanism: Age-associated adipose inflammation increases activity in depot-innervating sensory afferents, which engage central circuits that inhibit sympathetic drive and thereby reduce beige adipocyte recruitment. Prediction: Selective, reversible silencing of depot-innervating sensory afferents in aged mice increases local sympathetic firing and cold-induced thermogenesis before structural reinnervation can occur. Normal thermogenic responses to direct sympathetic terminal stimulation would support a circuit-level defect.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4848,
          "promptSha256": "bf89ebd6db8148174728347dea3092396450a9f31a3cf8d02ae2e4af5f7985bd"
        }
      ]
    },
    {
      "task": "R42810392",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 4
        },
        {
          "id": "H2",
          "hypothesisIndex": 2
        },
        {
          "id": "H3",
          "hypothesisIndex": 1
        },
        {
          "id": "H4",
          "hypothesisIndex": 0
        },
        {
          "id": "H5",
          "hypothesisIndex": 3
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing is strongly influenced by conserved systems that coordinate cellular metabolism with nutrient and energy availability. Genetic studies have shown that altering metabolic regulation can affect lifespan in several model organisms. Pharmacological studies, however, often use compounds with multiple targets, making it difficult to attribute longevity effects to a specific mechanism. It therefore remained unclear whether selective engagement of a single conserved metabolic target could directly produce longevity benefits across species.\n\nRESEARCH QUESTION\nCan direct pharmacological activation of a conserved metabolic target extend lifespan across evolutionarily diverse organisms and induce longevity-associated changes in mammals?\n\nHYPOTHESES\n[H1] Direct AMPK activation in intestinal cells is sufficient to extend lifespan in nematodes and flies by preserving epithelial integrity. Intestinal activation in aged mice reduces barrier leakage and systemic inflammation. Mechanism: AMPK maintains epithelial polarity and junctional organization, limiting the passage of microbial products that provoke chronic inflammation. Prediction: Intestine-restricted AMPK activation reproduces much of the systemic treatment benefit, whereas intestine-specific AMPK loss prevents it. Experimentally restoring barrier leakage despite treatment reverses the survival or inflammatory benefits without eliminating AMPK activation.\n\n[H2] Direct AMPK activation extends lifespan by suppressing excessive TORC1-dependent protein synthesis during adulthood. In aged mammals, this produces a corresponding reduction in translational burden and accumulation of damaged proteins. Mechanism: AMPK inhibits TORC1 signaling, reducing energy-intensive translation and limiting production of proteins that exceed cellular folding capacity. Prediction: Maintaining TORC1 activity experimentally prevents drug-induced lifespan extension despite intact AMPK activation, while partial adult-onset inhibition of translation reproduces the benefit. Mammalian tissues show reduced translation and protein damage without substantial weight loss or reduced food intake.\n\n[H3] Direct AMPK activation extends lifespan primarily by increasing autophagic clearance of damaged cellular components. The same mechanism reduces age-associated protein aggregation in mammals. Mechanism: AMPK activates the conserved ULK1/Atg1 autophagy machinery, increasing lysosomal degradation and recycling. Prediction: Treatment increases autophagic flux before survival benefits appear, but adult-onset disruption of ULK1/Atg1 or essential autophagy genes abolishes lifespan extension despite preserved AMPK activation. Aged mice show reduced protein aggregation only when autophagy remains functional.\n\n[H4] Direct pharmacological activation of AMP-activated protein kinase (AMPK) is sufficient to extend adult lifespan in evolutionarily diverse organisms, including nematodes and flies, and improve metabolic resilience in aged mice. Mechanism: Binding to a conserved regulatory site activates AMPK without first causing energy depletion, shifting metabolism toward cellular maintenance. Prediction: A biochemically validated activator increases lifespan in worms and flies and improves insulin sensitivity in aged mice without lowering cellular ATP. These benefits disappear with an AMPK mutation that selectively prevents drug binding while preserving normal kinase function.\n\n[H5] Direct AMPK activation extends lifespan by improving mitochondrial quality rather than by transiently poisoning mitochondrial respiration. In aged mammals, sustained activation improves mitochondrial function and physical endurance. Mechanism: AMPK coordinates selective removal of damaged mitochondria with mitochondrial biogenesis, maintaining a healthier mitochondrial population. Prediction: Treatment improves mitochondrial turnover and respiratory reserve without an initial respiratory inhibition. Disrupting the induced mitochondrial turnover pathway eliminates lifespan and endurance benefits while leaving other AMPK-dependent metabolic responses intact.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4739,
          "promptSha256": "441388562779572146d6bb041f97c54e837b17b074a0712fdc876ba6e643cfb2"
        }
      ]
    },
    {
      "task": "R42811497",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 0
        },
        {
          "id": "H2",
          "hypothesisIndex": 4
        },
        {
          "id": "H3",
          "hypothesisIndex": 1
        },
        {
          "id": "H4",
          "hypothesisIndex": 2
        },
        {
          "id": "H5",
          "hypothesisIndex": 3
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nLocalized scleroderma is characterized by excessive extracellular-matrix deposition and progressive skin fibrosis. Cellular senescence can promote persistent tissue remodeling and fibrotic disease through altered cell function and inflammatory signaling. Disturbances in organelle homeostasis have also been associated with both senescence and fibrosis. The causal molecular mechanisms connecting these processes in localized scleroderma, and whether they can be therapeutically reversed, remained incompletely understood.\n\nRESEARCH QUESTION\nWhat molecular mechanism drives cellular senescence and fibrosis in localized scleroderma, and can pharmacological disruption of that mechanism alleviate the disease phenotype?\n\nHYPOTHESES\n[H1] Excessive endoplasmic-reticulum–mitochondrial calcium transfer drives fibroblast senescence and fibrosis in localized scleroderma. Pharmacological disruption of the IP3R–GRP75–VDAC1 contact complex should reduce senescence-associated signaling and matrix production. Mechanism: Increased organelle coupling causes mitochondrial calcium overload, oxidative stress and persistent DNA damage, inducing a senescence-associated secretory phenotype that reinforces profibrotic signaling. Prediction: Patient-derived fibroblasts should show increased mitochondrial calcium uptake preceding senescence. Disrupting the complex should reduce these changes, whereas experimentally restoring mitochondrial calcium overload should negate the benefit without restoring organelle coupling.\n\n[H2] Excessive matrix stiffness maintains localized scleroderma through a fibroblast integrin–FAK–YAP/TAZ feedback loop that induces mitochondrial stress and senescence. Pharmacological FAK inhibition should weaken this loop and reduce established fibrotic activity. Mechanism: Stiff extracellular matrix promotes sustained mechanotransduction, contractility and metabolic demand, producing mitochondrial oxidative stress and senescence-associated secretion that further activates matrix-producing fibroblasts. Prediction: Patient fibroblasts cultured on compliant matrices should lose nuclear YAP/TAZ activity and subsequently show reduced mitochondrial stress and senescence. FAK inhibition should reproduce these effects on stiff matrices, while constitutively active YAP should prevent the rescue.\n\n[H3] Defective PINK1–Parkin-dependent mitophagy drives localized scleroderma by allowing damaged mitochondria to activate cGAS–STING signaling. Pharmacological STING inhibition should suppress the resulting senescence-associated inflammatory signaling and fibrosis. Mechanism: Impaired mitochondrial clearance permits mitochondrial DNA to accumulate in the cytosol, activating cGAS–STING and inflammatory signaling that maintains senescence and stimulates neighboring fibroblasts. Prediction: Restoring mitophagy or inhibiting STING should reduce inflammatory secretion and collagen production. Cytosolic mitochondrial DNA should persist during STING inhibition, while a STING agonist should restore downstream signaling after mitophagy rescue.\n\n[H4] Persistent endoplasmic-reticulum stress sustains a senescent, profibrotic fibroblast population through IRE1α RNase signaling. Pharmacological inhibition of this activity should reduce both senescence maintenance and extracellular-matrix deposition. Mechanism: Chronic protein-folding stress activates IRE1α-dependent RNA processing, maintaining stress and inflammatory programs that couple collagen secretory load to senescence-associated paracrine signaling. Prediction: An IRE1α RNase inhibitor and genetic disruption of its RNase activity should both reduce senescence markers and the ability of fibroblast-conditioned medium to induce collagen production in untreated cells, at exposures that preserve viability.\n\n[H5] Lysosomal iron accumulation drives fibroblast senescence and fibrosis in localized scleroderma through oxidative lysosomal injury. Pharmacologically reducing lysosomal redox-active iron should interrupt this process. Mechanism: Iron-dependent lipid oxidation destabilizes lysosomal membranes, impairs autophagic clearance and promotes mitochondrial damage, creating a self-sustaining source of senescence-inducing stress and profibrotic secretion. Prediction: Lysosome-targeted iron chelation should restore lysosomal integrity before reducing senescence and collagen production, with greater efficacy than an equally potent extracellular chelator. Selective lysosomal iron reloading should reverse the rescue.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5135,
          "promptSha256": "4953d702b325c7a2c88e0134b9811822f82386b3da20744827e7a4d98997f191"
        }
      ]
    },
    {
      "task": "R42821663",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 3
        },
        {
          "id": "H2",
          "hypothesisIndex": 2
        },
        {
          "id": "H3",
          "hypothesisIndex": 0
        },
        {
          "id": "H4",
          "hypothesisIndex": 4
        },
        {
          "id": "H5",
          "hypothesisIndex": 1
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nOsteoarthritis is a common degenerative disease whose incidence and severity increase with age. Mechanical damage and age-associated changes in joint tissues create susceptibility to progressive cartilage loss. Systemic metabolic disorders, including hypertension, have been associated with greater osteoarthritis risk and severity. However, it was unclear whether elevated blood pressure actively promotes joint degeneration through a defined biological mechanism rather than merely sharing risk factors with osteoarthritis.\n\nRESEARCH QUESTION\nThrough what causal mechanism does hypertension accelerate osteoarthritis in joints predisposed by aging or mechanical injury?\n\nHYPOTHESES\n[H1] Hypertension raises intraosseous pressure in subchondral bone, producing abnormal osteochondral strain that accelerates cartilage loss after aging or injury has weakened the matrix. Mechanism: Increased vascular filtration within poorly compliant subchondral bone elevates interstitial pressure and alters fluid movement across the osteochondral interface, activating PIEZO1-dependent calcium overload and catabolic signaling in chondrocytes. Prediction: Measured intraosseous pressure and chondrocyte calcium activity rise before accelerated degeneration. Local pressure normalization or inducible chondrocyte-specific PIEZO1 deletion prevents excess cartilage loss while systemic hypertension persists and subchondral oxygenation remains comparable.\n\n[H2] Hypertension accelerates degeneration by increasing synovial vascular leakage and fibrin deposition in susceptible joints. Fibrin sustains macrophage activation, converting transient injury-associated inflammation into persistent cartilage destruction. Mechanism: Elevated microvascular pressure and endothelial barrier dysfunction permit fibrinogen extravasation; deposited fibrin activates macrophage integrin signaling and promotes IL-1β and TNF production, inducing cartilage-degrading enzymes. Prediction: Joint fibrin deposition increases before cartilage deterioration, and selectively blocking fibrin–macrophage interactions prevents the additional damage caused by hypertension despite unchanged blood pressure and vascular leakage.\n\n[H3] Hypertension accelerates osteoarthritis by compromising subchondral microvascular perfusion in joints already damaged by aging or injury. Repeated ischemia and reperfusion drive pathological bone remodeling that increases stress on overlying cartilage. Mechanism: Pressure-induced arteriolar remodeling and endothelial dysfunction reduce subchondral perfusion, causing osteocyte injury, abnormal bone turnover, and eventual sclerosis that disrupts cartilage load distribution. Prediction: Subchondral perfusion defects precede accelerated cartilage loss, and restoring local endothelial function protects cartilage despite persistent hypertension. Protection tracks normalization of bone remodeling rather than suppression of synovial inflammation.\n\n[H4] Hypertension accelerates osteoarthritis by increasing the supply of inflammatory monocytes that are recruited into aged or injured joints. Persistent monocyte-derived macrophages amplify local tissue damage even after blood pressure normalizes. Mechanism: Hypertension-associated sympathetic activation stimulates bone marrow myelopoiesis and expands CCR2-positive monocytes; chemokines from susceptible joints recruit these cells, whose inflammatory mediators drive chondrocyte catabolism. Prediction: Lineage tracing reveals increased recruitment of marrow-derived macrophages before cartilage loss, and selective interruption of monocyte recruitment prevents hypertension-associated worsening without changing blood pressure. Monocytes from hypertensive donors produce greater joint damage than control monocytes after transfer into otherwise matched recipients.\n\n[H5] In hypertension accompanied by renin–angiotensin system activation, angiotensin II directly amplifies cartilage degeneration through chondrocyte AT1 receptors. Aging or mechanical injury sensitizes chondrocytes to this catabolic signal. Mechanism: AT1 receptor activation stimulates NADPH oxidase, mitochondrial oxidative stress, and NF-κB signaling, increasing MMP13 and ADAMTS5 production while reducing cartilage matrix synthesis. Prediction: Inducible chondrocyte-specific AT1 receptor deletion prevents hypertension-associated cartilage loss without lowering blood pressure. At matched blood pressure, protection is stronger in angiotensin II–dependent hypertension than in a model without renin–angiotensin activation.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5181,
          "promptSha256": "fd34e9d905e8432e1548a30b42806cd69369e296bbd78fe85194d7cf56b01add"
        }
      ]
    },
    {
      "task": "R42822442",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 2
        },
        {
          "id": "H2",
          "hypothesisIndex": 3
        },
        {
          "id": "H3",
          "hypothesisIndex": 4
        },
        {
          "id": "H4",
          "hypothesisIndex": 1
        },
        {
          "id": "H5",
          "hypothesisIndex": 0
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nSolid tumors create metabolically stressful microenvironments in which rapidly proliferating malignant and immune cells compete for limited nutrients. Adoptively transferred immune cells often lose function and fail to persist under these conditions, limiting therapeutic efficacy. Cellular senescence can produce durable functional decline in immune cells, but the metabolic signals that initiate this state within tumors have remained incompletely understood. Identifying the causal signaling events could reveal ways to preserve therapeutic immune-cell activity.\n\nRESEARCH QUESTION\nHow does nutrient scarcity in the solid-tumor microenvironment cause senescence and loss of persistence in adoptively transferred antitumor immune cells?\n\nHYPOTHESES\n[H1] Glutamine scarcity induces senescence primarily by limiting glutathione synthesis and allowing oxidative DNA damage to accumulate in transferred antitumor T cells. Persistent DNA-damage signaling then blocks their long-term expansion. Mechanism: Reduced glutamine-derived glutamate limits glutathione production, increasing mitochondrial oxidants and persistent DNA lesions, including telomere-associated damage. ATM–p53–p21 signaling converts this damage into durable proliferative arrest. Prediction: Restoring intracellular glutathione during glutamine deprivation prevents persistent DNA-damage foci and restores proliferation after refeeding without restoring glutamine-dependent anaplerosis. Greater protection from glutathione restoration than from anaplerotic supplementation would favor redox failure over carbon insufficiency.\n\n[H2] Methionine scarcity establishes senescence by depleting S-adenosylmethionine and weakening epigenetic repression of the CDKN2A locus in transferred antitumor T cells. Persistent p16 expression maintains arrest even after methionine becomes available again. Mechanism: A reduced S-adenosylmethionine:S-adenosylhomocysteine ratio impairs methyltransferase activity, lowering repressive H3K27me3 at CDKN2A. Resulting p16 induction maintains RB-mediated cell-cycle inhibition and restricts long-term clonal expansion. Prediction: Methionine deprivation produces loss of H3K27me3 at CDKN2A before sustained p16 induction. Locus-specific restoration of repression prevents arrest after refeeding despite continued global methyl-donor depletion, distinguishing this mechanism from generalized translational inhibition.\n\n[H3] Serine scarcity causes senescence in rapidly dividing transferred antitumor T cells by restricting nucleotide synthesis during antigen-driven proliferation. Replication stress produces irreversible arrest and subsequent failure of population maintenance. Mechanism: Insufficient serine-derived one-carbon flux reduces purine and thymidylate synthesis, causing nucleotide imbalance, stalled replication forks, and DNA breaks. Persistent DNA-damage signaling activates the p53–p21 arrest program. Prediction: Nucleoside supplementation during serine deprivation prevents replication-fork slowing and restores proliferation after nutrient replenishment without normalizing glutathione or methyl-donor availability. Preferential susceptibility of actively cycling cells, with little protection from antioxidants, would favor nucleotide insufficiency over redox or epigenetic mechanisms.\n\n[H4] Arginine scarcity causes senescence in transferred antitumor T cells through prolonged GCN2–eIF2α–ATF4 signaling. Chronic activation of this amino-acid stress response establishes a durable arrest rather than reversible nutrient-dependent quiescence. Mechanism: Accumulation of uncharged arginyl-tRNAs activates GCN2, producing sustained eIF2α phosphorylation and ATF4-dependent stress transcription. Prolonged signaling promotes p21 induction and loss of proliferative competence, limiting population persistence. Prediction: Transient GCN2 inhibition during arginine deprivation prevents arrest after arginine restoration while preserving viability, whereas inhibition initiated after arrest is established has little effect. Selective rescue by GCN2 disruption, but not by disruption of the alternative eIF2α kinase PERK, would support this mechanism.\n\n[H5] Glucose scarcity drives adoptively transferred antitumor T cells into senescence when sustained energy stress converts adaptive AMPK signaling into persistent p38–p53–p21 activation. This durable cell-cycle arrest prevents expansion and replenishment of the transferred population. Mechanism: Reduced glycolytic ATP production elevates the AMP:ATP ratio, sustaining AMPK-dependent stress signaling and p38 activation. Persistent p53 stabilization induces CDKN1A/p21 and establishes an arrest that remains after glucose availability improves. Prediction: Under matched glucose deprivation, inducible disruption of the AMPK–p38 signaling connection prevents persistent p21 induction and restores proliferation after nutrient replenishment despite equivalent initial ATP depletion. Protection without correction of oxidative damage would favor energy-stress signaling over a primary redox mechanism.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5698,
          "promptSha256": "b1c7ff2f5d653c9307cd700e176a8e49b6c45ee9742439e4c9eb1f2fae542f76"
        }
      ]
    },
    {
      "task": "R42826184",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 3
        },
        {
          "id": "H2",
          "hypothesisIndex": 1
        },
        {
          "id": "H3",
          "hypothesisIndex": 4
        },
        {
          "id": "H4",
          "hypothesisIndex": 0
        },
        {
          "id": "H5",
          "hypothesisIndex": 2
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nThree-dimensional genome organization helps regulate transcription by partitioning chromosomes into domains and controlling contacts between regulatory elements and gene promoters. Ageing is accompanied by widespread transcriptional dysregulation, including chronic inflammation and impaired immune function. Changes in chromatin structure have been observed during ageing, but whether they actively drive age-related gene-expression programs rather than merely accompany them has remained unclear. The molecular mechanisms connecting altered genome topology to physiological decline are also poorly understood.\n\nRESEARCH QUESTION\nWhat causal molecular mechanism remodels three-dimensional genome organization during ageing and thereby promotes age-associated inflammatory and activation-related transcription?\n\nHYPOTHESES\n[H1] Age-related impairment of transcription termination drives polymerase readthrough across nearby architectural boundaries, redistributing cohesin and weakening insulation. The resulting contacts activate neighboring inflammatory genes and create a self-reinforcing transcriptional circuit. Mechanism: Defective cleavage or termination allows elongating RNA polymerase II to invade boundary regions, displace boundary-associated proteins, and shift cohesin positioning, exposing adjacent promoters to inappropriate enhancers. Prediction: Installing an efficient termination cassette upstream of an affected boundary should restore local architecture and reduce neighboring inflammatory transcription while preserving expression of the initiating gene. Degrading the readthrough RNA without stopping polymerase passage should fail to rescue the boundary.\n\n[H2] Age-associated methylation of methylation-sensitive CTCF motifs erodes selected domain boundaries and exposes inflammatory promoters to previously insulated enhancers. Boundary methylation therefore initiates, rather than simply reflects, age-related transcriptional activation. Mechanism: CpG methylation reduces CTCF occupancy at susceptible motifs, weakening cohesin arrest and allowing enhancer–promoter communication across former boundaries. Prediction: Targeted demethylation of affected boundary motifs in aged cells should restore CTCF occupancy, insulation, and transcriptional restraint without changing enhancer methylation. Deleting those motifs should abolish the rescue, whereas targeted methylation in young cells should reproduce the phenotype.\n\n[H3] Age-associated depletion of chromatin-bound HMGB2 removes local insulation around inflammatory and activation-related gene clusters. This permits architectural reorganization that makes these loci persistently accessible to activating enhancers. Mechanism: Loss of HMGB2-mediated DNA bending and boundary organization changes local CTCF positioning and clustering, merging regulatory neighborhoods that were previously separated. Prediction: Acute HMGB2 depletion in young cells should reproduce the specific boundary and contact changes observed in aged cells before inflammatory expression increases. Restoring chromatin-binding-competent HMGB2 should rescue both architecture and transcription, whereas a DNA-binding-defective mutant should not.\n\n[H4] Age-dependent loss of WAPL-mediated cohesin unloading prolongs loop extrusion, enabling inflammatory enhancers to contact activation-related promoters across normally insulated boundaries. These ectopic contacts sustain inflammatory transcription after transient stimulation. Mechanism: Reduced WAPL abundance or recruitment increases cohesin residence time and permits extrusion past weak CTCF boundaries, expanding regulatory neighborhoods around inflammatory and immune-activation genes. Prediction: Restoring physiological WAPL levels in aged cells should shorten cohesin residence time and eliminate ectopic contacts before inflammatory transcripts decline. Selectively weakening the implicated CTCF boundaries should diminish this rescue.\n\n[H5] Loss of lamin B1-dependent chromatin tethering during ageing releases inflammatory and activation-related loci from repressive peripheral domains. Their relocation into active nuclear compartments enables regulatory contacts that increase basal expression and responsiveness to stimulation. Mechanism: Declining lamin B1 disrupts selected lamina-associated domains, permitting formerly peripheral loci to associate with active enhancers and transcriptional hubs. Prediction: Retethering released loci to the nuclear lamina in aged cells should reverse their compartment associations and suppress activation despite persistent age-associated signaling. Matched tethering to an interior nuclear scaffold should not produce the same rescue.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5332,
          "promptSha256": "fae0100ef3083219454576051334c588b5ec1ec51300dca5515fd4c0a371ef1f"
        }
      ]
    },
    {
      "task": "R42839094",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 1
        },
        {
          "id": "H2",
          "hypothesisIndex": 0
        },
        {
          "id": "H3",
          "hypothesisIndex": 3
        },
        {
          "id": "H4",
          "hypothesisIndex": 4
        },
        {
          "id": "H5",
          "hypothesisIndex": 2
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing is accompanied by widespread changes in metabolism and cellular composition. Lipids support membrane organization, signaling and energy storage, and age-associated lipid disturbances have been observed across many tissues and organisms. Some lipid changes correlate with age-related disease and physiological decline, but their functional importance remains uncertain. A central unresolved question is whether conserved lipid remodeling actively drives ageing or merely reflects it.\n\nRESEARCH QUESTION\nDoes a conserved form of lipid remodeling actively constrain lifespan, and what molecular regulator controls it?\n\nHYPOTHESES\n[H1] A conserved shift from very-long-chain to shorter-chain ceramides actively constrains lifespan. The relative activity of ceramide synthases with different acyl-chain preferences controls this shift. Mechanism: Accumulation of shorter-chain ceramides disrupts mitochondrial function and promotes stress signaling, while loss of very-long-chain species compromises protective membrane organization. Prediction: Adult manipulation of ceramide-synthase specificity restores a youthful chain-length distribution and extends lifespan in two species despite unchanged total ceramide abundance. Reinstating the age-associated chain-length distribution reverses the benefit.\n\n[H2] Age-dependent enrichment of membrane phospholipids with polyunsaturated fatty acids actively limits lifespan by increasing lipid peroxidation. ACSL4-dependent fatty-acid activation is a conserved regulatory bottleneck for this remodeling in species with comparable polyunsaturated lipid metabolism. Mechanism: ACSL4 supplies activated polyunsaturated fatty acids for membrane incorporation, increasing susceptibility to oxidative membrane damage and ferroptotic cell loss. Prediction: Adult-onset reduction of ACSL4 or its functional ortholog lowers membrane lipid peroxidation and extends lifespan across two species without reducing food intake. Restoring polyunsaturated phospholipid incorporation abolishes this benefit, whereas preventing downstream ferroptotic damage largely occludes it.\n\n[H3] An age-associated decline in membrane monounsaturated fatty acids relative to saturated fatty acids actively constrains lifespan. Reduced stearoyl-CoA desaturase activity is the conserved regulator responsible. Mechanism: Insufficient fatty-acid desaturation increases endoplasmic-reticulum membrane saturation, triggering chronic membrane stress and impairing protein processing. Prediction: Moderate adult induction of stearoyl-CoA desaturase orthologs restores membrane unsaturation and extends lifespan across two species. Blocking monounsaturated-fatty-acid incorporation into phospholipids abolishes the benefit despite preserved incorporation into storage lipids.\n\n[H4] An age-associated increase in the phosphatidylcholine-to-phosphatidylethanolamine ratio actively limits lifespan by restricting autophagic membrane function. Declining PCYT2-dependent phosphatidylethanolamine synthesis is a conserved control point. Mechanism: Reduced phosphatidylethanolamine availability impairs ATG8-family protein lipidation and autophagosome membrane dynamics, decreasing clearance of damaged cellular components. Prediction: Adult restoration of PCYT2 or its functional ortholog normalizes phospholipid balance, increases autophagic flux and extends lifespan across two species. Disrupting ATG8 lipidation eliminates lifespan extension despite successful correction of lipid composition.\n\n[H5] Age-associated remodeling of mitochondrial cardiolipin toward readily oxidized acyl chains actively limits lifespan. ALCAT1 or functionally equivalent cardiolipin acyltransferase activity controls this process. Mechanism: Maladaptive cardiolipin remodeling destabilizes respiratory-chain organization, increases electron leakage and creates a feedback loop between mitochondrial oxidant production and membrane damage. Prediction: Adult inhibition of the relevant acyltransferase preserves cardiolipin composition, respiratory function and lifespan across two species. Mitochondria-targeted restoration of the susceptible cardiolipin species eliminates protection even when other cellular lipid classes remain unchanged.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4860,
          "promptSha256": "e8ea0b8c3d2cf8aa9dddfa8e0fed4cd625f1ee40ca54063a98c6bb788ee6ed70"
        }
      ]
    },
    {
      "task": "R42841227",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 0
        },
        {
          "id": "H2",
          "hypothesisIndex": 4
        },
        {
          "id": "H3",
          "hypothesisIndex": 2
        },
        {
          "id": "H4",
          "hypothesisIndex": 1
        },
        {
          "id": "H5",
          "hypothesisIndex": 3
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nOlder individuals are more susceptible to severe influenza and often mount less effective antiviral immune responses. Ageing also alters the composition and metabolic activity of the gut microbiota, potentially affecting immune function at distant organs. Microbial metabolites are known to influence host immunity and gene regulation, but their contribution to age-related loss of antiviral protection remains poorly understood. It was therefore unclear whether altered microbial metabolism during ageing directly contributes to defective responses against respiratory viral infection.\n\nRESEARCH QUESTION\nDo age-related changes in gut microbial metabolism causally impair antiviral defense during influenza infection, and through what host mechanism can this deficit be counteracted?\n\nHYPOTHESES\n[H1] Ageing reduces gut microbial production of butyrate, weakening alveolar macrophage antiviral responses during influenza infection. Restoring butyrate availability rescues protection by relieving epigenetic repression of interferon-response genes. Mechanism: Reduced butyrate exposure increases histone deacetylase activity in alveolar macrophages, limiting chromatin accessibility at antiviral loci and diminishing their response to type I interferon. Prediction: In young germ-free recipients, aged-donor microbiota lowers butyrate availability and worsens influenza control. Physiological butyrate replacement or macrophage-targeted histone deacetylase inhibition restores antiviral chromatin accessibility and reduces viral burden; rescue persists without FFAR2 but disappears after macrophage-specific IFNAR1 deletion.\n\n[H2] Age-related enrichment of microbial bile acid conversion increases circulating deoxycholic acid, suppressing early antiviral activation of lung myeloid cells. Selectively reducing this microbial activity restores influenza resistance through relief of TGR5-mediated suppression. Mechanism: Elevated deoxycholic acid activates myeloid TGR5–cAMP signaling, dampening RIG-I–MAVS-dependent interferon induction during early infection. Prediction: In matched microbial communities, disabling bacterial 7-alpha-dehydroxylation lowers deoxycholic acid, restores early lung interferon production, and reduces influenza viral burden. Physiological deoxycholic acid add-back reverses protection in control mice but not in mice lacking myeloid TGR5.\n\n[H3] Ageing shifts microbial tryptophan metabolism away from protective indole derivatives, impairing pulmonary epithelial resistance to influenza. Restoring a defined microbial aryl hydrocarbon receptor ligand counteracts this defect through epithelial antiviral signaling. Mechanism: Reduced circulating indole-derived ligands diminish epithelial aryl hydrocarbon receptor activity, weakening type III interferon induction and barrier maintenance during infection. Prediction: Restoring indole-3-aldehyde exposure in mice carrying aged microbiota increases epithelial IFN-lambda production, lowers early lung viral titers, and preserves barrier integrity. These effects disappear after airway epithelial AHR deletion or IFN-lambda receptor blockade despite unchanged butyrate and desaminotyrosine concentrations.\n\n[H4] Age-related loss of microbial desaminotyrosine production reduces tonic type I interferon signaling, leaving pulmonary immune cells poorly prepared for influenza infection. Reconstituting this metabolic activity before infection restores antiviral protection. Mechanism: Insufficient microbial conversion of dietary flavonoids into desaminotyrosine lowers basal IFNAR-dependent expression of antiviral effectors in lung immune cells. Prediction: Under a controlled flavonoid diet, a desaminotyrosine-producing strain, but not an otherwise matched production-deficient mutant, restores basal lung interferon-stimulated gene expression and lowers influenza viral burden in recipients of aged microbiota. Metabolite supplementation reproduces the benefit, which requires host IFNAR signaling.\n\n[H5] Age-related depletion of microbiota-derived acetate limits the metabolic fitness of influenza-specific CD8 T cells, delaying viral clearance. Restoring acetate during T-cell expansion rescues antiviral defense through ACSS2-dependent acetate utilization. Mechanism: Reduced acetate availability limits acetyl-CoA generation in activated CD8 T cells, restricting effector-associated histone acetylation and cytotoxic gene expression. Prediction: Acetate supplementation during the expansion phase improves influenza-specific CD8 T-cell killing and late viral clearance without correcting early innate responses. Isotope tracing demonstrates acetate incorporation into T-cell acetyl-CoA and histone acetyl groups, and CD8-specific ACSS2 deletion abolishes rescue.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5384,
          "promptSha256": "33ed5c744ba9d5393eb7fc00435a93baa3ab737938674d3e788069279bb9f279"
        }
      ]
    },
    {
      "task": "R42842666",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 4
        },
        {
          "id": "H2",
          "hypothesisIndex": 1
        },
        {
          "id": "H3",
          "hypothesisIndex": 0
        },
        {
          "id": "H4",
          "hypothesisIndex": 2
        },
        {
          "id": "H5",
          "hypothesisIndex": 3
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nHutchinson-Gilford progeria syndrome is a premature-ageing disorder caused by an LMNA mutation and is characterized by severe, early-onset vascular disease. Its vascular pathology includes extracellular-matrix abnormalities, fibrosis, collagen accumulation and inflammation. Blood-vessel models have often examined individual vascular compartments in isolation, limiting understanding of how interactions among the vessel wall layers produce disease. The cellular origins of the distinct pathological features and the extent to which they depend directly on the causal mutation remained unresolved.\n\nRESEARCH QUESTION\nHow do the different cellular compartments of the vascular wall causally contribute to distinct features of Hutchinson-Gilford progeria vascular pathology?\n\nHYPOTHESES\n[H1] Collagen accumulation in the adventitia feeds back mechanically onto the media, selectively accelerating the loss of progerin-expressing smooth-muscle cells. Mechanism: Adventitial collagen cross-linking reduces vessel compliance and increases force transmission to mechanically vulnerable smooth-muscle-cell nuclei. Prediction: Increasing adventitial matrix stiffness while holding soluble signals constant causes disproportionately greater nuclear rupture and death in mutant than corrected smooth-muscle cells. Selectively reducing adventitial cross-linking rescues medial survival despite continued progerin expression and similar collagen abundance.\n\n[H2] Adventitial fibroblasts are the principal source of excess vascular collagen, but their fibrotic activation depends primarily on signals from mutant smooth-muscle cells rather than on their own LMNA mutation. Mechanism: Stressed mutant smooth-muscle cells activate fibroblast TGF-β–SMAD signaling, inducing myofibroblast differentiation and collagen synthesis. Prediction: Wild-type fibroblasts accumulate collagen when paired with mutant smooth-muscle cells, whereas mutant fibroblasts paired with corrected smooth-muscle cells show substantially less fibrosis. Fibroblast-specific TGF-β receptor inhibition suppresses lineage-traced collagen production without correcting medial cell loss.\n\n[H3] Progerin expression in medial vascular smooth-muscle cells directly causes elastic-matrix disorganization and medial cell loss, independently of mutations in the other vessel-wall compartments. Mechanism: Progerin-induced nuclear fragility impairs smooth-muscle-cell survival and elastic-matrix maintenance under pulsatile mechanical stress. Prediction: In layered vessels with independently controlled compartment genotypes, mutant smooth-muscle cells produce medial cell loss and elastic-matrix defects despite wild-type endothelium and adventitial fibroblasts. Smooth-muscle-specific LMNA correction rescues these defects under matched pressure and flow.\n\n[H4] Endothelial progerin independently initiates vascular inflammation by increasing leukocyte adhesion and transendothelial migration. Mechanism: Endothelial nuclear damage activates cGAS–STING and NF-κB signaling, increasing adhesion-molecule expression and compromising barrier integrity. Prediction: Vessels containing mutant endothelium and wild-type supporting layers exhibit increased leukocyte recruitment under matched flow. Endothelial-specific LMNA correction or STING inhibition reduces recruitment even when mutant smooth-muscle cells and fibroblasts remain present.\n\n[H5] Recruited macrophages amplify and sustain adventitial fibrosis after initial vessel-wall injury, even when the macrophages themselves lack the HGPS mutation. Mechanism: Uptake of dying medial cells promotes a macrophage program that supplies TGF-β and PDGF to fibroblasts, maintaining collagen production after the initiating injury. Prediction: Adding wild-type macrophages to injured HGPS vessel models increases persistent fibroblast activation and collagen deposition. Delayed macrophage removal or macrophage-specific suppression of these mediators reduces ongoing fibrosis without preventing the initial smooth-muscle-cell injury.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4667,
          "promptSha256": "874d109013949653ec37e90053727a3bf01d3788cdf5de87681ae6f45566c284"
        }
      ]
    },
    {
      "task": "R42844664",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 1
        },
        {
          "id": "H2",
          "hypothesisIndex": 4
        },
        {
          "id": "H3",
          "hypothesisIndex": 0
        },
        {
          "id": "H4",
          "hypothesisIndex": 2
        },
        {
          "id": "H5",
          "hypothesisIndex": 3
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nCardiovascular ageing is characterized by hypertension, arterial stiffening, endothelial dysfunction, and maladaptive cardiac remodeling. Chronic inflammation, impaired tissue barriers, and regulated inflammatory cell death can accelerate these changes. Dietary patterns can influence age-related cardiovascular health, but causal chains connecting specific eating schedules to vascular protection remain incompletely understood. Identifying the necessary and sufficient mediators of such protection is important for developing non-pharmacological strategies against cardiovascular decline.\n\nRESEARCH QUESTION\nThrough what causal mechanism does time-restricted feeding protect against accelerated cardiovascular ageing?\n\nHYPOTHESES\n[H1] Time-restricted feeding protects primarily through fasting-induced beta-hydroxybutyrate, which inhibits vascular macrophage NLRP3 activation and pyroptosis. This mechanism operates even when intestinal permeability and endotoxin exposure remain unchanged. Mechanism: Repeated ketone elevations inhibit NLRP3 inflammasome assembly, reducing caspase-1 activation, gasdermin D cleavage, and IL-1β release, thereby limiting arterial matrix remodeling and cardiac fibrosis. Prediction: Selective suppression of hepatic ketogenesis abolishes protection without disrupting feeding timing or intestinal barrier improvements; physiological beta-hydroxybutyrate replacement restores it. Ketone supplementation also protects unrestricted-fed animals, with little additional benefit after myeloid NLRP3 deletion.\n\n[H2] Time-restricted feeding protects primarily by restoring the daily rhythm of renal sodium excretion and the blood-pressure decline during the rest phase. Reduced cumulative pressure load subsequently limits arterial stiffening and maladaptive cardiac remodeling. Mechanism: Feeding-time entrainment of renal tubular clocks shifts sodium-transporter activity and aldosterone responsiveness, improving sodium balance and reducing sustained vascular and ventricular mechanical stress. Prediction: With identical sodium and calorie intake, improved sodium-excretion rhythms and rest-phase blood pressure precede vascular improvement. Experimentally maintaining the unrestricted-fed blood-pressure profile abolishes protection during time-restricted feeding, while reproducing its pressure profile in unrestricted-fed animals recapitulates protection despite persistent gut permeability and inflammasome activation.\n\n[H3] Time-restricted feeding protects against accelerated cardiovascular ageing by restoring intestinal barrier integrity and reducing circulating microbial inflammatory products. Reduced endotoxin exposure suppresses vascular macrophage inflammasome activation and subsequent endothelial injury. Mechanism: A consistent feeding–fasting cycle restores intestinal epithelial clock function and tight-junction maintenance, reducing lipopolysaccharide translocation and TLR4-dependent priming of NLRP3–caspase-1–gasdermin D signaling in vascular macrophages. Prediction: Under matched caloric intake, restoring circulating lipopolysaccharide to unrestricted-feeding levels eliminates vascular protection despite preserved feeding rhythms. Intestinal barrier restoration in unrestricted-fed animals reproduces protection, and myeloid NLRP3 deletion prevents the adverse effect of lipopolysaccharide restoration.\n\n[H4] Time-restricted feeding protects through alignment of the endothelial circadian clock with the active phase, independently of fasting duration alone. Endothelial clock restoration preserves nitric oxide availability and prevents hypertension-driven arterial and cardiac remodeling. Mechanism: Active-phase feeding restores rhythmic endothelial BMAL1-dependent regulation of eNOS coupling and antioxidant defenses, reducing superoxide-mediated nitric oxide loss and vascular resistance. Prediction: Equal-duration active-phase feeding provides greater protection than rest-phase feeding at identical caloric intake. Adult endothelial-specific Bmal1 deletion abolishes this advantage despite comparable ketone exposure and gut permeability, whereas endothelial clock rescue restores it.\n\n[H5] Time-restricted feeding protects by periodically suppressing vascular smooth-muscle mTORC1 activity, enabling autophagic removal of damaged mitochondria. Reduced mitochondrial stress prevents smooth-muscle senescence and the matrix remodeling that stiffens arteries. Mechanism: Fasting activates AMPK and reduces mTORC1 signaling, increasing autophagic flux and mitochondrial quality control in vascular smooth-muscle cells; this lowers mitochondrial reactive oxygen species, senescence-associated inflammatory secretion, and osteogenic switching. Prediction: Adult smooth-muscle-specific Atg7 deletion abolishes the reduction in arterial stiffness despite preserved improvements in circulating inflammatory markers. Smooth-muscle-targeted enhancement of autophagy reproduces the arterial benefit during unrestricted feeding, including reduced stiffness measured at matched distending pressure.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5689,
          "promptSha256": "b3977aebb210cee02e483d5739392ee37fec0aaba7170b2eb806a289c15b4113"
        }
      ]
    },
    {
      "task": "R42853938",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 2
        },
        {
          "id": "H2",
          "hypothesisIndex": 1
        },
        {
          "id": "H3",
          "hypothesisIndex": 4
        },
        {
          "id": "H4",
          "hypothesisIndex": 3
        },
        {
          "id": "H5",
          "hypothesisIndex": 0
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nTherapy-induced cellular senescence can durably arrest the proliferation of cancer cells and contribute to treatment efficacy. Cancer cells can acquire resistance to treatments that normally induce this state, allowing continued growth and disease progression. Alternative splicing and epigenetic regulation are both frequently altered during cancer evolution, but their causal roles in suppressing treatment-induced senescence remain incompletely understood. Identifying the molecular mechanism responsible could reveal a way to restore therapeutic sensitivity.\n\nRESEARCH QUESTION\nWhat splicing-dependent mechanism enables resistance to CDK4/6 inhibition, and can disrupting it restore therapy-induced senescence?\n\nHYPOTHESES\n[H1] A shift in H2AFY splicing from macroH2A1.1 toward macroH2A1.2 enables cancer cells to escape the stable senescence normally induced by CDK4/6 inhibition. Restoring macroH2A1.1 will convert reversible treatment-associated arrest into durable senescence. Mechanism: Loss of the ADP-ribose-binding macroH2A1.1 isoform disrupts chromatin regulation needed to stabilize the senescent state. Prediction: At matched total macroH2A1 abundance, macroH2A1.1 restoration will suppress clonogenic recovery after inhibitor withdrawal, whereas macroH2A1.2 will not. A macroH2A1.1 mutant defective in ADP-ribose binding will fail to reproduce this effect.\n\n[H2] Resistant cells preferentially produce an EZH2 splice isoform that supports greater PRC2 methyltransferase activity and silences senescence effectors. Selectively eliminating this isoform will restore senescence during CDK4/6 inhibition. Mechanism: Alternative splicing strengthens Polycomb-dependent H3K27 trimethylation at genes required for stable cell-cycle exit. Prediction: At matched total EZH2 abundance, replacing the resistance-associated isoform with the alternative isoform will reduce H3K27me3 at senescence-effector loci and restore persistent arrest. Re-expression of the resistance-associated isoform will reverse both effects only if its methyltransferase activity is intact.\n\n[H3] Some resistant cancers retain an intact RB1 gene but acquire nonproductive RB1 splicing that depletes functional RB protein. Correcting the splice defect will restore RB-dependent repression of E2F and treatment-induced senescence. Mechanism: Aberrant exon skipping or intron retention functionally disables RB, removing the downstream effector through which CDK4/6 inhibition arrests proliferation. Prediction: Correcting the endogenous splice defect will restore full-length RB, suppress E2F targets during treatment, and prevent colony regrowth after drug withdrawal. Subsequent RB1 knockout will eliminate the restored response, while splice correction in cells with genomic RB1 loss will have no benefit.\n\n[H4] In TP53-wild-type cancers, increased inclusion of MDM4 exon 6 sustains functional MDM4 expression and suppresses the p53–p21 response needed for CDK4/6 inhibitor-induced senescence. Forcing exon skipping will restore therapeutic sensitivity. Mechanism: Productive MDM4 splicing maintains p53 inhibition; exon skipping generates an unproductive transcript and releases p53-dependent senescence signaling. Prediction: An exon-skipping oligonucleotide will lower MDM4 protein, induce p21, and restore durable senescence during CDK4/6 inhibition. TP53 deletion or expression of splice-insensitive MDM4 will abolish this response, distinguishing it from p53-independent chromatin mechanisms.\n\n[H5] CDK4/6 inhibitor resistance is driven by a splice switch that increases catalytically active DNMT3B relative to inactive isoforms, maintaining DNA methylation at genes needed to establish senescence. Redirecting DNMT3B splicing toward inactive isoforms will restore treatment-induced senescence in RB1-intact cancer cells. Mechanism: Splicing-dependent DNA methylation prevents activation of the senescence transcriptional program despite CDK4/6 inhibition. Prediction: Splice-switching oligonucleotides will reduce methylation at repressed senescence-associated loci and restore durable arrest after drug withdrawal. A splice-insensitive, catalytically active DNMT3B construct will rescue resistance, whereas a catalytic-dead construct will not.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4868,
          "promptSha256": "769926fa910dbfa8d4b69910ec4c597fe01af2081045dbc5485fb73da6c18d95"
        }
      ]
    },
    {
      "task": "R42858183",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 1
        },
        {
          "id": "H2",
          "hypothesisIndex": 2
        },
        {
          "id": "H3",
          "hypothesisIndex": 4
        },
        {
          "id": "H4",
          "hypothesisIndex": 0
        },
        {
          "id": "H5",
          "hypothesisIndex": 3
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAging is accompanied by declining lysosomal activity, impaired autophagic clearance, and loss of protein homeostasis. These changes contribute to progressive functional deterioration and increase vulnerability to protein-aggregation disorders. Restoring cellular clearance systems can sometimes improve lifespan or healthspan in model organisms. However, interventions that preserve lysosomal competence during aging and the mechanisms through which they act remain incompletely understood.\n\nRESEARCH QUESTION\nCan a defined intervention preserve lysosomal function and protein homeostasis during aging, thereby extending lifespan and maintaining organismal function, and through what mechanism?\n\nHYPOTHESES\n[H1] Inducing a constitutively nuclear HLH-30 transcription factor in adult C. elegans will preserve lysosomal clearance capacity, delay proteostasis failure, and extend functional lifespan. Mechanism: Sustained HLH-30 activity coordinately increases lysosomal biogenesis, hydrolase expression, and autophagic cargo delivery, preventing clearance capacity from falling below the burden of damaged proteins. Prediction: The intervention will increase lysosomal degradative capacity and autophagic flux even when lysosomal pH remains unchanged. A DNA-binding-defective HLH-30 variant will fail, and adult-onset disruption of autophagosome–lysosome fusion will eliminate the proteostasis and lifespan benefits.\n\n[H2] Moderate adult-onset overexpression of the lysosomal calcium channel CUP-5 in C. elegans will preserve autophagosome–lysosome fusion during aging, thereby reducing aggregate accumulation and extending lifespan and mobility. Mechanism: Enhanced regulated lysosomal calcium release supports membrane fusion and cargo delivery to degradatively competent lysosomes. Prediction: CUP-5 expression will increase measured fusion events before aggregate burden declines, without requiring increased lysosome abundance or lower lysosomal pH. A conductance-deficient CUP-5 variant and disruption of calcium-dependent fusion machinery will each abolish the benefit.\n\n[H3] Adult-onset intestinal overexpression of the lysosomal lipase LIPL-4 in C. elegans will prevent age-related lysosomal lipid accumulation, preserve protein clearance, and extend lifespan while maintaining organismal function. Mechanism: Increased lysosomal lipid hydrolysis prevents lipid overload from impairing membrane trafficking and hydrolase access to cargo, indirectly sustaining protein degradation. Prediction: Reduced lysosomal lipid accumulation will precede restored protein turnover and reduced aggregation. Benefits will require both lipase activity and lysosomal localization; experimentally restoring lysosomal lipid overload will eliminate the clearance benefit despite continued LIPL-4 expression.\n\n[H4] Adult-onset intestinal overexpression of the lysosomal V-ATPase subunit VHA-13 in Caenorhabditis elegans will preserve lysosomal acidification during aging, reduce protein aggregation, and extend lifespan while maintaining locomotor function. Mechanism: Increased VHA-13 availability sustains functional proton-pump assembly, maintaining the acidic lumen required for lysosomal proteolysis and autophagic cargo degradation. Prediction: Lysosomal pH normalization will precede improved autophagic flux and reduced aggregation. Disrupting V-ATPase assembly will abolish these benefits despite maintained VHA-13 expression, supporting acidification as the causal mechanism.\n\n[H5] Adult-onset expression of lysosome-targeted ASP-1, an aspartyl protease, in C. elegans muscle will preserve lysosomal protein degradation and delay age-related muscle dysfunction, with sufficient systemic benefit to extend lifespan. Mechanism: Increasing intralysosomal protease capacity accelerates degradation of delivered damaged proteins, reducing the accumulation of aggregation-prone substrates. Prediction: Active, correctly targeted ASP-1 will improve lysosomal substrate turnover, muscle aggregate burden, and movement without changing lysosomal pH or fusion frequency. Catalytically inactive or mistargeted ASP-1 will fail despite comparable expression.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4777,
          "promptSha256": "62fd6893abafee0cca2d45bb11f5ec83071e775ef7b8897b755810f17f4dd271"
        }
      ]
    },
    {
      "task": "R42806945",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 4
        },
        {
          "id": "H2",
          "hypothesisIndex": 1
        },
        {
          "id": "H3",
          "hypothesisIndex": 3
        },
        {
          "id": "H4",
          "hypothesisIndex": 2
        },
        {
          "id": "H5",
          "hypothesisIndex": 0
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing is frequently accompanied by cognitive decline and chronic neuroinflammation. Cellular senescence and age-dependent changes in metabolic signaling can disrupt tissue homeostasis and contribute to functional deterioration in the brain. Although several circulating metabolic factors correlate with cognitive impairment, association alone does not establish which factors directly modify the ageing process. The molecular chain connecting a metabolic regulator to cellular dysfunction and cognitive outcomes therefore remained unresolved.\n\nRESEARCH QUESTION\nWhich metabolic regulator causally mitigates ageing-related cognitive impairment, and through what molecular mechanism does it suppress cellular senescence and inflammation?\n\nHYPOTHESES\n[H1] Restoring nicotinamide phosphoribosyltransferase (NAMPT) activity in astrocytes mitigates ageing-related cognitive impairment by replenishing intracellular NAD+ and preventing senescence. The relevant protective activity is intracellular NAD+ salvage rather than extracellular NAMPT signaling. Mechanism: Increased intracellular NAMPT restores NAD+-dependent SIRT1 activity, supports genome maintenance, and reduces acetylation-dependent NF-κB transcription. Reduced persistent DNA damage and inflammatory secretion limit astrocyte senescence and secondary microglial activation. Prediction: Catalytically active, intracellularly retained NAMPT improves astrocytic NAD+, senescence measures, and memory, whereas catalytically inactive NAMPT does not. Astrocytic SIRT1 deletion abolishes protection despite restored NAD+, while extracellular NAMPT neutralization leaves protection intact.\n\n[H2] Adiponectin mitigates ageing-related cognitive impairment by preventing mitochondrial damage-driven senescence in microglia. Its cognitive benefit requires microglial adiponectin receptor signaling. Mechanism: Adiponectin activates AdipoR1–AMPK signaling and mitochondrial quality control, reducing mitochondrial reactive oxygen species and cytosolic mitochondrial DNA. Reduced cGAS–STING activation limits inflammatory secretion and the establishment of persistent senescence-associated states. Prediction: Microglial AdipoR1 deletion eliminates adiponectin-induced reductions in cytosolic mitochondrial DNA, senescence, and cognitive impairment. Microglial STING deletion bypasses receptor loss and reproduces protection, supporting this pathway over a primarily vascular mechanism.\n\n[H3] The ketone body β-hydroxybutyrate mitigates ageing-related cognitive impairment through HCAR2-dependent suppression of microglial inflammation. Reduced inflammatory exposure subsequently prevents senescence in neighboring astrocytes and neural progenitor cells. Mechanism: β-Hydroxybutyrate activates microglial HCAR2, reducing NF-κB-dependent inflammatory priming and NLRP3 inflammasome activity. Lower IL-1β production interrupts inflammatory reinforcement of senescence and preserves hippocampal plasticity. Prediction: Microglial HCAR2 deletion eliminates protection despite maintained brain ketone uptake and oxidation. Selective HCAR2 activation reproduces protection without increasing ketone availability, distinguishing receptor signaling from an alternative-fuel mechanism.\n\n[H4] The exercise-induced metabolic hormone irisin mitigates ageing-related cognitive impairment by restoring autophagic clearance in astrocytes. This prevents damaged organelles from sustaining astrocyte senescence and inflammatory secretion. Mechanism: Irisin engages astrocytic αVβ5 integrin and activates an AMPK–TFEB program that increases lysosomal function and autophagic flux. Improved clearance reduces oxidative DNA damage and senescence-associated cytokine production, preserving hippocampal synaptic function. Prediction: Astrocyte-specific TFEB loss abolishes irisin-induced improvements in autophagic flux, senescence, and memory, whereas astrocytic TFEB activation reproduces them. These effects persist when circulating glucose and body weight are matched.\n\n[H5] Restoring circulating fibroblast growth factor 21 (FGF21) mitigates ageing-related cognitive impairment by suppressing senescence in brain endothelial cells. Reduced endothelial inflammatory signaling preserves blood–brain barrier integrity and limits secondary microglial activation. Mechanism: FGF21 activates endothelial FGFR1–β-Klotho signaling, increasing AMPK-dependent SIRT1 activity and reducing mitochondrial oxidative stress. This reduces persistent DNA damage, p53–p21 senescence signaling, and NF-κB-dependent inflammatory secretion. Prediction: Endothelial-specific deletion of β-Klotho abolishes FGF21-induced improvements in endothelial senescence, barrier integrity, and memory despite preserved peripheral metabolic responses. Endothelial SIRT1 restoration rescues these effects downstream of receptor loss.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5462,
          "promptSha256": "31962863408ce14260d530a97d25ad01ad7cca2b09c80afebeb91a9f469ed033"
        }
      ]
    },
    {
      "task": "R42723144",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 3
        },
        {
          "id": "H2",
          "hypothesisIndex": 4
        },
        {
          "id": "H3",
          "hypothesisIndex": 2
        },
        {
          "id": "H4",
          "hypothesisIndex": 0
        },
        {
          "id": "H5",
          "hypothesisIndex": 1
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nOvarian function declines with age, eventually causing reproductive senescence and broader endocrine changes that affect female healthspan. The pace of this decline varies substantially among individuals, even when chronological age is similar. Both nuclear and non-nuclear inherited factors could contribute to this variation, but their causal roles are difficult to separate because genetic backgrounds commonly differ at many loci. The mechanisms connecting inherited variation to follicle depletion, tissue pathology and loss of ovarian function therefore remain poorly understood.\n\nRESEARCH QUESTION\nCan naturally occurring inherited genetic variation alter the rate of ovarian ageing on equivalent heterogeneous nuclear backgrounds, and what cellular mechanism mediates this effect?\n\nHYPOTHESES\n[H1] Inherited mitochondrial variation changes ovarian ageing rates by altering the maintenance of primordial follicle dormancy. A susceptible mitochondrial genotype accelerates recruitment and exhausts the reserve earlier. Mechanism: Increased mitochondrial hydrogen peroxide signalling oxidatively inhibits PTEN in primordial oocytes, increasing PI3K–AKT activity and FOXO3 nuclear export, thereby triggering premature follicle activation. Prediction: With equivalent initial reserves, the susceptible genotype shows increased PTEN oxidation, FOXO3 export and primordial-to-growing follicle transitions before excess apoptosis. Preserving oocyte FOXO3 activity removes the genotype-dependent depletion difference.\n\n[H2] Naturally inherited mitochondrial sequence variants alter ovarian ageing by changing the intracellular expansion of dysfunctional mitochondrial genomes. Age-dependent clonal expansion causes an increasing fraction of oocytes to cross a respiratory-failure threshold. Mechanism: A mitochondrial variant confers a replication or persistence advantage on genomes with impaired respiratory function; incomplete mitochondrial quality control permits their accumulation within individual oocytes, eventually triggering oocyte death. Prediction: Single-oocyte measurements reveal increasing dysfunctional heteroplasmy and threshold-associated respiratory failure before accelerated follicle loss, even when bulk ovarian measurements show modest changes. Preventing preferential expansion preserves follicles without changing initial reserve size or recruitment rate.\n\n[H3] Naturally inherited mitochondrial variants accelerate ovarian ageing by provoking sterile inflammation within the ovary. The resulting inflammatory and fibrotic niche drives follicle loss on otherwise equivalent nuclear backgrounds. Mechanism: Mitochondrial instability increases cytosolic mitochondrial DNA in ovarian stromal cells and macrophages, activating cGAS–STING signalling and inflammatory cytokine production that promote fibrosis and follicular injury. Prediction: Cytosolic mitochondrial DNA and stromal or macrophage STING activation rise before genotype-dependent fibrosis and follicle depletion. Disabling this pathway in those compartments reduces the ageing difference despite persistence of the mitochondrial respiratory defect.\n\n[H4] Naturally occurring mitochondrial DNA variants alter ovarian ageing rates on equivalent heterogeneous nuclear backgrounds by changing oxidative damage in primordial oocytes. Variants that increase mitochondrial electron leakage accelerate follicle loss despite comparable initial ovarian reserves. Mechanism: Elevated mitochondrial reactive oxygen species cause oocyte DNA damage, activate the TAp63-dependent apoptotic checkpoint and increase primordial follicle death. Prediction: The faster-ageing mitochondrial genotype produces oxidative damage and checkpoint activation before accelerated follicle depletion. Oocyte-targeted suppression of mitochondrial oxidative damage preferentially rescues its follicle-loss rate without changing follicle recruitment.\n\n[H5] Inherited mitochondrial DNA variation accelerates ovarian ageing by impairing granulosa-cell energy production and survival. Loss of granulosa-cell support increases follicular atresia and advances endocrine failure. Mechanism: Reduced respiratory reserve limits granulosa-cell ATP production during follicle growth, promoting apoptosis and reducing steroid synthesis and metabolic support of oocytes. Prediction: Granulosa-cell respiratory failure precedes oocyte injury and increased atresia in the susceptible genotype. Restoring granulosa-cell bioenergetic function preferentially preserves growing follicles and endocrine function, whereas an oocyte-restricted antioxidant intervention provides little rescue.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5260,
          "promptSha256": "12d930299f935fba34ab7695f440ba44c0647c0156447eb0126d0eb34ca06b86"
        }
      ]
    },
    {
      "task": "R42808804",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 3
        },
        {
          "id": "H2",
          "hypothesisIndex": 4
        },
        {
          "id": "H3",
          "hypothesisIndex": 2
        },
        {
          "id": "H4",
          "hypothesisIndex": 1
        },
        {
          "id": "H5",
          "hypothesisIndex": 0
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAge-related hearing loss is a common progressive disorder associated with degeneration of cochlear structure and function. Maintenance of cochlear homeostasis depends on a specialized vascular barrier that controls exchange between the circulation and inner-ear tissues. Ageing can compromise this barrier, disturb the local microenvironment, and contribute to auditory dysfunction. However, the causal molecular events connecting cochlear ageing to barrier failure and hearing decline were not fully understood.\n\nRESEARCH QUESTION\nWhat causal mechanism links cochlear ageing to loss of blood-labyrinth barrier integrity and auditory dysfunction?\n\nHYPOTHESES\n[H1] Ageing reduces MFSD2A expression in strial endothelial cells, increasing transcellular transport across the blood-labyrinth barrier before tight junctions deteriorate. Entry of circulating proteins disrupts strial function and contributes to hearing loss. Mechanism: Loss of MFSD2A-dependent endothelial lipid transport alters membrane lipid composition and releases suppression of caveolae-mediated transcytosis, allowing excessive vascular protein passage into strial tissue. Prediction: Early ageing should increase tracer-containing endothelial vesicles and abluminal tracer delivery while junctional ultrastructure remains intact. Endothelial MFSD2A restoration should normalize these changes and preserve endocochlear potential and hearing, whereas a transport-deficient MFSD2A variant should fail.\n\n[H2] Age-related loss of GPX4-dependent lipid peroxide detoxification causes ferroptotic death of strial endothelial cells. Focal loss of endothelial continuity directly breaches the blood-labyrinth barrier and contributes to auditory decline. Mechanism: Declining glutathione–GPX4 activity permits iron-dependent phospholipid peroxidation, producing endothelial death and capillary discontinuities that impair strial homeostasis and reduce the endocochlear potential. Prediction: Endothelial-specific Gpx4 restoration or Acsl4 deletion should prevent endothelial loss, vascular leakage, and hearing decline despite persistent inflammatory signaling. Protection should track suppression of oxidized phospholipids and endothelial death; selective inhibition of apoptosis should provide substantially less protection.\n\n[H3] Ageing shifts strial perivascular macrophages toward a proteolytic inflammatory state that damages the vascular basement membrane and endothelial junctions. This extracellular damage initiates barrier leakage and subsequent auditory dysfunction. Mechanism: Age-dependent activation of NF-κB in resident perivascular macrophages increases MMP-9 secretion, promoting degradation of vascular basement-membrane components and destabilization of adjacent endothelial junctions. Prediction: Resident macrophage-targeted Mmp9 deletion should prevent basement-membrane damage, vascular leakage, and hearing decline while leaving upstream macrophage inflammatory activation detectable. Local reintroduction of catalytically active MMP-9, but not an inactive variant, should reverse the protection.\n\n[H4] Ageing reduces PDGFRβ-dependent survival of strial pericytes, and loss of their endothelial support initiates blood-labyrinth barrier failure. Barrier leakage subsequently compromises the electrochemical conditions required for hearing. Mechanism: Reduced pericyte PDGFRβ signaling causes pericyte detachment or death, decreasing local angiopoietin-1 delivery and endothelial TIE2 activation; endothelial junctions consequently destabilize. Prediction: Pericyte loss should precede vascular leakage, and restoring PDGFRβ signaling selectively in adult strial pericytes should preserve coverage, endothelial TIE2 activation, barrier integrity, and hearing. Endothelial TIE2 inhibition should abolish this protection despite preserved pericyte coverage.\n\n[H5] Age-related mitochondrial damage in strial endothelial cells activates cGAS–STING signaling, causing inflammatory disruption of the blood-labyrinth barrier. The resulting disturbance of strial ion homeostasis lowers the endocochlear potential and impairs hearing. Mechanism: Mitochondrial DNA escapes into the endothelial cytoplasm and activates cGAS–STING, inducing inflammatory signaling that reduces junctional claudin-5 and redistributes ZO-1, increasing paracellular permeability. Prediction: Inducible endothelial-specific Sting1 deletion before substantial cochlear degeneration should preserve junction organization, reduce vascular tracer leakage, and preserve endocochlear potential and auditory brainstem response thresholds despite persistent mitochondrial damage. Rescue without restored pericyte coverage would favor this mechanism over primary pericyte failure.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5356,
          "promptSha256": "6f7a1f9d1cfeeddf8830cfeda0d2759b888e997e63ca7d62612bcb61e84cbcd5"
        }
      ]
    },
    {
      "task": "R42585340",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 1
        },
        {
          "id": "H2",
          "hypothesisIndex": 0
        },
        {
          "id": "H3",
          "hypothesisIndex": 3
        },
        {
          "id": "H4",
          "hypothesisIndex": 2
        },
        {
          "id": "H5",
          "hypothesisIndex": 4
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing is accompanied by a progressive loss of protein homeostasis and an accumulation of damaged or aggregation-prone proteins. Mild perturbations of cellular physiology can trigger adaptive responses that increase stress resistance and extend lifespan in several species. Effective removal of damaged proteins is thought to contribute to these benefits, but the responsible transcriptional programs and degradation machinery are incompletely understood. It also remains unclear which components are causally required to connect such adaptive stress responses to improved proteostasis and longevity.\n\nRESEARCH QUESTION\nWhich molecular mechanism enables mild cellular stress to preserve protein homeostasis during ageing and extend organismal lifespan?\n\nHYPOTHESES\n[H1] Transient, mild proteasome inhibition extends adult C. elegans lifespan by triggering a compensatory SKN-1A-dependent increase in proteasome capacity. The resulting degradation of soluble damaged proteins prevents their subsequent aggregation during ageing. Mechanism: Proteasome stress promotes DDI-1-dependent processing of the endoplasmic-reticulum-associated transcription factor SKN-1A, inducing proteasome subunits and increasing assembled, active proteasomes after the stress ends. Prediction: Following inhibitor washout, stressed animals show faster turnover of pre-existing proteasome substrates before aggregate burden declines. Adult-specific loss of SKN-1A or DDI-1 eliminates this turnover increase and longevity benefit; processed SKN-1A bypasses DDI-1 loss.\n\n[H2] Mild heat stress preserves proteostasis and extends lifespan in Caenorhabditis elegans by activating an HSF-1-dependent selective autophagy program. Induction of the cargo receptor SQST-1 is required to connect the stress response to removal of aggregation-prone proteins. Mechanism: HSF-1 increases sqst-1 transcription; SQST-1 captures ubiquitinated damaged proteins and binds LGG-1 on autophagosomes, delivering the cargo to lysosomes for degradation. Prediction: Disrupting the stress-responsive HSF-1 binding site in the sqst-1 promoter abolishes stress-induced aggregate clearance and lifespan extension while preserving chaperone induction. Stress-independent expression of wild-type SQST-1 restores both benefits, whereas variants defective in ubiquitin or LGG-1 binding do not.\n\n[H3] Mild heat stress extends C. elegans lifespan through an HSF-1-dependent chaperone-to-proteasome triage pathway. Longevity requires selective destruction of irreversibly misfolded proteins, beyond the protection supplied by chaperone-mediated refolding. Mechanism: Induced HSP-70 binds damaged proteins and recruits the CHIP orthologue CHN-1, which ubiquitinates clients that fail to refold and directs them to the proteasome. Prediction: A CHN-1 variant that retains HSP-70 binding but lacks ubiquitin-ligase activity preserves initial chaperone-dependent stress protection yet eliminates accelerated damaged-client turnover and lifespan extension. Wild-type CHN-1 restores these effects without requiring increased bulk proteasome abundance.\n\n[H4] Mild energetic stress preserves proteostasis and extends C. elegans lifespan by activating an AAK-2–HLH-30 transcriptional program that restores lysosomal degradative capacity. Increased lysosomal acidification, rather than increased autophagosome formation alone, is the limiting causal step. Mechanism: AMP-activated protein kinase AAK-2 reduces TORC1 signaling, promoting nuclear accumulation of HLH-30 and expression of lysosomal acidification and proteolysis genes. Acidic, protease-active lysosomes complete degradation of damaged proteins delivered by autophagy. Prediction: Adult-specific attenuation of HLH-30-dependent lysosomal acidification abolishes stress-induced cargo degradation and lifespan extension despite maintained autophagosome production. Constitutively nuclear HLH-30 bypasses AAK-2 loss but fails to restore benefits when lysosomal acidification remains impaired.\n\n[H5] Mild mitochondrial stress preserves cytosolic proteostasis and extends C. elegans lifespan by inducing ATFS-1-dependent mitochondrial quality control coupled to PINK-1/PDR-1-mediated mitophagy. Removing damaged mitochondria reduces the continuing production of oxidatively damaged proteins. Mechanism: Transient mitochondrial import impairment allows ATFS-1 to accumulate in the nucleus and induce mitochondrial repair and quality-control genes. PINK-1 and PDR-1 then target persistently dysfunctional mitochondria for autophagic removal, lowering mitochondrial oxidant production and subsequent cytosolic protein damage. Prediction: Adult-specific pink-1 or pdr-1 loss preserves ATFS-1 target induction but prevents the sustained reduction in mitochondrial oxidants, cytosolic protein oxidation, and mortality. Pulse-chase measurements show reduced formation of newly damaged cytosolic proteins without a comparable increase in clearance of pre-existing cytosolic aggregates.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5600,
          "promptSha256": "1211dccc83740805773588e274165043b45f824d6cfc117e768c34eb8d9e645c"
        }
      ]
    },
    {
      "task": "R42669067",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 3
        },
        {
          "id": "H2",
          "hypothesisIndex": 2
        },
        {
          "id": "H3",
          "hypothesisIndex": 4
        },
        {
          "id": "H4",
          "hypothesisIndex": 1
        },
        {
          "id": "H5",
          "hypothesisIndex": 0
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nCellular senescence is an irreversible growth-arrest state that contributes to ageing and age-related pathology. Senescent cells undergo changes in genome organization and can activate normally repressed repetitive DNA elements. Such activation may compromise genome stability and provoke inflammatory signaling. The regulatory mechanisms that preserve repeat silencing and thereby limit senescence remained incompletely understood.\n\nRESEARCH QUESTION\nHow does SIRT1 regulate L1 retrotransposon activity, and does this regulation affect cellular senescence?\n\nHYPOTHESES\n[H1] SIRT1 limits L1 activity after transcription by promoting autophagic clearance of L1 ribonucleoprotein complexes, reducing genome damage and senescence. Mechanism: SIRT1-dependent activation of autophagy accelerates turnover of L1 RNA–protein complexes, limiting their persistence and downstream DNA synthesis. Prediction: SIRT1 activity reduces L1 protein abundance, ribonucleoprotein persistence, and L1-associated DNA damage without substantially changing nascent L1 transcription. Disruption of autophagic clearance abolishes these effects and the accompanying reduction in senescence.\n\n[H2] SIRT1 preserves long-term L1 repression by supporting maintenance DNA methylation at L1 promoters, thereby delaying senescence during repeated cell division. Mechanism: SIRT1 sustains DNMT1 recruitment or retention at L1 DNA, preventing replication-associated loss of promoter methylation and subsequent L1 derepression. Prediction: SIRT1 deficiency causes progressive L1 promoter demethylation across cell divisions, followed by increased L1 transcription. Preserving promoter methylation prevents L1 activation and reduces senescence despite SIRT1 loss, whereas DNMT1 deficiency eliminates SIRT1-dependent protection.\n\n[H3] SIRT1-mediated L1 repression primarily restrains the inflammatory phenotype of senescent cells rather than preventing their initial growth arrest. Mechanism: Reduced L1 expression limits accumulation of reverse-transcribed L1 DNA in the cytoplasm, decreasing cGAS–STING signaling and the senescence-associated secretory phenotype. Prediction: In already senescent cells, restoring SIRT1 or selectively suppressing L1 decreases cytoplasmic L1 DNA and inflammatory secretion without restoring proliferation. Disabling cGAS–STING removes the additional anti-inflammatory benefit of L1 suppression while leaving upstream L1 abundance largely unchanged.\n\n[H4] SIRT1 maintains L1 silencing through SUV39H1-dependent heterochromatin formation, and disruption of this pathway promotes cellular senescence. Mechanism: SIRT1-dependent deacetylation supports SUV39H1 activity, maintaining H3K9 trimethylation and HP1 occupancy at L1 loci. Prediction: SIRT1 loss reduces L1-associated H3K9 trimethylation and HP1 occupancy before L1 activation. Restoring SUV39H1-dependent repression suppresses L1 expression and delays senescence despite continued SIRT1 deficiency, while SUV39H1 deficiency prevents SIRT1 from providing these benefits.\n\n[H5] SIRT1 directly represses L1 transcription by deacetylating histones at L1 promoters, thereby limiting L1-dependent DNA damage and senescence initiation. Mechanism: Promoter-associated SIRT1 removes activating histone acetylation, reduces chromatin accessibility, and suppresses transcription of intact L1 elements. Prediction: Loss of SIRT1 increases promoter acetylation and nascent L1 transcription before senescence develops. Catalytically active SIRT1 restores repression, whereas catalytically inactive SIRT1 does not; selective L1 suppression partially prevents the subsequent stable growth arrest.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 4268,
          "promptSha256": "a0d3a055562e4614571e2f566b05c80dcae24772262d1e2873396e00825538d2"
        }
      ]
    },
    {
      "task": "R42811065",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 4
        },
        {
          "id": "H2",
          "hypothesisIndex": 0
        },
        {
          "id": "H3",
          "hypothesisIndex": 1
        },
        {
          "id": "H4",
          "hypothesisIndex": 3
        },
        {
          "id": "H5",
          "hypothesisIndex": 2
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nChronic stress can disrupt bone remodeling and promote osteoporosis through sustained sympathetic nervous system activity. Cellular senescence within the bone marrow microenvironment can impair regenerative functions and contribute to reduced bone formation. Neural and endocrine signals are therefore plausible links between psychological stress and deterioration of skeletal health. However, the local mediator responsible for stress-induced senescence and the mechanism by which peripheral stimulation could restore osteogenesis were unresolved.\n\nRESEARCH QUESTION\nWhich local mechanism connects stress-induced sympathetic activity to cellular senescence and impaired osteogenesis, and can it be modulated non-invasively?\n\nHYPOTHESES\n[H1] Stress-induced sympathetic activity suppresses protective calcitonin gene-related peptide release from marrow sensory fibers, allowing osteogenic progenitors to become senescent. Non-invasive stimulation of the corresponding peripheral sensory nerve restores osteogenesis by replenishing local peptide signaling. Mechanism: Norepinephrine inhibits sensory-terminal peptide release through presynaptic α2-adrenergic receptors. Loss of CGRP signaling through stromal CALCRL–RAMP1 receptors weakens mitochondrial antioxidant defenses, increasing DNA damage and stable cell-cycle arrest. Prediction: Peripheral sensory stimulation restores marrow CGRP and osteogenesis even when norepinephrine remains elevated, but its benefit disappears after stromal Ramp1 deletion. Local CGRP replacement mimics stimulation, and sensory-neuron-specific disruption of inhibitory α2-adrenergic signaling prevents the stress-induced CGRP decline.\n\n[H2] Stress-induced norepinephrine release directly drives senescence in bone marrow mesenchymal stromal cells through β2-adrenergic receptors. Non-invasive transcutaneous peripheral nerve stimulation restores osteogenesis by reducing local norepinephrine exposure. Mechanism: Persistent β2-adrenergic signaling increases mitochondrial reactive oxygen species and DNA damage, activating p53–p21-dependent stable cell-cycle arrest and reducing osteoblast differentiation. Prediction: Inducible stromal-cell-specific Adrb2 deletion prevents stress-induced senescence despite elevated marrow norepinephrine. Peripheral stimulation lowers marrow norepinephrine and protects control animals, whereas local norepinephrine replacement abolishes protection only when stromal β2-adrenergic receptors remain intact.\n\n[H3] Sympathetic activity induces a marrow macrophage inflammatory relay that causes neighboring osteogenic progenitors to become senescent. Transcutaneous peripheral nerve stimulation protects osteogenesis by interrupting this relay. Mechanism: Sustained adrenergic exposure promotes macrophage mitochondrial damage and NLRP3 inflammasome activation; released IL-1β induces oxidative stress and persistent cell-cycle arrest in stromal progenitors. Prediction: Macrophage-specific Nlrp3 deletion or stromal-cell-specific Il1r1 deletion prevents progenitor senescence without lowering marrow norepinephrine. Local IL-1β replacement reverses the benefit of peripheral stimulation, and conditioned medium from stressed macrophages induces senescence only when recipient stromal cells retain IL-1R1.\n\n[H4] Sympathetic activity amplifies glucocorticoid action within the marrow by increasing stromal 11β-hydroxysteroid dehydrogenase type 1 activity. Peripheral nerve stimulation prevents senescence by reducing this local steroid amplification. Mechanism: Adrenergic induction of HSD11B1 increases conversion of inactive glucocorticoids to active hormones within stromal cells; sustained glucocorticoid receptor activation impairs mitochondrial function and promotes senescence and loss of osteogenic competence. Prediction: Stromal Hsd11b1 deletion prevents stress-induced senescence when circulating glucocorticoid concentrations and marrow norepinephrine are matched. Local delivery of active glucocorticoid, but not its inactive precursor, bypasses this deletion and reverses protection from peripheral stimulation.\n\n[H5] Sympathetic vasoconstriction causes recurrent marrow hypoperfusion and reoxygenation, which drive osteogenic progenitor senescence. Non-invasive peripheral nerve stimulation restores bone formation by normalizing marrow perfusion. Mechanism: Norepinephrine activates α1-adrenergic receptors on marrow vascular mural cells, producing oxygen fluctuations that damage progenitor mitochondria and trigger a persistent DNA-damage response. Prediction: Measured perfusion and oxygen fluctuations precede progenitor senescence. Selective interruption of mural-cell α1-adrenergic signaling protects osteogenesis despite persistent sympathetic activity, while experimentally maintaining marrow hypoperfusion eliminates the protective effect of peripheral stimulation.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5491,
          "promptSha256": "4f6caca220ffb801dc4d5d944f66095cbef1be757c466cfcd3b432360dfda4fb"
        }
      ]
    },
    {
      "task": "R42841610",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 2
        },
        {
          "id": "H2",
          "hypothesisIndex": 4
        },
        {
          "id": "H3",
          "hypothesisIndex": 3
        },
        {
          "id": "H4",
          "hypothesisIndex": 0
        },
        {
          "id": "H5",
          "hypothesisIndex": 1
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAgeing commonly causes a progressive loss of skeletal muscle mass, strength and regenerative capacity known as sarcopenia. Mitochondrial respiratory dysfunction is a prominent feature of ageing muscle and is associated with cellular senescence. Senescent cells undergo extensive metabolic changes that may compromise tissue function. However, the causal metabolic processes connecting senescence to mitochondrial impairment and functional muscle decline remained incompletely understood.\n\nRESEARCH QUESTION\nWhat causal metabolic mechanism links cellular senescence to mitochondrial dysfunction and functional decline in ageing skeletal muscle, and can this mechanism be therapeutically reversed?\n\nHYPOTHESES\n[H1] Senescent muscle-resident cells suppress mitochondrial pyruvate oxidation in neighboring myofibers through persistent induction of pyruvate dehydrogenase kinases. Restoring pyruvate dehydrogenase activity reverses a substrate-utilization defect and improves muscle performance. Mechanism: Senescence-associated signals increase pyruvate dehydrogenase kinase activity, maintaining inhibitory phosphorylation of pyruvate dehydrogenase. Reduced glucose-derived acetyl-CoA entry into the tricarboxylic acid cycle limits oxidative ATP production despite initially preserved respiratory-chain capacity. Prediction: Affected muscle shows reduced glucose-derived carbon entry into the tricarboxylic acid cycle but relatively preserved respiration with substrates that bypass pyruvate dehydrogenase. Muscle-specific suppression of the induced kinase restores glucose oxidation and fatigue resistance while senescent-cell burden remains unchanged.\n\n[H2] Senescence impairs lysosomal iron recycling, generating mitochondrial iron overload that drives respiratory dysfunction and muscle decline. Correcting iron distribution reverses the metabolic defect without requiring senescent-cell clearance. Mechanism: Defective ferritin turnover and intracellular iron trafficking increase redox-active iron in mitochondria. Iron-catalyzed lipid oxidation damages cardiolipin and respiratory complexes, reducing ATP production and compromising muscle-cell survival and repair. Prediction: Compartment-resolved measurements reveal increased mitochondrial labile iron and oxidized cardiolipin before loss of respiratory capacity. Selectively normalizing mitochondrial iron restores respiration and muscle force despite persistent senescence markers; correcting total tissue iron without correcting mitochondrial iron fails to rescue.\n\n[H3] Senescence creates excessive polyamine oxidation in skeletal muscle, producing reactive aldehydes that damage mitochondrial proteins. Inhibiting this metabolic branch after dysfunction develops restores mitochondrial activity and regenerative capacity. Mechanism: Increased spermine oxidase activity converts spermine to spermidine while generating hydrogen peroxide and 3-aminopropanal. These products promote oxidative damage and aldehyde adduct formation on mitochondrial proteins, impairing respiration in myofibers and satellite-cell progeny. Prediction: Senescent muscle exhibits increased polyamine oxidation flux and mitochondrial aldehyde adducts before respiratory decline. Genetic suppression of spermine oxidase restores respiration and regeneration; replacing spermidine alone does not reproduce the rescue, whereas restoring the implicated oxidation products eliminates it.\n\n[H4] Senescent cells drive skeletal-muscle dysfunction by increasing CD38-dependent NAD+ consumption in the local tissue environment. Restoring muscle NAD+ availability reverses mitochondrial impairment and improves strength even before senescent-cell abundance declines. Mechanism: Senescence-associated inflammatory signals induce CD38 in muscle-resident immune cells, increasing NAD+ turnover and limiting NAD+ availability in neighboring myofibers. Reduced mitochondrial NAD+ compromises oxidative metabolism and SIRT3-dependent maintenance of mitochondrial enzymes. Prediction: After muscle dysfunction is established, immune-cell-specific CD38 inhibition restores myofiber mitochondrial NAD+, ATP-linked respiration and specific force despite persistent senescence markers. Preventing mitochondrial NAD+ replenishment abolishes this rescue, distinguishing NAD+ depletion from a purely inflammatory mechanism.\n\n[H5] Senescence redirects sphingolipid metabolism toward excess ceramide production, which directly impairs muscle mitochondrial membranes and respiration. Reducing the responsible ceramide species reverses mitochondrial dysfunction and muscle weakness. Mechanism: Senescence increases ceramide synthesis or sphingomyelin breakdown in muscle-resident cells. Accumulation of specific long-chain ceramides in myofiber mitochondria disrupts inner-membrane organization, increases electron leakage and decreases ATP production. Prediction: Selective suppression of the ceramide-producing enzyme identified by lipid tracing lowers mitochondrial ceramide and restores respiration and specific force without first restoring NAD+ or reducing senescent-cell numbers. Reintroducing the implicated ceramide species abolishes the rescue, whereas an unrelated sphingolipid does not.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5840,
          "promptSha256": "28da7a0c4c423ea5c90e9c41ad5545f8ae91609ceb295cc802b71bef6007cdd4"
        }
      ]
    },
    {
      "task": "R42806003",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 4
        },
        {
          "id": "H2",
          "hypothesisIndex": 2
        },
        {
          "id": "H3",
          "hypothesisIndex": 0
        },
        {
          "id": "H4",
          "hypothesisIndex": 1
        },
        {
          "id": "H5",
          "hypothesisIndex": 3
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nAdvanced maternal age is associated with placental dysfunction, impaired fetal growth, and increased risks to offspring health. Ageing tissues commonly exhibit metabolic disruption, chronic inflammation, and accumulation of senescent cells with a senescence-associated secretory phenotype. The placenta contains interacting maternal and fetal compartments whose metabolic state and inflammatory environment influence pregnancy outcomes. However, the causal processes through which maternal ageing induces placental senescence and developmental complications remained unclear.\n\nRESEARCH QUESTION\nWhat intercellular mechanism causes placental senescence during maternal ageing, and can disrupting this mechanism restore placental and offspring health?\n\nHYPOTHESES\n[H1] Senescent maternal decidual stromal cells release excess TGF-β that induces senescence and dysfunction in fetal placental endothelial cells, creating hypoxia that subsequently drives trophoblast senescence. Blocking endothelial TGF-β signalling should interrupt this amplification loop and improve fetal growth and later offspring vascular health. Mechanism: Maternal TGF-β activates endothelial TGF-β receptor–SMAD signalling, restricting placental vascular expansion; reduced oxygen delivery then causes trophoblast mitochondrial stress and persistent DNA damage. Prediction: Endothelial senescence and perfusion defects should precede trophoblast senescence. Fetal endothelial-specific TGF-β receptor disruption should restore oxygen delivery and prevent downstream trophoblast senescence despite continued maternal TGF-β production, whereas trophoblast-specific receptor disruption should provide substantially less protection.\n\n[H2] Age-related glycolytic reprogramming in maternal decidual stromal cells produces excessive lactate that drives premature senescence in adjacent trophoblast progenitors. Reducing maternal lactate export or trophoblast lactate uptake should restore placental development and offspring growth. Mechanism: Stromal lactate export and trophoblast uptake increase histone lactylation at inflammatory and senescence-associated loci, stabilizing a pathological transcriptional programme. Prediction: Maternal stromal lactate should contribute directly to trophoblast histone lactylation before senescence develops. Blocking stromal lactate export should protect trophoblasts, and pH-controlled lactate replacement should restore senescence only when trophoblast lactate uptake remains functional.\n\n[H3] Maternal ageing increases CD38-dependent NAD+ consumption in decidual macrophages, causing them to release IL-1β that induces premature senescence in fetal trophoblast progenitors. Interrupting macrophage NAD+ depletion or trophoblast IL-1 signalling should preserve placental function and improve offspring growth. Mechanism: Macrophage NAD+ depletion impairs mitochondrial function and promotes inflammasome-dependent IL-1β secretion; trophoblast IL-1 receptor activation sustains oxidative stress and a senescence-associated secretory phenotype. Prediction: Macrophage-specific CD38 loss and trophoblast-specific IL-1 receptor loss should each reduce premature trophoblast senescence in aged pregnancies. Restoring IL-1β should reverse protection from macrophage CD38 loss but not from trophoblast receptor loss, establishing the proposed signalling order.\n\n[H4] Senescent maternal decidual stromal cells transmit mitochondrial DNA to fetal trophoblasts through extracellular vesicles, activating trophoblast DNA sensing and secondary senescence. Disrupting this transfer should improve placental nutrient transport and fetal development despite persistent maternal stromal senescence. Mechanism: Vesicle-associated mitochondrial DNA reaches the trophoblast cytosol and activates cGAS–STING signalling, producing inflammatory transcription and persistent cellular stress. Prediction: Vesicles from aged decidual stromal cells should induce senescence in young trophoblasts, whereas otherwise comparable vesicles depleted of mitochondrial DNA should not. Trophoblast-specific cGAS loss should block the effect while leaving responses to soluble inflammatory cytokines intact.\n\n[H5] Maternal ageing impairs decidual natural killer cell clearance of senescent fetal trophoblasts, allowing these cells to accumulate and propagate senescence through their secretory phenotype. Restoring selective immune clearance should improve placental function and offspring outcomes. Mechanism: Reduced NKG2D-dependent recognition of stressed trophoblasts decreases their removal; surviving senescent cells release factors that induce secondary senescence in neighbouring trophoblast progenitors. Prediction: Aged and young pregnancies should initially generate comparable numbers of senescent trophoblasts, but aged pregnancies should show slower clearance. Restoring natural killer cell recognition should shorten senescent-cell persistence and suppress secondary senescence, with protection lost when trophoblast recognition ligands are absent.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5667,
          "promptSha256": "ec31dca1df6d328cf8a5f8f9777c966c2dfe3df71e82caa8561df75098e46be0"
        }
      ]
    },
    {
      "task": "R42806572",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 0
        },
        {
          "id": "H2",
          "hypothesisIndex": 4
        },
        {
          "id": "H3",
          "hypothesisIndex": 1
        },
        {
          "id": "H4",
          "hypothesisIndex": 3
        },
        {
          "id": "H5",
          "hypothesisIndex": 2
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nSenescent cells accumulate with age and can promote tissue dysfunction through persistent inflammatory and remodeling signals. Experimental removal of these cells can improve several age-related phenotypes, supporting cellular senescence as a causal contributor to declining health. Immune-mediated senolysis offers a way to eliminate selected senescent cells, but differences between therapeutic and toxic exposure can complicate translation. A major open problem is whether an externally controllable treatment can achieve effective senolysis in both rodents and primates while providing a practical marker of emerging toxicity.\n\nRESEARCH QUESTION\nCan a dose-titratable immune engager safely eliminate senescent cells and alleviate age-related pathology across mice and non-human primates, and what measurement can guide its safe dosing?\n\nHYPOTHESES\n[H1] A soluble uPAR×CD3 bispecific immune engager can selectively eliminate uPAR-high senescent cells in aged mice and non-human primates within an exposure range that spares essential nonsenescent cells. Mechanism: Simultaneous binding to uPAR on target cells and CD3 on T cells triggers cytotoxic synapses preferentially above a target-antigen density threshold. Dose titration exploits a proposed difference in uPAR density between senescent cells and healthy tissues. Prediction: Both species show an exposure interval with loss of independently verified senescent cells and preserved healthy tissue function. Target blockade or a CD3-binding-deficient engager abolishes killing; equivalent killing of uPAR-low healthy cells would contradict the proposed selectivity.\n\n[H2] The early post-dose rise in circulating interleukin-6 can guide safer dosing by identifying excessive immune activation before overt organ injury develops. Mechanism: Engager-driven T-cell activation recruits a secondary myeloid inflammatory response that releases interleukin-6. An excessive or sustained increase signals that immune activation has exceeded the exposure needed for selective senolysis. Prediction: In each species, baseline-adjusted interleukin-6 trajectories prospectively predict subsequent clinical or biochemical toxicity beyond drug exposure and baseline inflammation. A prespecified dose-holding rule based on this measurement reduces toxicity while preserving senescent-cell clearance compared with fixed dosing; elevations restricted to effective, nontoxic treatment would invalidate its proposed discriminatory value.\n\n[H3] Intermittent exposure to a rapidly cleared immune engager preserves senolytic efficacy while reducing systemic toxicity relative to continuous exposure in both species. Mechanism: Brief exposure commits target cells to apoptosis, whereas sustained exposure prolongs T-cell activation and cytokine production. Drug clearance therefore terminates further immune recruitment after sufficient target killing has occurred. Prediction: At comparable senescent-cell depletion, intermittent treatment produces less sustained cytokine elevation and organ injury than continuous treatment. T-cell activation declines after withdrawal; persistent activation despite drug clearance would undermine external controllability.\n\n[H4] Cross-species senolytic efficacy is determined primarily by tissue antigen density, engager target occupancy, and local T-cell availability rather than administered dose per kilogram. Mechanism: These variables jointly determine productive cytotoxic synapse formation, while species differences in clearance and binding affinity alter the exposure required to achieve it. Prediction: With species-reactive reagents and measured binding affinities, senescent-cell depletion in mice and primates follows a shared relationship with target occupancy and local effector-to-target ratio more closely than with dose per kilogram. Persistent species differences after matching these variables would argue against this mechanism.\n\n[H5] Engager-mediated removal of senescent stromal cells improves age-related tissue dysfunction by durably reducing their inflammatory and profibrotic secretions. Mechanism: Eliminating the cellular source of the senescence-associated secretory phenotype reduces recruitment of inflammatory cells and activation of matrix-producing fibroblasts, allowing tissue remodeling to subside. Prediction: In aged mice and primates with baseline fibrotic pathology, verified stromal-cell depletion precedes reduced tissue inflammatory signaling, reduced collagen accumulation, and improved organ function after drug washout. A binding-matched engager unable to recruit T cells fails to reproduce these benefits, distinguishing clearance from target-receptor blockade.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5314,
          "promptSha256": "f71590c1662fdf5e9c0654e52d4cc42d8a47ecde134f569c4d49013dd3fb18bc"
        }
      ]
    },
    {
      "task": "R42748238",
      "generator": "gpt-6-astra",
      "arm": "N",
      "mapping": [
        {
          "id": "H1",
          "hypothesisIndex": 0
        },
        {
          "id": "H2",
          "hypothesisIndex": 4
        },
        {
          "id": "H3",
          "hypothesisIndex": 3
        },
        {
          "id": "H4",
          "hypothesisIndex": 2
        },
        {
          "id": "H5",
          "hypothesisIndex": 1
        }
      ],
      "requests": [
        {
          "protocol": "direct-confirmation-grok-v2",
          "system": "Return a JSON object.\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now.",
          "user": "For each hypothesis below, will it be confirmed experimentally?\n\nBACKGROUND\nMicrovascular function declines with age, impairing tissue perfusion, nutrient delivery, and waste clearance. Vascular deterioration is associated with dysfunction across multiple organs and with increased frailty and mortality. Cellular senescence and altered metabolic homeostasis are recognized contributors to age-related tissue decline. However, the molecular mechanism by which vascular aging can drive organism-wide aging and shorten lifespan remained unclear.\n\nRESEARCH QUESTION\nWhat molecular mechanism causes age-related vascular deterioration to promote systemic senescence and shorten lifespan?\n\nHYPOTHESES\n[H1] Ageing endothelial cells increase CD38-dependent degradation of extracellular NAD+ precursors, limiting NAD+ replenishment in surrounding tissues. The resulting loss of sirtuin activity drives systemic senescence and shortens lifespan. Mechanism: Increased endothelial CD38 activity reduces extracellular nicotinamide mononucleotide availability, lowering parenchymal NAD+ and compromising SIRT1-dependent DNA repair and SIRT3-dependent mitochondrial protection. Prediction: Endothelial-specific CD38 deletion in aged mice would restore precursor availability and tissue NAD+, reduce senescence across organs, and extend survival despite persistent capillary rarefaction; disrupting NAD+ salvage in recipient tissues would abolish this protection.\n\n[H2] Age-related endothelial barrier failure permits fibrinogen leakage and persistent extravascular fibrin deposition, activating tissue macrophages that propagate senescence. Chronic activation of this vascular–immune circuit accelerates organ dysfunction and shortens lifespan. Mechanism: Deposited fibrin engages macrophage CD11b/CD18, promoting oxidant and inflammatory cytokine production that induces persistent DNA damage and senescence in neighbouring cells across affected organs. Prediction: Selectively blocking fibrin engagement of CD11b/CD18 while preserving coagulation would reduce macrophage activation, tissue senescence, and mortality despite continued vascular leakage; senescence would spatially track fibrin deposits and activated macrophages.\n\n[H3] Ageing endothelial cells release extracellular vesicles enriched in miR-34a that transmit a senescence programme to distant tissues. Suppression of recipient-cell SIRT1 converts local vascular deterioration into systemic tissue dysfunction and shortened lifespan. Mechanism: Endothelial vesicles deliver functional miR-34a to parenchymal cells, repressing SIRT1 translation and increasing p53 acetylation, persistent cell-cycle arrest, and secondary inflammatory secretion. Prediction: Selective depletion of endothelial vesicular miR-34a would reduce distant tissue senescence and extend survival without improving perfusion; recipient cells carrying a miR-34a-resistant SIRT1 transcript would resist aged endothelial vesicles.\n\n[H4] Microvascular rarefaction causes recurrent tissue hypoxia and reoxygenation, generating mitochondrial oxidative damage that establishes senescence across multiple organs. Accumulation of these senescent cells progressively reduces organ reserve and shortens lifespan. Mechanism: Unstable oxygen delivery produces mitochondrial reactive oxygen species and persistent nuclear DNA damage, activating p53–p21 and p16–RB pathways in affected parenchymal and stromal cells. Prediction: Senescence would arise preferentially in regions with documented oxygen fluctuations, and stabilizing tissue oxygenation would reduce DNA damage, senescence, and mortality even if the endothelial inflammatory secretome remained elevated.\n\n[H5] Age-related mitochondrial damage activates endothelial cGAS–STING signalling, producing circulating inflammatory signals that induce senescence in distant organs. This endothelial inflammatory programme contributes to shortened lifespan independently of impaired perfusion. Mechanism: Mitochondrial DNA released into the endothelial cytosol activates cGAS–STING and downstream inflammatory transcription, increasing type I interferon and senescence-associated secretory signals that sustain stress responses in recipient cells. Prediction: Endothelial-specific STING deletion would reduce circulating inflammatory activity, distant tissue senescence, and mortality without restoring capillary density or tissue oxygenation; plasma from these animals would lose its ability to induce senescence in recipient cells.\n\nReturn a JSON object with a \"forecasts\" array. For each hypothesis include its \"id\" and a boolean \"confirmed\".\n\nYou have no tools, no files and no internet access. Give your complete final answer in this single reply, in the requested format. Never describe what you are going to do; do it now. Your reply must start with { and be only the JSON object.",
          "candidateIds": [
            "H1",
            "H2",
            "H3",
            "H4",
            "H5"
          ],
          "promptChars": 5052,
          "promptSha256": "a811b43cb70ac110195ef092be98fbf34d1b8d9d0a5057f2cb50aec0538219b6"
        }
      ]
    }
  ]
}
